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Introduction
 Systems biology is a reemerging discipline. Its origins are found in Ludwig von Ber-
talanffy’s general system theory, which eschews reductionism and treats the organism 
thermodynamically as an open system. A good exposition of this approach is con-
tained in his compendium  [1] , which is still relevant. 
 Although general system theory had a significant impact on various disciplines, 
notably informatics, its consideration in biology, from which it sprung, waned. Sys-
tems biology rose again on this substratum around the year 2000. A significant im-
petus for this was the development of various ‘-omics’, with their capability of gener-
ating vast datasets pertaining to cell and organism behavior. The majority of efforts 
have since been devoted to the generation of networks, and layers of networks, to de-
duce the multiple interactions of the variables in these datasets.
 Another antecedent to the current systems biology is the work of mathemati-
cal biologists, whose efforts to model biological processes dynamically feature 
importantly in some ‘strains’ of systems biology. Metabolic control analysis 
comes to mind immediately, as does the literature on the mathematical modeling 
of the cell cycle. These modeling approaches often incorporate nonlinear func-
tions, and they frequently take into account stochastic elements. These facets are 
kindred to the consequences of the interaction between components of a system 
in general system theory. The efforts of both the network systems biologists and 
the dynamic systems biologists should be juxtaposed to the work of bioinforma-
ticians, who devise methods for manipulating large datasets and cataloging their 
features.
 The systems biology of aging has an even more recent history, although the rele-
vance of the systems approach to aging was already heralded in 1996  [2] . The two sorts 
of systems biology referred to in the previous paragraph coincide roughly with bot-
tom-up and top-down approaches to the modeling of biological systems. A useful 
consideration of how these distinct approaches can be profitably integrated has been 
presented  [3] . Most efforts to date attempt to understand the aging process as a deter-
minant of longevity or demise. Little attention has been paid, however, to the emer-
gence of disease and dysfunction as a result of aging, or to the information this emer-
gence has on the biological aging process itself.
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 The initial idea for this monograph was to explore the frontiers of knowledge con-
necting aging and health, within a systems biology framework. The crucial impor-
tance of this approach lies in the possibility of improving population health by post-
poning aging or by slowing down individual aging rates. For various reasons, this idea 
was difficult to realize fully. One reason is that many aspects of the aging process 
remain unclear and continue to be under intense study, making a discussion of their 
connections to health perhaps premature. Another reason is that the systems biology 
of aging is a developing discipline as well, with many new ideas and methods still to 
appear and to evolve. These factors restricted the scope of this volume and focused it 
on the foundations and specific aspects of the systems biology of aging, with particu-
lar attention to the links between aging changes and diseases of the elderly where cor-
responding information is available.
 The first two chapters introduce the reader to network systems analysis. In the first 
one by Tarynn M. Witten, the author briefly addresses the history of systems biology 
and introduces the notion of complexity, which manifests itself through nonlinear dy-
namics, hierarchies and network analysis and can be used to study the intricate and 
fascinating behaviors of living systems. She suggests treating the biological organism 
as a network. Then, she explains how network mathematics (graph theory) can pro-
vide deeper insight and can even predict potential genes and proteins that are related 
to the control of organismal life span. The author reviews the history of network anal-
ysis at the cellular level and introduces various commonly used network variables. She 
shows how these variables can be used to predict potential targets for experimental 
analysis. She also discusses some of the challenges that network methods face.
 The second chapter by Christopher Wimble and Tarynn M. Witten applies the ideas 
and methods described in the first chapter to concrete examples, using  Saccharomyces 
cerevisiae and  Caenorhabditis elegans . The authors consider possible aging-related 
changes in a network, which include inactivation of active nodes/activation of inac-
tive nodes (e.g. genes) and loss of connectivity/increase in connectivity. The factors 
affecting these processes are not considered. The authors show that the network 
structure determines its vulnerability to possible targeted attacks. Attacks that knock 
out essential genes disrupt the life span network because the organism dies when an 
essential gene is knocked out. The authors believe that understanding patterns in net-
work decomposition could lead to early detection of potential neurodegenerative dis-
orders and to potential pharmaceutical intervention at earlier points of disease devel-
opment.
 The third chapter by  Mark Mc Auley  and Kathleen M. Mooney  focuses on the ap-
plication of computational systems biology in aging research starting with the ra-
tionale for using it for investigating the aging process. The authors discuss alterna-
tive theoretical frameworks that can be used to build models of the complex age-
related disorders associated with unhealthy aging. The chapter starts with the 
description of dynamic modeling using differential equations. Then, it incorporates 
aspects of network analysis and agent-based modeling. Computational modeling is 
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supposed to be an integral component of systems biology, amalgamating with the 
other techniques discussed in this book to quantitatively represent and simulate 
biological systems.
 The evolutionary theories of aging of biological systems are widely discussed in the 
literature  [4–11] . These theories claim that because aging is largely a postreproductive 
phenomenon, it should not evolve by natural selection.  Joshua Mitteldorf believes that 
aging could be advantageous for stability of ecosystems and hence can be the result 
of natural selection. The author pays attention to the fact that animals and plants have 
biological clocks that help to regulate circadian cycles, seasonal rhythms, growth, de-
velopment and sexual maturity. He puts forth the hypothesis that evolutionarily 
evolved aging is also clock driven. He focuses on the epigenetic process of DNA meth-
ylation, as a clock mechanism, and its relevance to stem cell aging, in particular, in 
his chapter. Research on the relationship between methylation and aging is still in an 
early stage, and it has not yet even been proven that alterations of the methylation state 
are a cause and not simply a product of aging. The hypothesis that the body’s age is 
stored within the cell nucleus as a methylation pattern suggests a program of research 
and an anti-aging strategy. If validated, this hypothesis would point to a challenging 
target for medical intervention. Recent results  [12] provide additional information for 
thinking in this direction.
 To what extent can insights derived from the systems biology of aging in animal 
model systems be applied to human aging?  Michael Rose  and his colleagues argue that 
systems biology of aging might have a different focus in two types of species. The au-
thors provide evolutionary arguments that aging processes taking place in species 
with rare sexual recombination are quite different from those in which it is frequent. 
In the species of first type, the systems biology of aging can focus on large-effect mu-
tants, transgenics, and combinations of such genetic manipulations. In frequently 
recombining species, the systems biology of aging can examine the genome-wide ef-
fects of selection.
 Many gerontologists have the strong belief that aging is nonprogrammed and pro-
vide arguments supporting this view  [13] . Many others provide arguments that aging 
is likely to be programmed  [14–16] . Further studies are needed to resolve the issue. 
 Bruno Cesar Feltes  and his colleagues  treat aging as a programmed process and con-
sider it as a continuation of developmental processes. To overcome environmental 
challenges, the embryo needs to adapt its metabolism in response to environmental 
fluctuations. Epigenetic programming is responsive to perturbations or imbalances 
of intrinsic and/or extrinsic factors experienced in utero. Immune system develop-
ment and aerobic respiration/glucose metabolism processes are modulated during 
early development. Small changes in developmental mechanisms and adult trait spec-
ification that occur during early development might result in significant morpho-
logical alterations during later stages. This can promote an adaptive response and 
influence gene expression patterns, leading to age-associated diseases, such as cancer, 
osteoporosis and the decline of the immune system. This concept underpins a net-
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work approach to aging that provides a framework for the appearance of diseases of 
aging.
 In the chapter that follows, Arnold Mitnitski  and Kenneth Rockwood describe the 
use of their frailty or deficit index to characterize the state of an aging human. This 
is a top-down approach that incorporates age-related disease and dysfunction into its 
derivation. The authors propose that the frailty index can be used as an indicator of 
an individual’s biological age. This index manifested reproducible properties includ-
ing nonlinear increase with increasing age, higher values in women, strong associa-
tion with mortality and other adverse outcomes, as well as other properties. Impor-
tantly, the authors employ a stochastic dynamics approach to model how the organ-
ism recovers as a function of age.
 Aging is associated with immunosenescence, and it is accompanied by a chronic 
inflammatory state which contributes to development of chronic conditions. The 
chapter by  Verónica Guarner  and Maria Esther Rubio-Ruiz  shows how low-grade sys-
temic inflammation may be the basis of multiple dysfunctions that evolve during ag-
ing, including metabolic syndrome, diabetes, and their cardiovascular consequences. 
Cardiovascular diseases and endothelial dysfunction are characterized by a chronic 
alteration of inflammatory function, markers of inflammation, and the innate im-
mune response. Inflammation may thus serve as the integrating factor that makes the 
frailty index a global measure of system function.
 Pharmacologic interventions are believed by many gerontologists as a possibility 
for slowing down or postponing individual aging processes. A widely discussed target 
for such interventions is the mTOR (mammalian target of rapamycin) nutrient re-
sponse pathway. In multicellular organisms, TOR regulates cell growth and metabo-
lism in response to nutrients, growth factors and cellular energy state. Deregulation 
of TOR signaling alters whole-body metabolism and causes age-related disease. The 
life-extending effects of dietary restriction in yeast, worms, flies and mice appear to 
be due largely to inhibition of TOR signaling. There is evidence that TOR may also 
control aging via modulation of stress-responsive genes and through autophagy. In-
hibition of this pathway extends life span in model organisms and confers protection 
against a growing list of age-related pathologies. In the next chapter,  Simon Johnson 
and his colleagues focus their attention on mTOR signaling. The authors inform that 
some medical interventions affecting this pathway are already clinically approved, 
and others are under development. Thus, targeting the mTOR pathway is a promising 
strategy for slowing down the aging rate and improving health of the elderly.
 In the following chapter,  Rüdiger Hardeland discusses melatonin as a systemic in-
tegrating agent that interfaces with the environment. A number of studies support the 
anti-aging properties of melatonin  [17, 18] . Melatonin is a derivative of the amino acid 
tryptophan and widely distributed in food sources, such as milk, almonds, bananas, 
beets, cucumbers, mustard, and tomatoes. In humans, melatonin is primarily synthe-
sized by the pineal gland, but it is also produced in the gastrointestinal tract and ret-
ina. Melatonin and its metabolites are potent antioxidants with anti-inflammatory, 
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hypotensive, cell communication-enhancing, cancer-fighting, brown fat-activating, 
and blood lipid-lowering effects, and thereby protecting tissues from a variety of in-
sults. Melatonin has been shown to support circadian rhythm, hormone balance, re-
productive health, cognition, mood, blood sugar regulation, and bone metabolism, 
while improving overall antioxidant status and lowering blood pressure. Melatonin 
may assist in preventing diabetic complications, and improving treatment outcomes 
in patients with cardiovascular disease and certain types of cancer. Consuming mel-
atonin neutralizes oxidative damage and delays the neurodegenerative process of ag-
ing  [19] .  Hardeland here shows that this chronobiotic impinges on multiple physio-
logic systems with implications for health and disease during aging. The chapter dis-
cusses the associations of the loss of melatonin secretion and rhythm amplitudes with 
aging and development of age-related diseases.
 It is well known that a diet rich in plant-based foods has many advantages in rela-
tion to the health and well-being of an individual. Much less known is the large con-
tribution of the gut microbiota to this effect.  Denise B. Lynch  and her colleagues ex-
pand the discussion of aging, health, and disease to encompass the gut microbiome 
and its mutual relationship with the host. This relationship goes beyond an uneasy 
symbiosis implicated in immune-related disorders because the host genome and the 
microbial ecosystem constitute a supergenome. Thus, this is more than an interaction 
of the host with the environment with significant consequences for healthy aging.
 The penultimate chapter by  Anuradha Chauhan  and colleagues serves as a coda. 
The authors reprise the history of the systems biology of aging and the different meth-
odological approaches it encompasses. They provide the rationale for using the meth-
ods of systems biology in the analyses of the aging of biological systems. They outline 
the main features of the methodology emphasizing that the structure and functions 
of the biological systems are investigated by analyzing experimental data through the 
use of sophisticated mathematical and computational tools, including advanced sta-
tistics, data mining, and mathematical modeling. The methodology also includes 
formulation of working hypotheses, designing new experiments able to prove these 
hypotheses, and developing computational tools with predictive ability in a biomedi-
cal environment. The authors provide several examples that make direct use of the 
system motifs introduced in previous chapters, and they point to the importance of 
expanding upon the rudimentary achievements of the systems biology of aging at the 
present time if we are to intervene in the appearance and progression of age-related 
disease. The authors believe that the optimal design of biomedical strategies to coun-
teract aging-associated pathologies will require the use of tools and strategies adapted 
from engineering.
 The final chapter by  Vladimir N. Anisimov addresses the issue of interventions 
raised again by  Chauhan and colleagues. He describes experimental studies evaluat-
ing effects of biguanides and rapamycin on survival and carcinogenesis in mice pay-
ing attention to similarity in the majority of effects of these drugs on patterns of 
changes observed during normal aging and in the process of carcinogenesis. Anisi-
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mov considers whether an antiaging drug is in hand, one that combats age-related 
disease. The conclusion is that promising leads may already be available.
 This book is bound to leave the reader unsatiated. The systems biology of aging is 
a new field. Although it is based on established methodologies, their application has 
been relatively limited to date. Furthermore, aging presents problems that are pecu-
liar to it. Some of these peculiarities derive from the forces underlying its evolution. 
Others are the result of its fundamentally stochastic nature and its heterogeneity 
among individuals. Its presentation as a set of multiple morbidities and comorbidities 
only adds to the difficulty. We expect that future research will make use of new con-
cepts and new tools to allow these aspects of aging to be adequately treated. Further-
more, we trust that this volume will stimulate such endeavors. 
S. Michal Jazwinski, New Orleans, La.
 Anatoliy I. Yashin, Durham, N.C. 
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 Abstract 
 This chapter will briefly address the history of systems biology and complexity theory and its use in 
understanding the dynamics of aging at the ‘omic’ level of biological organization. Using the idea of 
treating a biological organism like a network, we will examine how network mathematics, particu-
larly graph theory, can provide deeper insight and can even predict potential genes and proteins 
that are related to the control of organismal life span. We will begin with a review of the history of 
network analysis at the cellular level and follow that by an introduction to the various commonly 
used network analysis variables. We will then demonstrate how these variables can be used to pre-
dict potential targets for experimental analysis. Lastly, we will close with some of the challenges that 
network methods face.  © 2015 S. Karger AG, Basel 
 In this chapter, we will briefly address the history of systems biology and complex-
ity theory and their use in understanding the dynamics of aging at various levels of 
biological organization. Using the idea of treating a biological organism like a net-
work, we will examine how network mathematics, focusing on graph-theoretic 
methods, can provide deeper insight and can even predict potential genes and pro-
teins that are related to the control of organismal life span and perhaps even related 
to diseases associated with age-related changes within the organism or health span. 
We will begin with a review of the history of network analysis as related to the study 
of aging and follow that by an introduction to the various commonly used network 
analysis constructs. We will then demonstrate how these network variables can be 
used to further understand and possibly predict potential targets for experimental 
analysis. Lastly, we will close with some of the challenges that network methods face. 
 Introduction to the Theory of Aging 
Networks 
 Tarynn M. Witten  
 Center for the Study of Biological Complexity, Virginia Commonwealth University,  Richmond, Va. , USA 
2  Witten 
 Aging – being old – is defined both biologically and psychosocially  [1] , ‘The geri-
atric or elderly patient is defined as an individual whose biological age is advanced. 
By definition, such an individual has one or more diseases, one or more silent lesions 
in various organ systems.’ In addition, physiological changes affect the response to 
or handling of various medications. Social aspects of aging are also complex, and they 
include adapting to lessened physical capabilities and often to reduced income and 
to reduced social network support. For example, many older persons find themselves 
living alone after decades of marriage, partnership, and/or child rearing. Aging is an 
intricate spatial and temporal hierarchy of dynamic behaviors that are coupled to-
gether in a complex dance across the life span. Thus, aging is a complex, multidimen-
sional, hierarchical process not easily dissected into disjoint subprocesses. How then 
do we grapple with the problem of understanding such systems?
 In the Beginning: Reductionism 
 Historically, the pursuit of science has taken place by breaking objects apart and sub-
sequently trying to understand how the pieces work at increasingly smaller and small-
er levels of organization, the reductionist methodology. It was tacitly assumed that 
one could just glue the pieces back together and understand the behavior of the un-
broken original system. Reductionist methods have been and continue to be widely 
used to understand biological systems and their dynamics. For example, the early ge-
nomic studies of aging identified numerous single genes related to survival  [2] . If sur-
vival is related to ‘aging’ and the connections between genes/proteins are known, then 
perhaps networks of genes/proteins can be constructed that should predict other 
genes/proteins related to aging. If we understand how these genes and proteins func-
tion within an organism, then perhaps we can find ways to extend health span  [3] , 
control mortality and morbidity and better treat diseases associated more commonly 
found in elders of a population. Reductionist science has certainly yielded numerous 
insights into mechanisms underlying the processes of aging, the control of life span 
and the dynamics of age-related disease/decline in vitality. We now know many more 
genes and related proteins that appear to control or to be connected with these pro-
cesses and we have even identified network pathways of importance  [4] . Thus, reduc-
tionist approaches have led us part of the way down the path to understanding the 
processes of life span control. However, as we shall soon see, understanding these 
systems is not as straightforward as simply gluing genes together to form networks 
and subsequently gluing networks together to form the whole organism  [5] . 
 As we will be making use of a large number of terms, any number of which may 
be unfamiliar to the readers of this text. We begin by defining terms so that we may 
all begin with a uniform understanding of the chapter vocabulary and how these 
concepts apply to the study of biological systems as a whole and ‘aging’ in particu-
lar. We begin by defining the words ‘complex’ and ‘complicated’.
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 Introduction to the Theory of Aging Networks 3
 Is a System Complicated or Is It Complex? 
 The terms ‘complicated’ and ‘complex’ are frequently used interchangeably in much 
the same way that the words ‘sex’ and ‘gender’ are now assumed to be linguistically 
equivalent, though they refer to significantly different conceptual constructs. The 
same can be said about the words complicated and complex. Given that a system has 
many parts, a system is said to be  complicated if infinite knowledge of the behaviors 
of the system’s components allows an experimenter to predict all possible behaviors 
of the system. For example, a pocket watch would satisfy the complicated but not 
complex criteria. We can understand the behavior of all of the cogs, wheels and 
springs in the system and, with some effort, we can arrive at what would be consid-
ered reasonable inferences concerning what the watch does and how it works. Break-
ing apart an organism costs information about how the ‘whole’ organism functions. 
This begs the question of whether or not aging can even be reduced to discrete causes, 
or whether it involves a ‘complexity effect’ that no single part or collection of parts 
can fully explain. Systems that lose information in breaking them apart are called 
‘complex’ systems. But what does a complex system actually look like? What might 
its properties be? 
 Properties of Complex Systems 
 If we were to examine a large collection of different complex systems, we would find 
that complex systems have certain common or unifying characteristics: 
 • They demonstrate emergent behavior; behavior that cannot be inferred from a 
linear analysis of the behavior of the components. 
 • They contain many components that are dynamically interacting (feedback, 
 controllers, detectors, effectors and rules). There is no master controller. The 
parts interact extensively at their local level with nearest neighbors. 
 • The components are diverse, thereby leading to a significant diversity of infor-
mation in the system. 
 • The components have surrendered some of their uniqueness or identity to serve 
as elements of the complex system. This is called dissolvence. 
 • All interactions of the components within the system and the system acting as a 
component in a higher hierarchy occur locally. There is no action at a distance. 
 • These interactions take place across a number of scale levels, and they are 
 arranged in a hierarchical structure where fine structure (scale) influences 
 large-scale behavior. 
 • They are able to self-organize, to adapt and to evolve. 
 As we can see, complex systems have properties that we do not expect to see in a 
pocket watch. Complex systems possess additional properties (e.g. control features, 
feedback loops and branches) that add order, robustness and stability to the system. 
Complex systems also exhibit an ability to adapt (i.e. evolve) to changing conditions. 
For example, changes in one free radical-scavenging pathway can up- or downregu-
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late other pathways. Another way to think of complex systems is that they are systems 
in which the whole is greater than the sum of the parts  [6] . Why is this distinction 
important?
 One of the most important properties that distinguish complex systems from 
complicated systems is the property of emergence. Consider the following examples. 
Infinite knowledge of a single bird or fish would not allow an experimenter to predict 
the phenomena of swarming or schooling or the synchronization of firefly lights  [7] . 
Infinite knowledge of a single female’s menstrual cycle would not predict cycle lock-
ing in a college dorm room. These systems are termed complex  [8] . They have ‘emer-
gent properties’, meaning that a behavior that was not predicted from infinite knowl-
edge of the parts emerges as part of the system’s behaviors  [9] . Living systems, wheth-
er they are cells or ecosystems, do not function like pieces of a jigsaw puzzle. Instead, 
they are often fuzzy or stochastic, with backup systems and redundancies that belie 
their true structure. An examination of these systems requires a different conceptual 
framework. From a Positive Psychology perspective, Maddi  [10] makes the argument 
to ‘…consider creativity as behavior that is innovative…’. We could easily argue that 
innovative behavior is emergent behavior, and therefore creativity is an emergent and 
unpredictable process. Thus, in order to understand complex systems, we must un-
derstand them through a reverse engineering perspective rather than a reductionist 
perspective.
 Nonlinear Dynamics and Aging 
 By the early 1800s, studies of biological systems, ecosystems in particular, were ob-
served to demonstrate a variety of nonlinear behaviors; particularly oscillations, ap-
parently chaotic time series and radical behavioral changes that could not be explained 
by traditional reductionist constructs  [7] . From the early work of von Bertalanffy  [11] 
and many others emerged the concepts of systems dynamics and systems theory as 
applied to a variety of living systems. Very early on, ecologists saw the value of systems 
theoretic approaches in understanding the complex ecological systems with which 
they worked. However, it was not until the work of Rosen  [12] on MR systems and 
the subsequent work of May  [13] and others who began to write about simple nonlin-
ear models with complex dynamics (these are classic papers) that we began to see the 
emergence of previously described nonlinear phenomena such as chaos. 
 Nonlinear systems theory and multifractal analysis have already been used to un-
derstand fall safety in elders, frailty in the elderly, wandering in community-dwelling 
older adults, understanding interactions of geriatric syndromes and disease and in 
understanding the brain structures of Alzheimer patients. Network analytic methods 
have been used to construct longevity gene-protein networks and to predict potential 
gene targets of importance to longevity and perhaps to pharmacological intervention. 
Consequently, systems biology is now emerging as a powerful paradigm for under-
standing networks of longevity genes and proteins. With the sequencing of the human 
genome, massive amounts of data have been generated by the ‘omics’ disciplines over 
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the past twenty years; including genomics, proteomics, metabolomics, transcrip-
tomics, and interactomics. An excellent discussion of complex systems dynamics and 
nonlinear dynamics may be found in Strogatz  [7] .
 The application of the pantheon of mathematical and computational tools of sys-
tems biology has the potential to help transform the massive amounts of data into 
useful information that can be used to understand the biomedical processes associ-
ated with human disease and potentially how they relate to the dynamics of aging. By 
integrating omic data with the identification of critical networks and pathways associ-
ated with specific diseases of age and with vitality and longevity, greater understand-
ing of these biological processes can be achieved. This enhanced understanding can 
help biomedical researchers design new and better approaches to treat or to manage 
the diseases of age and to help develop strategies to promote enhanced vitality and 
longevity, what is more currently known as health span. As the ‘baby boomers’ move 
into their 60s and 70s, increased demand for care for the diseases of age and for ap-
proaches to enhance vitality and promote longevity means that new and improved 
remedies and interventions will be required. Consequently, a systems approach to the 
study of aging and its processes offers promise as a means of attaining potentially sig-
nificant gains in the management and treatment of age-related diseases.
 On the one end of the spectrum, we have reductionist methods that have allowed 
us to see into the organism and determine genes associated with life span. At the oth-
er end of the spectrum, we have holistic or complexity theoretic methods that allow 
us to probe an organism with minimal perturbation. Where does Systems Biology 
fit in?
 The Emergence of Systems Biology 
 Systems science takes a middle ground approach, neither reductionist nor holistic 
 [14] . It attempts to look at the parts and it tries to glue them back together under the 
assumption that whatever complexity-related information is lost does not profound-
ly affect understanding the behavior of the system. Like a jigsaw puzzle, pieces are 
linked into chains that are then used to form small networks from which a picture of 
the process begins to emerge. While it was often possible to gain insights into the 
system behavior by gluing parts back together, for many systems it just did not work. 
This was particularly true for living systems in all of their forms and beauty. Life, it 
seems, was far more ‘complex’ than had been thought  [15] . However, given the early 
lack of data on the pieces of biological systems and the minimal knowledge on how 
they were connected, it seemed that the only obvious approach was to try to glue 
pieces into potential networks, then glue the networks into hierarchies and finally see 
what results were obtained. The initial developments, particularly as applied to stud-
ies in gerontology and geriatrics, evolved from the idea of building reliable biological 
organisms. 
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 An Example: Reliability Theory 
 One of the earliest aging-related uses of systems biological approaches was the use of 
what is now called  reliability theory . The constructs of reliability theory emerged 
from the 1950s  gedankt experiments of the computer scientist John Von Neumann 
 [16] . Von Neumann’s interest [see  17 ] was in how one would go about building a 
reliable biological organism out of unreliable parts. This question led to the develop-
ment of the field of reliability theory and the subsequent adaptation of the field of 
reliability theory to become what is now known as the field of survival theory. Until 
the thought experiments of von Neumann, the concept of reliability had not been 
well defined. 
 Von Neumann’s argument proceeded as follows. He began by defining the concept 
of the  conditional instantaneous failure rate , denoted by λ (t) . We interpret this as fol-
lows. The condition is that the failure has not occurred at time  t given that the organ-
ism has survived until time  t . With this in mind, we may then define the reliability  R(t) 
of an organism as the probability of no failure of the organism before time  t . If we let 
 f(t) be the time to (first) failure (this is the same as the failure density function), then 
the reliability  R(t) is given by  R(t)  = 1 − F(t) , where  
   [18] .
 How do we actually obtain an equation for the reliability  R(t) ? We do this as follows. 
Suppose we ask what is the reliability  R ( t  + Δ t ) where Δ t is a small time increment. In 
other words, suppose that we know the reliability of the organism at time  t and we want 
to know the organism’s reliability at a small time increment Δ t later than time  t . In or-
der for the organism to be operational at time  t  + Δ t , the organism must have been 
operational until at least time  t and then not have failed in the time interval ( t , t  + Δ t ). 
We can express this mathematically as follows. The reliability  R ( t  + Δ t ) is given by
 R ( t  + Δ t ) =  R(t) −  λ (t)R(t) Δ t  (1)
 Reading equation 1, we see that to be functional (operational) at time  t  + Δ t , the or-
ganisms had to be functional at time  t [denoted by the reliability term  R(t) on the right 
hand side of the equation]. Next, we have to subtract out all of the items that failed in 
the time interval ( t , t  + Δ t ); given by the second term on the right hand side of equa-
tion 1. What remains after this subtraction is all of the organisms or items that remain 
functional at time  t  + Δ t . A bit of algebraic rearrangement and we have 
  = λ (t)R(t) (2)
 It follows that letting Δ t  → 0 (remembering our calculus), equation 1 becomes the 
simple differential equation given by
  = –λ (t)R(t)  (3)
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 Thus, if we can specify the form of the function λ (t) , we can solve for  R(t) . The litera-
ture in these fields often uses the term ‘failure rate function’ interchangeably with 
the term ‘hazard’ function. For those readers who have dabbled in demography or 
survival analysis, these constructs should seem quite familiar. Most people are famil-
iar with either the Gompertz mortality rate (hazard rate/failure rate) λ( a ) =  h 0 e γ a 
where  h 0 and γ are parameters typically estimated from population data for a given 
organism. Given the large literature on different mortality rate functions and their 
applicability to population modeling, we direct the interested reader to the relevant 
literature in that field. An excellent starting place may be found in Carnes et al.  [20] . 
 Systems biology, as applied to the biology of aging was simultaneously and inde-
pendently originated by Doubal  [21] , Gavrilov and Gavrilova  [22] , Koltover  [23] , 
Witten and Bonchev  [24] , in the mid-to-late 1980s. Additional application of network 
theory to aging may be found in Kirkwood  [25] and more recently in Qin  [26] and 
Wieser et al. [53]. These papers focused on two application areas, genetic and general 
network theoretic applications. The thinking was that biological systems, particularly 
cellular systems, could be thought of in the same way as networks with interconnect-
ed parts that had certain failure rates. The death of the organism, and hence its life 
span, could be thought of as a network failure. The discipline of reliability theory, 
coupled with network analysis/graph theory, allowed these researchers to hypothesize 
certain network structures and to subsequently calculate failure curves for those net-
work structures. In a number of cases, the shapes of the network survival curves mim-
icked the population survival curves seen in real biological populations, suggesting 
that reliability theoretic approaches, coupled with network assumptions, might have 
something to offer in understanding aging at a demographic level. This is because 
concepts of reliability have direct analogs to the longevity and lifespan of an organism. 
The most obvious one is that life span can be thought of as ‘the time to failure’ of an 
organism. If death can be viewed as a failure, then there is a natural linkage between 
survival and reliability. Thus, the ideas of reliability mutated and the mutation became 
what we now know as the field of survival theory. Reliability theory allows researchers 
to predict the age-related failure kinetics for a system of given architecture (reliability 
structure, network, graph) and given reliabilities of its components.
 During the past decade, with the increase in pathway ‘omic’ information, there has 
been an increased use of complexity theoretic and systems biological tools and tech-
niques to address putting the pieces of cellular networks back together so that their 
network properties can be better understood  [27] . These methods have also been ap-
plied to understanding the dynamics of cellular and molecular aging networks  [28–
30] . The systems biology approach has begun to allow researchers to understand the 
effects of multiple complex interactions in these aging networks, thereby further ad-
vancing our understanding of how longevity, vitality, and aging-related diseases may 
be managed. While reductionist approaches are still important, systems biology meth-
ods and complex systems theory constructs such as dynamical systems theory, net-
work analysis, fractal dynamics, multi-level computational modeling and swarm the-
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ory can extract real information out of terabytes of data, and the role of systems biol-
ogy and complex systems theory is now emerging as the front-running paradigm for 
understanding molecular and cellular networks of longevity genes and proteins. How 
then do we begin to understand networks?
 Networks and Graphs 
 Much of the early work in graph theoretic applications to aging was based upon as-
sumptions about how the genes were connected, as large databases of genes and 
networks simply did not exist. As available biological data increased, theoretical ap-
proaches, though more rigorously tied to experimental data, still struggled with 
questions around accuracy and reliability of the ‘omic’ data being used. As the data 
became cleaner, it became possible to connect single life span-related genes and pro-
teins into component networks. Other networks that controlled heat shock and 
other biological processes began to be identified. And now, with GWAS methods, 
we can begin to tie multiple cellular networks to the longevity gene networks. These 
networks could then be represented as mathematical structures called graphs  [31, 
32] . These graphs could then be analyzed using the techniques of mathematical 
graph theory, particularly in light of the recent developments in network topology 
 [33] and its implication for small-world theory  [34] , scale-free theory  [35] , redun-
dancy  [36] , robustness  [37] , frailty  [38] , evolvability  [39] and resilience  [40] of the 
original biological network. 
 From Data to Graphs 
 A graph  G is simply a set of  nodes or  vertices  n1, n2, ... nG and  edges  E ij that connect some 
or all of the nodes to each other. From a biological perspective, we can consider the 
nodes to be genes or proteins and the edges as paths between them. We represent the 
overall network connectivities in a matrix format called the  adjacency matrix which we 
denote with the symbol  A . The elements of  A are denoted  a ij and are simple; if node  n i 
is connected to node  n j , we enter the number one in the ( i , j )th   element of the matrix  A , 
otherwise we enter a zero. Observe that if  n i is connected to  n j , then it follows that  n j is 
connected to  n i so that the matrix  A is a symmetric matrix. In the case where there are 
multiple edges connecting the same nodes, we enter the number of edges. Thus, if two 
different edges connect  n i to node  n j , we would enter the number two. Nodes that are 
not connected to anything in the graph  G are called  islands . The edges can have  weights , 
denoted  w ij , assigned to them where, for example, the weight value may correspond to 
a rate of reaction. An edge  E ij can also have a direction assigned to it. For example, if  E 12 
represents the edge between nodes  n 1 and  n 2 , we might denote the fact that  n 1 is up-
stream of  n 2 by  E 1  →  2 . An edge that does not have any direction assigned to it is said to 
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be  undirected , whereas edges that have a direction assigned to them are called  directed 
edges. Note that we can have other types of edges in a network. For example,  multi-
edges are multiple edges between nodes, and  self-edges occur when a node is connected 
to itself. With this simple set of definitions, we have some powerful tools with which to 
investigate the structure of a network and how it might inform us about the biological 
dynamics of the overall network. We begin with the concept of connectivity. 
 Network Structures and Connectivity 
 It is natural to conclude that the more edges going in and out of a node, the more 
likely that the given node is going to be of importance to the network.  Hubs or nodes 
with large numbers of connections are known to play central roles in keeping complex 
networks connected. This is important when we consider, in an upcoming section, the 
concepts of  robustness ,  resilience and  frailty of a network. The number of connections 
ki going in and out of a node  n i is called the  connectivity or  degree  k i of the  i th node. 
Sometimes you will see the degree of a node expressed using  d(n i ) . In mathematical 
terms 
 
,
 
where  N is the number of nodes in the network and  a ij is the ( i , j ) th  element of the ad-
jacency matrix  A . Computing the connectivity of a large set of nodes leaves us with 
nothing more than a frequency table, and it is hard to interpret this string of numbers 
 k i , particularly if the number of nodes in the network is large. In order to assist us in 
understanding the connectivity structure of the network, we create a connectivity 
plot. To do this, we first count the number of nodes with a given connectivity  k , where 
the connectivity varies from zero to the maximum connectivity value. The number of 
nodes with a given connectivity  k is called the frequency of that connectivity and is 
denoted  f(k) . Next, plot the frequency  f(k) versus the connectivity  k . 
 Studies of the statistical behavior of various network structures  [41, 42] have shown 
that networks can have a small variety of overall topologies  [43] : random, regular, 
small world and scale free. Moreover, each of these network topologies has a classic 
pattern form for its degree distribution plot.  Random networks are just what you would 
imagine them to be; nodes are randomly connected to each other.  Regular networks 
can be thought of as lattices where there is a repetitive pattern of connections such as 
a grid. Small-world and scale-free networks are of greater interest because they have 
some fascinating underlying properties. Moreover, many real-world networks can be 
shown to be small world or scale free  [34] . A  small-world network can be described as 
a network in which most nodes are not neighbors of one another, but most nodes can 
be reached from every other node by a small number of hops or steps  [34] . A  scale-free 
network may appear to be a random network; however, in a scale-free network the links 
between the nodes are preferentially attached to the most highly connected nodes, 
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thereby creating a greater frequency of links connected to a smaller number of nodes 
 [35] . Because scale-free networks are ubiquitous and highly relevant to our discussion, 
let us look at them a bit more closely. In examining  figure 1 , we see that not all nodes 
in the network have the same number of edges. If we divide the y-axis in  figure 1 by 
the total number of nodes in the network, call that  N , then f(k)/N represents the prob-
ability  P(k ) that a randomly selected node has exactly  k  edges. In a randomly con-
nected graph, the edges are placed at random, and one can show that the majority of 
the nodes will have approximately the same connectivity which is close to the  average 
connectivity < k >. In fact, it has been shown that the connectivities  k in a random net-
work follow a Poisson distribution with a peak at < k >.
 What became interesting is that, for larger networks like gene, protein and meta-
bolic networks, these networks did not follow the traditional Poisson probability dis-
tribution. Rather, they followed a probability distribution where the connectivity 
probability  P(k) was a power law of the form
 P ( k ) =  Bk –γ  (4)
 Observe that since  P(k) is a probability, when we sum over all of the values of k, the 
result had better add up to one. Thus, the parameter value of  B is chosen so that this 
is true. We will not get into all of the varied aspects of scale-free networks  [31, 33] . 
However, how can we determine if we have a scale-free distribution? 
 Power Plots and Scale-Free Networks 
 We observe that if we take the log of both sides of equation 4 the better the fit, the 
more linear the plot should be. Thus, networks whose connectivity structure fol-
lows a power law of the form  f(k)  =  Bk –γ , where  B and γ are parameters to be esti-
mated and should look like negative slope lines if they are scale free. The simplest 
way to estimate the parameters is to perform a linear regression on the log-log 
transformed f(k) versus  k data, dropping the  k  = 0 data point because there are no 
connectivities. The more linear this curve, the more the connectivity behaves like a 
power law. 
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 Why should we even care about degree distributions and power law networks in the 
first place? As we noted earlier, scale-free networks are ubiquitous in living and even 
nonliving systems. Scale-free networks are also special in that they are built in a unique 
way. To build a scale-free network, you start off with a set of  N nodes in which each 
node in the network is connected to all of the other nodes. Next, to add a new node, 
you make  k connections to existing nodes in the network. However, whether a new 
node  m is connected to an already existent network node  n i is determined by the de-
gree of the given node  n i ; the greater the degree of  n i the more likely  m is going to be 
connected to  n i . In other words, the probability that node  m will be connected to node 
 n i is given by
 
 (5)
 Notice that this connectivity algorithm means that if you are already very tightly con-
nected in the network, then you are more likely to get even more connected in the 
network. Many scale-free networks have an exponent γ  ≈ 3. However, the exponent 
value very much depends upon the rule used for the probability of new node connec-
tion. Equation 5 is a very simple example. Given the large number of biological net-
works, particularly at the cellular level, that have been shown to be small-world for-
mations, this suggests that tendency to create small-small world networks is a natural 
evolutionary pathway. 
 Categorizing Small-World Networks 
 Because of the unique nature of scale-free networks, a log-log connectivity plot is 
enough to let you know if you are dealing with a scale-free network or not. However, 
this does not work for other network forms. Because many biological systems also dem-
onstrate small-world network behavior  [34] , we briefly examine how to determine 
whether or not a network is a small-world network. Remember, a working definition of 
a small-world network is a network in which most of the neighbors of a node are neigh-
bors themselves (think regular network here, lattice structure for example). However, 
in addition to this property, the average number of connections between two chosen 
random nodes in the network  n i and  n j is small (similar to the properties of a random-
ly connected network). To help characterize small-world networks, we introduce a few 
new network descriptors. The first is the  average path length of a network. Path length 
is the distance or number of edges between two nodes in the network. So, choose two 
random nodes in the network, figure out all of the different paths between them and 
count the number of edges in each of the paths. Then compute the average number of 
edges and you have the average path length. We can use the idea of path length to con-
struct the  minimum path length between node  n i and node  n j and denoted ℓ ij and the 
average minimum length of a network as <ℓ> using the same ideas as the average path 
length. 
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 Node-Node Connectivities 
 Another common network term is the  centrality of a node. Centrality is a measure 
of the ‘position’ or relative importance of a node in a network. In the literature, there 
are four main measures of centrality of a node:  degree centrality ,  betweenness central-
ity ,  closeness centrality and  eigenvector centrality . From an aging-related perspective, 
understanding node centrality of the nodes in a network could lead to potential tar-
gets for pharmaceuticals that might help hinder disease progression or extend life 
span. The simplest of the centrality measures is degree centrality.  Degree centrality 
of a node is defined by  C D (n i )  =  d(n i ) . In other words, the degree centrality of a node 
 n i is simply the number of edges that are connected to the given node  n i . Obviously, 
this measures the chance that a given node  n i in the network will receive something 
flowing along the network. In the case where the graph is directed, or we know the 
flow along the edges (upstream, downstream), we can define two new concepts  C inD 
and  C outD as the number of edges going in and out of  n i . These are called  indegree and 
 outdegree , respectively.  Closeness centrality , denoted  C C (n i ) is the idea that the more 
central that a node is in a network, the lower its total distance is to all of the other 
nodes in the network. In other words, if a node  n i is very close to all of the nodes, it 
should take a small number of edges to get to every other node in the network. From 
a biological perspective, closeness can be thought of as a measure of how long it will 
take to send a chemical or other biological signal out from  n i to all of the other nodes 
in the network.  Betweenness centrality , denoted  C B (n i )  looks at how often, in a net-
work, a given node  n i acts as a bridge along the shortest path between two other 
nodes. From a biological perspective, knocking out a node with high betweenness 
centrality would force a signal to reroute itself along a path that was not the shortest 
path. Lastly,  eigenvector centrality , denoted  C E (n i )  is a measure of the ‘influence’ of a 
node in a network. Here, the idea is that not all connections between nodes are equal. 
That is, if a node is influential and it is connected to another node, it is likely that it 
will have more influence on that node than a node that is not that influential. An ex-
cellent discussion of the various concepts of centrality can be found in Opsahl et al. 
 [44] . 
 Clusters and Hierarchies 
 Earlier on, we mentioned the concepts of clustering. Many biological networks, meta-
bolic networks and protein interaction networks demonstrate both clustering and scale-
free properties  [45] . When examining network structures of this class of networks, we 
find that they are often modular and  hierarchical in nature. That is, networks that ex-
hibit the combination of small-worldness and clustering appear to be built out of mod-
ules that are themselves networks. One measure of the intrinsic hierarchical nature of a 
network is to make use of the mathematical result that deterministic scale-free networks 
that are hierarchical tend to have a clustering coefficient that goes as  C ( k )  ≈  k –1 . That is, 
if a node  n i has  k connections, then its clustering coefficient is approximately k–1. Thus, 
the higher a node’s degree, the smaller its clustering coefficient. Moreover, the larger 
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 k gets, the more likely the clustering coefficient of the given node behaves as k–1 stud-
ies of many biological systems have, indeed, shown that the networks demonstrate 
modularity  [27] . 
 Robustness, Resilience and Frailty 
 We all have an intuitive idea of what robustness, resilience and frailty mean. From 
an intuitive perspective, resilience can be defined as the ability of a system, when 
perturbed, to return to its original state of operation  [40] . Some people loosen the 
definition to allow the system to return to a state of operation that is close to the 
original state of operation, where closeness is defined in such a way that the system 
is still functional as if it were still in its original state. Like most of the terms that we 
have been using, resilience is a complexity-related concept. For example, a system 
can take a short time or a long time to return to its operational zone. Are both of 
these the same degree of resilience? Surely not! A system can be perturbed for a fixed 
length of time and then the perturbation stops. What if the return to normalcy time 
depends upon the length of the perturbation? Are systems that return faster more 
resilient than ones that take longer to return? Can resilience be used up or built up? 
Thus, the term resilience encompasses a number of facets, most of which are ig-
nored or tacitly assumed when talking about the subject of resilience. What we need 
to understand is that resilience is a system response property that allows the system 
to compensate after it has been perturbed. Since it is a global system property, com-
plexity theory teaches us that it can have unpredictable outcomes due to its inner 
complexity. Bonanno et al.  [46] point out that there are many ‘independent predic-
tors of resilient outcomes’. This suggests two things. First, it suggests that resiliency 
analysis requires nonlinear methods in order to more effectively represent it. Sec-
ond, it suggests that the human ‘resilience system’ may be built with some form of 
redundancy/back-up system, some form of alternative and/or compensatory path-
ways in case some portion of the resilience system fails. Notice that the constructs 
of backup and redundancy tie back to our discussion on reliability of network sys-
tems  [47] . This type of organizational structure suggests that the human ‘resilience 
system’ may have a fractal dimension that lies in what is often called the ‘robust to 
attack’ domain. That is, the resilience system may have evolved in such a way that it 
is not frail; not easily vulnerable to attack and/or perturbation. If the system is frac-
tal in nature, then this also suggests the various paths to prototypical outcome tra-
jectories  [46] . 
 In the previous discussion, we noted that resilience is a measure of the system’s 
ability to return to an operational space upon perturbation. The fact that the system 
was able to be perturbed indicates that it was not able to resist the forces of pertur-
bation. This brings us to the concept of robustness. There are many definitions for 
 robustness , and they are all context dependent. In one sense, robustness and resil-
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ience are opposite concepts. Robustness can be viewed as resistance to perturbation, 
and resilience is the ability to return to one’s original state, or – in the case of posi-
tive psychology – to subsequently ‘[achieve a] positive adaptation despite major as-
saults on the developmental process’ after a perturbation. Thus, robustness to stress 
implies that it is hard for stress to move a person off their current trajectory (life 
course), while resilience says that if the individual is moved away from the life course 
trajectory then how long, if you will, does it take to get back to the original trajec-
tory or to a trajectory that will serve as an acceptable surrogate for the original tra-
jectory.
 Systems that are robustly designed are often more difficult to study because 
they have built in ability to resist perturbation and, if they blow a circuit or an 
operational unit, they often have backup systems that can keep the living system 
(or nonliving system) operating in a functional way  [48] . Robustness, or ‘resis-
tance to perturbation’ can be enhanced by developing the client’s strengths. Thus, 
the construct of robustness may be seen as an emergent consequence of a system 
design that has built in buffers against assaultative pressures. Thus, like resilience, 
robustness is a global catch-all term designed to describe a system’s ability to de-
fend itself against perturbation. Because robustness represents a system’s ability to 
resist perturbation, robustness could also represent a threat to evolvability and 
adaptability.
 Evolvability [52] is the system’s ability to alter itself in response to changes in exter-
nal forces in such a way as to allow the system to continue to function – adaptive evolu-
tion. A living system is said to be evolvable if it can acquire novel functions through 
genetic change, functions that help the organism survive and reproduce. Because the 
concept of evolvability originally arose in the field of organismal evolution, it carries 
with it the ideas associated with genetic evolution in the face of exogenous pressures. 
However, it is not unreasonable to think of living systems such as organizations as hav-
ing constructs that are equivalent to genes and to ask how an organization might evolve 
in the face of external pressures such as economic stress. Thus the important nodes in 
the hierarchy can change as can the connections  [39] . These changes can lead to new 
emergent dynamics that could be considered adaptations to the exogenous stressors or 
forces.
 Conclusion 
 Closing Thoughts 
 In this chapter, we reviewed the literature on systems biology in aging from a his-
toric as well as current perspective. We discussed how systems biology of aging 
emerged from the dynamic interplay of reductionist methodological approaches 
and the need to address concepts of complexity theory that began to develop in the 
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early 1970s. We showed how these considerations and the perspective of consider-
ing a biological system as a network allowed scientists to use graph-theoretic meth-
ods to begin to understand the impact of an organism’s network structure on its 
behavior. We then examined some basic concepts of network theory and how they 
apply to studying cellular aging systems. We discovered that many longevity-related 
cellular networks have small-world and/or scale-free network properties. Further, 
it appears that these networks are also very modular in nature. It has been pointed 
out that this suggests that modularity is important, not because modules exist as 
somewhat independent subnetworks, but rather because they are combined so that 
they are tightly connected to each other. These modules are then used to build high-
er-level network components and networks themselves. We raised questions around 
what happens when networks ‘age’. We saw that this raises questions around net-
work robustness, frailty and susceptibility to various forms of attack, and we exam-
ined how network structure may or may not make a network more vulnerable to 
perturbation, thereby potentially reducing its resilience/robustness and potentially 
making it more frail. In this chapter, we have focused solely upon graph-theoretic 
approaches in systems biology. There are many other systems methodological ap-
proaches to understanding systems biology of aging. For example, Kriete et al.  [49] 
use a rule-based systems approach to modeling aging systems. Albert et al.  [19] use 
a Boolean network simulation approach. And Huang et al.  [50] use a machine learn-
ing approach. 
 Future Directions 
 The bulk of network aging studies are based upon a snapshot of a single time point 
in the organism’s life span, a cross-sectional picture of the network. In order to re-
ally understand how an organism ages (how its networks age), we must better un-
derstand how networks evolve over the life span of the organism. There is no reason 
to believe that network nodes remain active throughout the whole life span, nor 
should we assume that network edges remain present throughout the life span of an 
organism. Longitudinal network analyses are now needed. Determining the weights 
and directions of network connections in aging-related network structures is now 
important so that accurate simulations of the network dynamics can be developed 
 [51] . 
 In the following chapter, we apply some of these concepts to actual aging networks 
and illustrate for the reader how to make some of the calculations we discussed in this 
chapter. Due to chapter restrictions, many relevant references were left out of both 
this chapter and the following chapter. For this, the author can only apologize for the 
citation choices made. To compensate for this, I am providing an exhaustive reference 
list for both chapters. This reference bibliography may be found at http://www.people.
vcu.edu/ ∼ tmwitten.
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 Abstract 
 This chapter will introduce a few additional network concepts, and then it will focus on the applica-
tion of the material in the previous chapter to the study of systems biology of aging. In particular, 
we will examine how the material can be used to study aging networks in two sample species:  Cae-
norhabditis elegans and  Saccharomyces cerevisiae.  © 2015 S. Karger AG, Basel 
 In the previous chapter, we addressed the importance of understanding how com-
plexity theory, as manifested through nonlinear dynamics, hierarchies and network 
analysis, can be used to study the intricate and fascinating behaviors of living systems. 
We discussed why reductionism, while it has its uses, also causes us to lose important 
information about the behavior of a system because breaking a system apart costs us 
information about how the ‘whole’ organism functions. We discussed the difference 
between a complicated system and a complex system, and we then detailed the core 
properties of a complex system. We pointed out that if we were to examine a large 
collection of different complex systems, we would find that complex systems have 
certain common or unifying characteristics. We argued that complex systems have 
‘emergent properties’ meaning that a behavior that was not predicted from infinite 
knowledge of the parts emerges as part of the system’s behaviors. Living systems, 
whether they are cells or ecosystems, do not function like pieces of a jigsaw puzzle. 
Instead, they are often fuzzy or stochastic, with backup systems and redundancies that 
belie their true structure. And we pointed out that an understanding of these systems 
requires a different conceptual framework. Thus, in order to understand complex sys-
tems, we must understand them through a reverse engineering perspective rather 
than a reductionist perspective. One approach to gaining this understanding is 
through the use of network representations of living systems. 
 Applications to Aging Networks 
 Christopher Wimble · Tarynn M. Witten 
 Center for the Study of Biological Complexity, Virginia Commonwealth University,  Richmond, Va. , USA 
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 Networks and Graphs 
 In the previous chapter, we introduced the basics of network theoretic methods as 
a beginning means to understand the complexity of living systems. In particular, we 
introduced the concept of a graph  G that has nodes  n j (or vertices) and edges  E ij (a 
connection between node  n j and node  n i ). We illustrate an undirected longevity 
gene-protein network in  figure 1  [1, 2] . We then introduced the idea of the adja-
cency matrix  A . With this simple set of definitions, we now have some powerful 
tools with which to investigate the structure of a network and how it might inform 
us about the biological dynamics of the overall network. We began with the concept 
of  connectivity . Consider the network in  figure 1 . We note that some of the nodes 
appear to have very many connections while others have but a few. Does this imply 
anything about the network and its behaviors? What information could we glean 
from this? 
 Fig. 1. Illustration of a sample  C. elegans longevity gene- protein network. See Witten and Bonchev 
 [2] for more  details. 
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 Creating a Longevity Network: An Example with Yeast 
 To understand network dynamics, particularly as applied to aging, we first discuss 
how one can actually go about creating a longevity gene-protein network. The answer 
is, it is not easy, and it takes a good deal of time. The network in  figure 1 took nearly 
a year of database searching, literature review and peer collaboration to create. Of 
course, when we started the project, the available databases were not nearly as efficient 
or sophisticated and the data far less abundant than they are now. 
 Let us first consider  Saccharomyces cerevisiae .  S. cerevisiae was chosen as the model 
organism for this study because it is well understood, highly studied, and regarded as a 
good model with which to study aging processes  [3] . Yeast has two different ways that it 
can age; replicative life span (RLS) and chronological life span. When constructing a lon-
gevity network, genes having an effect on chronological life span and RLS can both be 
considered. Chronological life span is a measure of the length of time a nondividing cell 
can survive, while RLS measures how many times a cell can divide  [4, 5] . While both are 
useful, RLS was chosen because it is easier to study with yeast and has been shown to have 
an overlap with more complicated organisms  [4] . Each of the proteins in the longevity 
network was shown to increase RLS when removed from the genome as a result of gene 
knockout studies  [6–34] . We illustrate the RLS network for  S. cerevisiae in  figure 2 .
Regulation
Direct regulation
Genetic interaction
Proteins are colored by group:
Protein kinases
Extracellular proteins
Nuclear receptors
Phosphatases
Transcription factors
Ligands
Binding
 Fig. 2. Illustration of the  S. cerevisiae RLS extension network. The different color connecting lines in-
dicate different types of interaction; binding (purple), regulation (dotted lines), genetic interaction 
(green) and direct regulation (grey). The different shapes represent different types of factors in-
volved in the connections. 
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 Notice that there are a number of unconnected nodes. These are our  islands . They are 
likely unconnected because we do not know how they are connected in the network.
 In this example, we are interested in how different subnetworks (TOR: target of ra-
pamycin, and CRH: cellular response to heat) are tied to the RLS network. And in un-
derstanding how the addition of other subnetworks to the RLS network might further 
inform us about the dynamics of aging at a genetic level. We choose the TOR pathway 
due to its demonstrated effect on RLS, and we choose the CRH as a model for how the 
cell responds to environmental stressors  [18, 35–37] . Biological aging has been described 
as a cascading breakdown of processes resulting in decreased ability of an organism to 
respond to stress, and thus a model of stress response was included  [5] . We illustrate the 
TOR and CRH networks in  figure 3 and  figure 4 . The combined total network TOT is 
illustrated in  figure 5 . All of the images were created using Pathway Studio software.
 All of the networks were built by mining the literature [for details see  2, 24 ] and on-
line databases. In particular, we added information from the Saccharomyces Genome 
 Fig. 3. Illustration of the  S. cerevisiae TOR network. The different color connecting lines indicate  different 
types of interaction; binding (purple), regulation (dotted lines), genetic interaction (green), expression 
(blue), protein modification (golden green), promotion of binding (lime green) and  direct regulation 
(grey). The different shapes represent different types of factors involved in the  connections. 
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Database, YEASTRACT, The Comprehensive Yeast Genome Database, The NetAge 
Database, Sageweb, and AmiGO. Items on the list were verified by comparing them to 
results from papers that measured the effect on RLS of gene deletions (see previous 
references). Lists for the TOR as well as the CRH were constructed using gene ontol-
ogy terms on AmiGO  [35] as well as the Saccharomyces Genome Database  [37] .
 Once the lists were prepared, protein-protein interaction data were obtained using 
a yeast interaction database developed to work with the software program Pathway 
Studio. A network of direct connections (DC) was constructed as well as a shortest-
path network (SP) for the RLS, TOR, and CRH subnetworks. A TOT was also con-
structed. TOT was constructed by fusing the three networks together into the larger 
TOT. Not only did Pathway Studio show the connections between proteins, but it also 
yielded information on their function and the type of interaction. We illustrate a sam-
ple list for the CRH network in  table 1 .
 Fig. 4. Illustration of the  S. cerevisiae CRH network. The different color connecting lines indicate 
 different types of interaction; binding (purple), regulation (dotted lines), genetic interaction (green), 
expression (blue), protein modification (golden green), promotion of binding (lime green) and 
 direct regulation (grey). The different shapes represent different types of factors involved in the 
connections. 
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 Analyzing the Network: An Example with Yeast and  Caenorhabditis elegans 
 As we mentioned in the previous chapter, it is natural to conclude that the more edg-
es going in and out of a node, the more likely that the given node is going to be of im-
portance to the network. In order to assist us in understanding the connectivity struc-
ture of the network, we create a connectivity plot ( fig. 6 ). To do this, we first count the 
number of nodes with a given connectivity  k where the connectivity varies from zero 
 Fig. 5. Illustration of the  S. cerevisiae combined network TOT. The combined network is composed 
of RLS, TOR, and CRH. Here, we used the software program cytoscape to graphically represent all 
three networks combined, where nodes are color coded to show which network the protein it rep-
resents is part of. Yellow nodes represent proteins in the RLS network, green for the CRH group, and 
blue for the TOR network. 
Table 1.  Connection types for the CRH network
Connection type n
Binding 39
Direct regulation 17
Expression 2
Genetic interaction 29
Promoter binding 1
Protein modification 2
Regulation 8
The connection types are generated as output from the software. The right-hand 
column represents the number of each connection type.
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to the maximum connectivity value. The number of nodes with a given connectivity 
 k is called the frequency of that connectivity and is denoted  f(k) . Next, plot the fre-
quency  f(k) versus the connectivity  k . We illustrate this for  Caenorhabditis elegans in 
 figure 6 . Because the  C. elegans network is large, it has a smoother look to it. Let us 
look at the yeast RLS shortest-path network (RLS-SP) and construct the power-law 
graph ( fig. 7 ). 
 As we mentioned in the previous chapter, studies of the statistical behavior of var-
ious network structures have shown that networks can have a small variety of overall 
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 Fig. 6. Illustration of a sample 
connectivity or degree 
 distribution plot for the 
 network in figure 1. See  Witten 
and Bonchev  [2] for more 
 details. The rhombs  represent 
the complete  distribution. The 
squares are the data points 
binned into groups of three. 
The black  solid line is the non-
linear  regression line. Results 
are significant at p < 0.05. 
 Fig. 7. The degree distribution plot for yeast RLS-SP network. The horizontal axis is the connection 
number  k and the vertical axis is the frequency  f(k) . Notice that the degree distribution is more ir-
regular and that there are an enormous number of zero and one values in the network. This makes 
fitting a power curve more difficult and also increases the likelihood that the fit will not be statisti-
cally significant due to the small sample size (number of nodes). Sometimes binning can help when 
there are zero node numbers. However, that also affects the fit. 
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topologies; random, regular, small-world and scale-free. Moreover, many real-world 
networks can be shown to be small-world or scale-free. Because scale-free networks 
are ubiquitous and highly relevant to our discussion, let us look at them a bit more 
closely. How can we determine if we have a scale-free distribution?
 Power Plots and Scale-Free Networks 
 It is hard to interpret a plot like that illustrated in  figures 6 and  7 . However, we observe 
that if we take the log of both sides of  f(k)  =  Bk –γ , the more linear the data plot, the 
more likely it fits a power curve. This follows because we would have ln[ f(k) ] =  − γln (k)  + 
ln (B) . Thus, networks whose connectivity structure follows a power law of the form 
 f(k)  =  Bk –γ where  B and γ are parameters to be estimated should look like negative 
slope lines if they are scale free. The simplest way to estimate the parameters is to per-
form a linear regression on the log-log transformed  f(k) versus  k data, dropping the 
 k =  0 data point because there are no connectivities. We found that  B =  1,992.4 and 
γ  =  2.2499 with an  r 2  = 0.969 ( fig. 8 ). Thus, our  C. elegans longevity gene-protein net-
work  [2] can be said to be a scale-free network. 
 Categorizing Small-World Networks 
 Due to the unique nature of scale-free networks, a log-log connectivity plot is enough 
to let you know if you are dealing with a scale-free network. However, this trick does 
not work for other network forms. Because many biological systems demonstrate 
0.5000 1.0000 1.5000 2.0000 2.5000 3.0000 3.5000
ln k
ln
 f(
k)
0
1.0000
2.0000
3.0000
4.0000
5.0000
6.0000 r2 = 0.969
Fig. 8. Illustration of the log-
log data and regression curve 
through the data of figure 6. 
The outer lines are the 95% 
confidence interval 
 boundaries for the linear 
 regression estimate. See 
 Witten and Bonchev  [2] for 
more details.
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small-world network behavior, we briefly examine how to determine whether or not 
a network is a small-world network. 
 To help characterize small-world networks, in the previous chapter, we introduced 
a few new network descriptors. The first was the  average path length of a network. Path 
length is the distance or number of edges between two nodes in the network. We used 
the idea of path length to construct the  minimum path length between node  n i and 
node  n j and denoted it by ℓ ij . We now introduce the concept of the  diameter of a net-
work. The diameter is the largest direct distance between any two nodes in the net-
work. Consider the example network in  figure 9 .
 Now, consider the adjacency matrix  A derived from the network in  figure 9 and 
which is illustrated on the left hand side of  table 2 . The matrix  A represents the num-
A
G
H
E
B
D
F
C
 Fig. 9. Illustration of a simple hypothetical 
 network. 
Table 2.  Sample adjacency matrix A (left block of numbers)
A B C D E F G H A B C D E F G H
A 0 0 1 0 0 0 1 0 0 0 21 0 23 0 13 0
B 0 0 1 0 1 0 0 0 0 0 29 0 36 0 15 0
C 1 1 0 0 0 1 0 0 21 29 0 15 0 29 0 22
D 0 0 0 0 1 0 0 0 0 0 15 0 21 0 8 0
E 0 1 0 1 0 1 0 1 23 36 0 21 0 36 0 29
F 0 0 1 0 1 0 0 0 0 0 29 0 36 0 15 0
G 1 0 0 0 0 0 0 1 13 15 0 8 0 15 0 14
H 0 0 0 0 1 0 1 0 0 0 22 0 29 0 14 0
On the right, we have multiplied A times itself five times. The non-zero number in the entry repre-
sents the number of possible paths between node ni and node nj.
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ber of length 1 paths between node  n i and node  n j . If we multiply  A  ×  A , the entries 
that are non-zero represent the number of length 2 paths between each pair of nodes. 
If we repeat this process exactly  N  – 1, then we get the total number of paths of length 
1,2,…, N  – 1 for the network between each pair of nodes in the network where  N is the 
total number of nodes in the network. The right hand side of  table 2 illustrates  A  × 
 A  ×  A  ×  A  ×  A , which is the number of paths of length five between each pair of nodes. 
So, for example, there are 29 possible paths of length 5 between node  C and node  B . 
At some point between 1 and  N  – 1 multiplies, every element in the matrix or its sub-
sequent multiplies A, A2, A3, A4, . . ., AN – 1 will have been non-zero during the multi-
ply sequence. The diameter is the minimum number of times the adjacency matrix  A 
has to be multiplied by itself so that each entry has taken a value greater than 0 at least 
once during the multiply sequence. For this particular network, the diameter is 4.
 A network is considered a small-world network if the diameter is small relative to 
the number of nodes in the network. Obviously, 4 is not small relative to 8. To really 
understand small-worldness, one network sample is not sufficient. You actually need 
a set of graphs. However, we have only the one network graph. Therefore, we need 
other means to study the behavior of networks to understand if they are small-world 
networks. To do this, we introduced the ideas of clustering. Observe that even for a 
small network such as the one we have illustrated, the calculations can become te-
dious. We will discuss software at a later point in this chapter.
 Node-Node Connectivities 
 In the previous chapter, we talked about the idea of the  centrality of a node where cen-
trality is a measure of the ‘position’ or relative importance of a node in a network. In 
the literature, there are four main measures of centrality of a node:  degree centrality , 
 betweenness centrality ,  closeness centrality and  eigenvector centrality . From an aging-
related perspective, understanding node centrality of the nodes in a network could 
lead to potential targets for pharmaceuticals that might help hinder disease progres-
sion or extend life span. Briefly, the main centrality measures are: 
 •  Degree centrality of a node is denoted by  C D (n i ) ; it measures the chance that a 
given node  n i in the network will receive something flowing along the network. 
 •  Closeness centrality , denoted  C C (n i ) can be thought of as a measure of how long it 
will take to send a chemical or other biological signal out from  n i to all of the 
other nodes in the network. 
 •  Betweenness centrality , denoted  C B (n i ) looks at how often, in a network, a given 
node  n i acts as a bridge along the shortest path between two other nodes. From a 
biological perspective, knocking out a node with high betweenness centrality 
would force a signal to reroute itself along a path that was not the shortest path. 
 •  Eigenvector centrality , denoted  C E ( n i ) is a measure of the ‘influence’ of a node in a 
network. 
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 Eigenvalue centrality is commonly used as a centrality measure because it is an 
influence measure for a node, and these could be potential targets for further study 
or drug design. In  figure 10 , we illustrate the SP for the RLS network. For a discus-
sion of SPs in aging, see Managbanag et al.  [24] . In  figure 11 , we illustrate the corre-
sponding eigenvalue centrality measures for the various nodes in the RLS-SP net-
work. The larger the eigenvalue centrality, the larger the influence in the RLS-SP 
network.
 Thus, from  figure 11 , we would infer that  GPA2 ,  CDC25 ,  SCH9 and  CYR1 are in-
fluential nodes and therefore likely candidates to investigate further. SCH9 – AGC 
 Fig. 10. Illustration of the RLS-SP network. Note how highly connected the one node in the upper 
left hand side is. That node, by the way, is RPL16B ribosomal 60S subunit protein L16B; N-terminally 
acetylated, binds 5.8 S rRNA; transcriptionally regulated by Rap1p; homologous to mammalian ribo-
somal protein L13A and bacterial L13  [37] . 
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family protein kinase; functional ortholog of mammalian S6 kinase; phosphorylated 
by Tor1p and required for TORC1-mediated regulation of ribosome biogenesis, trans-
lation initiation, and entry into G0 phase; involved in transactivation of osmostress-
responsive genes; regulates G1 progression, cAPK activity and nitrogen activation of 
the FGM pathway  [37] . CYR1 – adenylate cyclase is required for cAMP production 
and cAMP-dependent protein kinase signaling; the cAMP pathway controls a variety 
of cellular processes, including metabolism, cell cycle, stress response, stationary 
phase, and sporulation  [37] . CDC25 – Membrane-bound guanine nucleotide ex-
change factor; indirectly regulates adenylate cyclase through activation of Ras1p and 
Ras2p by stimulating the exchange of GDP for GTP; required for progression through 
G1  [37] . GPA2 – Nucleotide-binding α-subunit of the heterotrimeric G protein inter-
acts with the receptor Gpr1p, has signaling role in response to nutrients  [37] . Witten 
and Bonchev  [2] illustrate these concepts for the  C. elegans longevity gene network il-
lustrated in figure 1 of that paper.
 Most network analysis programs calculate the basic centrality and other measures. 
The algorithms for these calculations are tedious and not trivial to program. There-
fore, it is better to use one of the programs discussed in the upcoming software sec-
tion rather than to write your own programs to make the calculations. In  table 3 , we 
illustrate the properties of all four of our original networks and their corresponding 
SPs.
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Fig. 11. Illustration of the eigenvalue centrality measures for the yeast replicative shortest-path life 
span network. The horizontal axis is the node name in the network, the vertical axis is the eigen-
value centrality value. The larger the eigenvalue centrality, the larger the influence in the RLS-SP 
network.
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 Interpreting the Results 
 From the eigenvalue centrality, we have already seen a number of genes worth inves-
tigating due to their influential nature in the networks. From the graph of the DC, 
we discovered that the TOR1 protein was shared between the RLS and TOR net-
works, and the HOS2 gene was shared between the RLS and the CRH networks. It 
was also discovered that the TOR and CRH networks were densely connected to the 
RLS network. However, there were relatively few connections between the CRH and 
TOR networks. TOR1 is responsible for PIK-related protein kinase and rapamycin 
target; subunit of TORC1, a complex that controls growth in response to nutrients 
by regulating translation, transcription, ribosome biogenesis, nutrient transport and 
autophagy; involved in meiosis  [37] . HOS2 is histone deacetylase and subunit of Set3 
and Rpd3L complexes; required for gene activation via specific deacetylation of ly-
sines in H3 and H4 histone tails; subunit of the Set3 complex, a meiotic-specific re-
pressor of sporulation-specific genes that contains deacetylase activity  [37] . We ob-
serve that all of these targets are related to growth and division in some way. 
 We were able to demonstrate that the SPs followed a power-law distribution. This 
was not the case in the DC perhaps due to their relatively small sample size. Mean 
vertex degree was noticeably different between the SPs and DCs. It was more pro-
nounced in the TOR network, the shortest-path mean vertex degree being nearly 
double what it was in the DCs. This was even more noticeable between the TOTs, 
which was more than double. There was a large difference in node densities with the 
SPs having ones lower than the DCs. Between the RLS networks, this was far less pro-
nounced with the SP having half the node density of the DC. The TOR shortest-path 
Table 3.  Some of the basic network variables for the original CRH, RLS, TOR and TOT networks and 
their corresponding shortest-path networks
Network Number
of nodes
Number
of edges
Vertex
degree
range
Node
density
Mean
Vertex
degree
Mean node
distance
Network 
diameter
CRH DC 28 70 1–8 0.18519 5 3.146 7
CRH SP 119 460 1–35 0.06552 7.7311 2.6 5
RLS DC 37 46 1–6 0.06907 4.383 2.7059 10
RLS SP 169 524 1–47 0.03691 6.2012 2.893 6
TOR DC 16 42 1–11 0.35000 5.25 1.942 4
TOR SP 331 1,500 2–110 0.02746 9.0361 2.855 5
TOT DC 76 158 1–11 0.05544 4.1579 5.774 13
TOT SP 558 2,467 1–110 0.01587 8.853 3.171 6
Fragmentation (DC) 0.59158
Fragmentation (SP) 0.51203
Clustering coefficient (DC) 0.20142
Clustering coefficient (SP) 0.04330
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node density was a one tenth of the DCs. The network diameter was similar for the 
TOR DCs and the SPs, yet for the RLS and TOTs the shortest-path diameter was half 
what it was in the DC.
 Software for Network Analysis 
 Due to the fact that many networks have large numbers of nodes and connections, it 
is not possible to hand-calculate the various network descriptors that we have dis-
cussed. Over the past decade, a number of network analysis software packages have 
become available. Two of the most commonly used packages are Pajek, available at 
http://vlado.fmf.uni-lj.si/pub/networks/pajek/, and Cytoscape, which is available at 
http://www.cytoscape.org/. Another excellent package is NetworkX from Los Alamos 
National Laboratories. It can be downloaded at http://networkx.lanl.gov/index.html. 
All of these packages offer free downloads on numerous computation platforms and 
operating systems. 
 One of the challenges in understanding large complex networks, including biologi-
cal networks, is visualizing them. Both Pajek and Cytoscape offer network visualization 
tools. However, a number of other visualization tools are now available, and these are 
very powerful visualization software packages. CFinder, available at http://cfinder.org/ 
is a cluster and community software package designed for finding and visualizing dense 
groups of nodes in networks. Gephi, available at https://gephi.org, is an open graph vi-
sualization program that allows the user to perform exploratory data analysis on a giv-
en network, link analysis and generate high-quality printable network images. There 
are many other social network analysis software packages now available. The packages 
frequently allow the user to analyze biological networks as well as other network forms. 
An excellent discussion of available network analysis and visualization software may be 
found at http://en.wikipedia.org/wiki/Social_network_analysis_software.
 Future Directions 
 Future directions for the research include adding additional yeast subnetworks that 
are believed to have a tie to aging processes. In addition, we will add networks that are 
believed to be unrelated to replicative aging processes. These unrelated networks will 
serve as control networks. For the TOT of direct interactions, proteins were labeled 
to show which group they belonged to (TOR, heat-shock, RLS, or shared). It would 
be helpful to do the same for the TOT of shortest-path connections. 
 We will also take what we have learned about studying yeast networks, and use this 
to study protein-protein interaction networks in other species, such as  C. elegans ,  Dro-
sophila melanogaster and eventually in humans. By using  C. elegans , a wider variety of 
genes that have an effect on aging can be studied, i.e. genes such as the FOXO gene. 
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However, because it is multicellular, the  C. elegans genome would be more complex, 
having about 20,000 genes as opposed to only 6,000 in yeast. Homologs to yeast genes/
proteins in other organisms can be investigated as possible important genes/proteins. 
Using human interaction networks allows the study to be directly related to the study 
of aging in humans, which is the ultimate goal. With an expanded yeast network, it will 
be easier to show links between existing data and studies of other model organisms. It 
might also help guide decisions on which networks to study in  C. elegans and humans.
 Closing Thoughts 
 In the previous sections, we introduced a large number of concepts and constructs 
that are based upon the premise that biological systems can be represented as network 
graphs. These concepts described how network nodes were interconnected and the 
consequences of certain specific classes of connectivity and network structure. At the 
1982 Palo Alto American Mathematical Society meeting, Witten presented a paper on 
representing aging using the model of network decay. Of course, in those days, net-
work analysis was not what it is today, and we had next to nothing of the genomic and 
network level data that we now have. However, even then, it was natural to consider 
aging as the temporal decay of a hypothetical organismal ‘aging network’. How then 
may we extend these ideas to the study of aging? 
 While little is currently known about how aging-related networks evolve across the 
organism’s life span, it is reasonable to assume that two possible changes can occur; in-
activation of active nodes/activation of inactive nodes and loss of connectivity/increase 
in connectivity. How or why nodes become inactive or edges disappear is irrelevant 
here; just that they do. It turns out that the structure of small-world networks, due to 
their hub connectivity, makes them vulnerable to targeted attacks aimed at specific 
hubs. Attacks that knock out essential genes are knocking out the life span network be-
cause the organism dies when an essential gene is knocked out. Thus, essential genes 
are critical hub genes  [2, 38, 39] . Small-world neural networks have been shown to ex-
hibit short-term memory capability. This suggests that memory decay, such as that seen 
in Alzheimer’s disease may be related to decay of brain neural network structure in such 
a way as to remove the small-worldness property of the memory network. Understand-
ing patterns in network decomposition could lead to potential early AD detection and 
to potential pharmaceutical intervention at earlier points in the disease course.
 Connectivity gain and loss also have implications when it comes to discussing the 
hierarchical modularity of aging-related network architectures. Loss of connectivity 
through inactivity of a node or through loss of an edge could unlink an entire module of 
importance. Thus, nodes that connect modules within a larger network are critical to the 
functioning of the network. Questions around the role of evolutionary processes in the 
development of network architectures of various organisms may be of importance in 
understanding how network architectures related to aging processes are constructed. 
Yashin AI, Jazwinski SM (eds): Aging and Health – A Systems Biology Perspective.
Interdiscipl Top Gerontol. Basel, Karger, 2015, vol 40, pp 18–34 ( DOI: 10.1159/000364925 )
 Applications to Aging Networks 33
Why are some components of a network redundant while others are not (see also all of 
the citations on reliability theory)? What is the role of backup subnetworks? What is the 
importance of robustness and resilience? Why are some networks more robust to attack 
[46–50], less fragile than others or more frail [40–44]? How do we balance the need to 
adapt and evolve with robustness [45]? What, if any, is the association of life span with 
network architecture? These and many other questions remain to be answered.
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 Abstract 
 Computational modelling is a key component of systems biology and integrates with the other tech-
niques discussed thus far in this book by utilizing a myriad of data that are being generated to quan-
titatively represent and simulate biological systems. This chapter will describe what computational 
modelling involves; the rationale for using it, and the appropriateness of modelling for investigating 
the aging process. How a model is assembled and the different theoretical frameworks that can be 
used to build a model are also discussed. In addition, the chapter will describe several models which 
demonstrate the effectiveness of each computational approach for investigating the constituents 
of a healthy aging trajectory. Specifically, a number of models will be showcased which focus on the 
complex age-related disorders associated with unhealthy aging. To conclude, we discuss the future 
applications of computational systems modelling to aging research.   © 2015 S. Karger AG, Basel 
 Aging has intrigued and troubled scholars since the beginning of civilization. It is 
a process that can be described generally as the changes that take place during the 
life span of an organism which progressively renders them more likely to die. The 
alterations that bring about a gradual increase in the probability of mortality in-
volve all aspects of biology, from molecular mechanisms to whole-body physiolog-
ical systems. Moreover, there is little doubt that aging is modulated extrinsically by 
diet, while intrinsically the velocity of aging also appears to be shaped by a wide 
variety of genetic mutations. For instance, mutations to daf-2/daf-16 regulate life 
span in the nematode  [1] , while the FOXO3A genotype has been strongly linked 
with variations in human longevity  [2] . Paradoxically, genetic homogeneity does 
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not mean the velocity of aging will be the same, as genetically identical species can 
display a variety of aging rates  [3] . Furthermore, evolution has given rise to sig-
nificant life span variations between different species  [4] . Aging is also seen as cen-
tral to the understanding of many disease states; for example, in certain tissues the 
accumulation of senescent cells can lead to cancer via a pro-inflammatory response 
 [5] , while neurodegeneration underpins the progression of Alzheimer’s (AD) and 
Parkinson’s disease  [6] . Moreover, free radical damage has been implicated in a 
variety of disease pathologies from cardiovascular disease (CVD) to dementia. His-
torically, biologists have investigated the complexities of aging using conventional 
wet laboratory techniques; however, it is increasingly recognized that to fully ap-
preciate the uniqueness of aging, systems biology approaches are a necessity  [7] . A 
fundamental aspect of systems biology is computational systems modelling, a pro-
cedure which involves the development of in silico models. Such models are ideal 
for describing the innate complexity and dynamics of aging. However, it is often 
misunderstood as to what exactly computational systems modelling is. It is not 
statistical data analysis, the three-dimensional visualization of proteins or database 
mining; instead, it involves using a computer to quantitatively represent the com-
ponents of a biological system of interest. How the components interact based on 
current biological understanding is described with mathematical equations. The 
computer then simulates the interactions between the components to give an over-
all graphical account of the dynamics of the system  [8] . Thus, computational sys-
tems modelling can be easily integrated with other disciplines under the systems 
biology umbrella, as quantitative data from diverse fields including genomics, me-
tabolomics and proteomics can be utilized to inform model construction and re-
finement. Moreover, model predictions can be used to direct the future design of 
wet laboratory experiments and also give insights into how a biological system will 
behave under a wide-variety of different conditions. For instance, the proposed ef-
fects of the aging process can be incorporated into a model by including something 
as straightforward as the age-associated decline in the activity of the key enzymes 
of the cellular pathway of interest. Despite the clear advantages outlined above, the 
utility of modelling to aging research can often be overlooked, or traditional ger-
ontologists can be sceptical about the validity of the model or the modelling pro-
cess generally. Thus, it is important to extend further the rationale for using com-
putational systems modelling and why it is central to improving our understanding 
of the aging process. 
 Rationale for Using Systems Modelling for Aging Research 
 As outlined, computational models are capable of the quantitative representation 
and analysis of biological systems, something that is not always possible to achieve 
in a wet laboratory for a number of reasons. Firstly, biological systems are both in-
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herently detailed and inherently complex. This level of detail and complexity gives 
rise to a diverse web of overlapping metabolic networks which are comprised of 
multiple connections between each node in the network. Many of the nodes inter-
act in a non-linear fashion and often communicate with each other via sophisti-
cated feedback or feed-forward loops. This places a significant cognitive burden on 
the human brain to retain this level of complexity and detail. For instance, if the 
activity of NAD+ dependent deacetylases, commonly referred to as sirtuins are ex-
plored, such complexity becomes apparent as the seven mammalian sirtuins per-
form numerous interrelating actions and modulate a number of pathways connect-
ed to age-related disease  [9] . Likewise, the mammalian target of rapamycin (mTOR) 
pathway is equally complex. This system is known to regulate life span in model 
organisms, and recently has been suggested as a central intracellular regulator, 
mechanistically connecting aging, oxidative stress and cardiovascular health  [10] . 
Thus, it is highly improbable that one can reason about such complex systems by 
human intuition alone and as such computational modelling offers a complimen-
tary means of dealing with the complexity associated with aging. Another reason 
for using the systems approach is to identify and unravel molecular and biochemi-
cal hubs that are key regulators, whose robust dynamics ultimately impact the 
health of tissues and whole-organ systems. To this end, computational systems bi-
ology is beginning to accommodate the representation of biological systems in a 
multi-scale way  [11, 12] . This type of representation contrasts with many conven-
tional methodologies which focus on a small manageable component of a biological 
system. This is particularly significant for aging, as the most probable way to gain 
a deeper understanding of this intriguing phenomenon is to investigate the syner-
gistic behaviour of cells, tissues and organ systems. The next section will explore 
further the advantages of computational systems biology compared to convention-
al approaches to studying aging. 
 Advantages over and Interactions with Conventional Techniques 
 There are many conventional approaches that can be used to study aging. These 
experimental methodologies have been valuable in aiding our understanding of the 
aging process and will have a role to play in future aging research; however, such 
methodologies have limitations. If for example longitudinal studies are examined, 
this approach certainly has value; however, it can be resource intensive, expensive 
and time consuming. Most significantly, this approach will not offer immediate 
benefits for an aging Western population which urgently requires remedies to dis-
eases such as dementia, which almost half of the oldest old (those  ≥ 85 years) in the 
USA and UK suffer from  [13] . Cross-sectional studies, where individuals of varying 
ages from a population are assessed at the same time point are not as costly as lon-
gitudinal investigations. However, distinguishing cause and effect in cross-section-
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al studies from straightforward association is inherently difficult. As an example, 
recent evidence has indicated an association between the decline in global DNA 
methylation and age in humans. DNA methylation is an epigenetic mark that plays 
an important role in gene expression, gene imprinting and transposon silencing. 
Paradoxically, advancing age has been associated with the hypermethylation of cer-
tain genes, which can result in age-related disease  [14] . If a cross-sectional study 
was conducted to examine DNA methylation status in a cohort of individuals, this 
phenomenon would more than likely be apparent. However, it would be challeng-
ing to disentangle its causes, as a wide variety of intrinsic and extrinsic factors are 
conjectured to modulate DNA methylation. These factors include a methyl-defi-
cient diet, genetic polymorphisms within the folate pathway and age-related altera-
tions to the activity of DNA methyl transferases, the family of enzymes responsible 
for transferring methyl groups to the DNA molecule  [14] . It is possible that hetero-
geneous individual combinations of these factors could independently result in the 
methylation paradox and a cross-sectional study would not be able to unravel this. 
The significance of biological heterogeneity is further emphasized by the knowl-
edge that clonal populations of cells display significant phenotypic variations. This 
phenomenon is suggested to arise from stochasticity or noise in gene expression 
 [15] . Aging researchers need to be acutely aware of biological stochasticity and that 
simulations by computational systems models are capable of representing both in-
ter-individual and inter-cellular stochasticity  [16] . When studying aging, it is also 
important to take account of the ethical considerations, for instance dietary inter-
vention studies are regularly employed to explore potential nutrients that could 
modulate the aging trajectory; however, there is a moral imperative to consider 
here. For example, rodents are routinely used to investigate dietary regimes in ag-
ing research; but it could be argued that it is unethical to overuse animals in studies 
of this nature. Significantly though, model organisms have helped to reveal that 
caloric restriction (CR) can extend life span  [17] . However, this raises the issue of 
whether such findings can be translated to humans, as many difficulties surround 
these investigations, not least that extended timeframes are needed to decipher the 
optimal regime most beneficial to healthy aging. It is also important to be cautious 
when making inferences about the potential effects of CR in humans. We need only 
look to the disciplines of toxicology and pharmacology to recognize that the phys-
iology of animals does not always translate well to humans. Thus, an in silico hu-
man representation of CR would be worth establishing prior to any trial of CR in 
humans, as modelling could help to reveal any potential dangers of this regime. 
This is not improbable as computational systems models are currently used to study 
the long-term effects of diet on the pathological signatures that characterize un-
healthy aging  [18] . Thus, computational systems modelling can overcome a variety 
of challenges by providing a framework for aging-centred questions that are unsuit-
able to test with conventional approaches. 
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 Computational Systems Modelling Approaches for Aging Research 
 Modelling approaches differ significantly from traditional in vivo  or  in vitro  tech-
niques used to study aging. Firstly, a model can be used as a cheap and rapid test bed 
for hypothesis exploration. For example, computational models have long been used 
for testing life history theories that attempt to frame aging within an evolutionary 
template  [19] . Moreover, no matter what framework is used, constructing a model can 
improve or augment our understanding of the age-related process under examina-
tion. This is a result of having to consider the system of interest in an unambiguous 
and precise fashion using mathematics; and there are several mathematical frame-
works which can be adopted to deal with the complexities of aging. The theoretical 
framework that is employed will depend on the nature of the system to be modelled. 
Importantly however the model needs to encapsulate the biological essence underpin-
ning the aging process under consideration, and the framework that is employed 
should be directly informed by biological evidence and not by modeller bias for a par-
ticular approach. 
 Ordinary Differential Equations and Partial Differential Equations 
 This approach treats biological systems as reaction networks, which can be repre-
sented mathematically by ordinary differential equations (ODEs). ODEs are known 
as ordinary because they depend on one independent variable (time), and it uses the 
assumption that biological species exist in a well-mixed compartment, where con-
centrations can be viewed as continuous. It also assumes that large numbers of mol-
ecules are involved in reactions and that the average behaviour of the population of 
molecules is not influenced by variability  [20] . ODEs can be coded on the computer 
and an algorithm solves them numerically to produce a deterministic output. They 
are the most common mathematical framework used in computational systems bi-
ology; however, they are unsuitable for modelling transport processes, diffusion, 
molecular spatial heterogeneity and stochasticity. The latter of these limitations is 
important for aging research as intracellular processes such as oxidative stress are 
often viewed as stochastic events. Recent examples of ODE models that have been 
employed in aging research include deterministic models used to represent apopto-
sis  [21] , immunosenescence in humans  [22] , and cardiac ventricular dimension al-
terations during aging in mice  [23] . In contrast to ODEs, partial differential equa-
tions (PDEs) are multivariable functions with partial derivatives. Not as ubiquitous 
as ODE models, the main advantage of PDEs is the ability to handle both spatial and 
temporal dependencies. This is best demonstrated by a recent model of tumour 
growth, which included cell age, cell size, and the mutation of cell phenotypes  [24] . 
Moreover, it also incorporated proliferating and quiescent tumour cells indexed by 
successively mutated cell phenotypes of increasingly proliferative aggressiveness. 
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The model was able to structure tumour cells by both cell age and cell size. A dis-
advantage of PDE models is that they can be computationally intensive and thus 
slow  [20] . 
 Stochastic Reaction Networks and Probability-Based Models 
 Stochastic reaction models attempt to represent the discrete random collisions be-
tween individual molecules, which is vital when considering that random accumula-
tion of cellular damage has long been implicated with intracellular aging. This type of 
reaction is suggested to take place if the molecules exist in small numbers or there are 
fluctuations in their behaviour, for instance variations in cellular free radical levels. 
Stochastic simulations treat molecule reactions as random events. Computationally, 
this approach involves an algorithm treating each reaction in the model as a probabil-
ity/propensity function, e.g. reactions have different probabilities of occurring, which 
can be altered based on the reaction type. A stochastic algorithm is not concerned with 
average behaviour, rather the probabilistic formulation determines firstly when the 
next reaction occurs and secondly what reaction it will be  [16] . Due to its historical 
connection with the free radical theory of aging, mitochondrial/oxidative stress mod-
els are commonplace. Recently, a stochastic systems model was used to simulate mito-
chondrial function and integrity during aging  [24] . The model demonstrated that cy-
cles of fusion/fission and cell degradation are required to maintain optimal levels of 
mitochondria, even during periods of stochastic damage  [25] . Another recent model 
by Kowald and Kirkwood  [26] examined the accumulation of mitochondrial DNA de-
letions with age in post-mitotic cells. Computer simulations were used to study how 
different mutation rates affect the extent of heteroplasmy. The model showed that ran-
dom drift works for life spans of around 100 years, but for short-lived animals, the re-
sulting degree of heteroplasmy was incompatible with experimental observations  [26] . 
Another recent stochastic model focused on the age-related factors that contribute to 
neurodegeneration by investigating the potential role of glycogen synthase kinase 3 
and p53 in AD  [27] . The model was able to predict that high levels of DNA damage 
leads to increased activity of p53  [27] . A model based on the same field of study by Tang 
et al. [28] illustrates the complementary nature of computational modelling and wet 
laboratory experimentation. The authors used fluorescent reporter systems imaged in 
living cells and computer modelling to explore the relationships of polyQ, p38MAPK 
activation, generation of reactive oxygen species, proteasome inhibition and inclusion 
body formation. Several other probability/stochastic network models have attempted 
to replicate the dynamics of telomere erosion. For instance, a computational model 
was able to explore the idea that telomere uncapping is the main trigger for cellular 
senescence  [29] . A more recent stochastic model made the assumption that cell divi-
sion in each time interval is a random process whose probability decreases linearly with 
telomere shortening  [30] . Computer simulations of this model were also able to pro-
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vide a qualitative account of the growth of cultured human mesenchymal stem cells 
 [30] . Variability in biological systems can also be represented with a bayesian network 
(BN). BNs are a type of probabilistic network graph, where each node within the graph 
represents a variable. Nodes can be discrete or continuous and are connected to a prob-
ability density function, which is dependent on the values of the inputs to the nodes 
 [31] . Recently, a special type of BN called a dynamic BN was applied to the Baltimore 
Longitudinal Study of Aging. The advantage of this approach over conventional BNs 
was its ability to model feedback loops. The model showed that interactions among 
regional volume change rates for a mild cognitive impairment group were different 
from that of a ‘normal’ aging cohort  [32] . A limitation of BNs is that they are entirely 
probabilistic and do not represent biological systems mechanistically. 
 Petri Net Models, Boolean Networks and Agent-Based Models 
 Petri nets are a directed bipartite graph, with two types of nodes, called places and tran-
sitions, which are represented diagrammatically by circles and rectangles, respectively. 
Circles represent ‘places’ while rectangles represent ‘transitions’. Places and transitions 
are connected via arrows/arcs. Each circle or place contains a number of tokens which 
is a kin to a discrete number of biochemical molecules, while the stoichiometry is in-
dicated by the weight above the arrow/arc. Tokens can be both consumed and pro-
duced within the Petri net, while a Petri net functions by input-output firing at the 
‘transitions’ within the network. The ‘firing’ of transitions is a kin to a biochemical 
reaction taking place. The firing of ‘transitions’ is controlled incrementally using time 
steps. There are many different variants of Petri net, including coloured, hybrid, con-
tinuous and stochastic, each having a slightly different mode of operation. Petri nets 
are ubiquitously employed to study genetic regulatory networks  [33] . From an aging 
perspective, a recent Petri net model involved modelling the high osmolarity glycerol 
signalling pathway, an important regulator of several transcription factors that re-
spond to oxidative stress  [34] . The model focused on  Saccharomyces cerevisiae and was 
able to successfully integrate key signalling, metabolic and regulatory processes in a 
systems orientated fashion. Boolean network models are also comprised of nodes that 
can either be in an ‘on’ or ‘off’ state. The dynamics of the model are acted out by a se-
ries of time steps, with the state of each Boolean variable being updated at each time 
step. Similar to Petri nets, Boolean models are regularly employed to examine gene 
regulatory networks. A recent example of a Boolean model relevant to aging research 
described the behaviour of the apoptosis network. The model provided insights into 
the interactions between pro- and anti-apoptotic factors  [35] . Agent-based models 
have been increasingly used in aging research also  [36] . This is a rule-based approach 
which is used to investigate biological systems using clusters of independent agents 
whose behaviour is underpinned by simple rules. These agents are capable of interact-
ing with one another through space and time. Agent-based models have been applied 
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to many areas of aging research, including signalling pathways, and immune respons-
es. An agent-based model has recently been used to model the NF-κB (nuclear factor-κ 
light chain enhancer of activated B cells). The model incorporated individual mole-
cules, receptors, genes and structural components such as actin filaments and cytoskel-
eton, while providing a detailed outline of this network  [37] . 
 Model Building 
 The steps in model building in aging research are presented in  figure 1 . 
 Step 1: Selecting a System to Model, and Step 2: Checking for Previous Models 
 Increasingly, modellers are becoming part of the infrastructure of modern wet labo-
ratories, and in theory computational modelling should directly compliment the 
other systems biology techniques outlined in this book thus far. Therefore, the direc-
tion the computational model takes should be informed by the overall research focus 
of the wet laboratory and should also be integrated with other laboratory experi-
ments  [38] . Once an aging-focused system is identified, it is necessary to determine 
whether the model will simply describe the systems of interest or whether it will fo-
cus on predicting the behaviour of the system (a hypothesis-driven model). This 
decision should be determined by the goals and motivations of the research team. 
The team will then be required to decide on the components of the model. This is 
an abstract process, and it is not possible to include every biological species or reac-
tion. As a rule of thumb, model boundary points should be informed by the idea or 
hypothesis that is under consideration. It is also important to perform a literature 
search to determine if the system of interest has been modelled previously. This step 
can be facilitated by the BioModels database, an archive of published peer-reviewed 
systems models (http://www.ebi.ac.uk/biomodels-main). Models archived in the 
BioModels database are coded in the model exchange framework, the Systems Biol-
ogy Markup Language (SBML; http://sbml.org/Main_Page). If no suitable model 
exists, it will be necessary to develop a list of biological species and to determine how 
they interact with each other before visually displaying their interactions in a net-
work diagram. 
 Step 3: Network Diagram Construction, and Step 4: Deciding on a Mathematical 
Framework 
 A network diagram is necessary to outline precisely how the biological species interact 
and to illustrate model boundary points. A variety of approaches can be used to do this, 
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and recently an attempt has been made to standardize how network diagrams are repre-
sented using a framework called Systems Biology Graphical Notation  [39] which could 
become the standard means of representing models diagrammatically in the future. To 
illustrate the network building process, an example of an elementary model of the mTOR 
signal cascade was developed ( fig. 2 ). The purpose of including this diagram was firstly 
to illustrate the precise nature of network diagrams. Secondly, the diagram emphasizes 
that one must abstract when model building. For example, the mTOR signal cascade is 
a complex network, with >50 components; thus, it was necessary to be selective in order 
to identify key hubs in the pathway. The network diagram (hypothetical model) com-
mences with the extrinsic stimulation of P13K by growth factors such as those from the 
Hypothesis(1)
Check for
existing models
(2)
Use existing
model
Network
diagram
(3)
Mathematical
framework
(4)
Select
software tool
(5)
Set initial
conditions
(6)
Model
simulation(7)
Model
validation
(9)
Hypothesis
exploration
(8)
Revisit hypothesis
Further wet lab
experiments
(10)
 Fig. 1. The 10 steps involved in the modelling process; the process is cyclic with wet laboratory ex-
perimentation generating a hypothesis which in turn can be tested by constructing a model; the 
model in turn feeds further wet laboratory experimentation. 
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insulin-like growth factor family. This is significant from an aging perspective as CR 
inhibits the activation of this pathway. AKT is activated by P13K in a manner which de-
pends on the rate at which P13K has been activated (reactions are indicated by arrows, 
with their kinetic reaction rates indicated by the symbols k 1 –k 10 ). Both P13K and AKT 
have degradation rates. From an ageing perspective it would be worthwhile investigat-
ing how changes to these rates impact the system as a whole. Alterations to the levels of 
AKT have been implicated in the progression of age-related diseases such as cancer and 
Extrinsic signal 
P13K
k2
AKT
k1
Activation
signal
PRAS40
PRAS40Phos
mTOR
k5
Phosphorylation
rate  
Cell
metabolism
Metabolic activation 
Degradation 
k9
Inhibition  
Cell
k4
k3
k6
k7
k8
Signal degradation
k10
SignalRates can be changed 
to reflect aging, 
dietary restriction or 
the inclusion of 
resveratrol 
 Fig. 2. Diagrammatic representation of mTOR signalling for illustrative purposes. Arrows represent 
stimulation or conversion reactions; while feedback inhibition is represented by T-shaped arrows. 
k 1 –k 10 represent kinetic reaction rate constants for each of the steps in the model. k 1  = Rate of acti-
vation of P13K; k 2  = rate of activation of AKT; k 3  = degradation rate of P13K; k 4  = degradation rate of 
AKT; k 5  = rate of PRAS40 phosphorylation; k 6  = rate of PRAS40 degradation; k 7  = inhibition of mTOR 
signal; k 8  = mTOR signal input; k 9  = metabolic activation; k 10  = metabolic signal degradation; P13K = 
phosphoinositide 3-kinase; AKT  = protein kinase B; PRAS40  = proline-rich AKT1 substrate 1; 
 PRAS40Phos = phosphorylated PRAS40. 
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type 2 diabetes; therefore, this is another aspect of the model that could be explored from 
an intrinsic aging perspective. Dietary regimes associated with longevity could also be 
investigated; for example, it would be straightforward to incorporate the effects of CR 
on this pathway or to include the proposed inhibitory effects of the phenolic compound 
resveratrol.  
 Step 5: Identify a Suitable Modelling Tool, and Step 6: Setting the Initial Conditions/
Parameters 
 There are many software tools available to build models of biological systems. Ex-
amples include commercial software packages such as Mathematica and MATLAB, 
while non-commercial tools include Copasi (http://www.copasi.org), CellDesigner 
(http://www.celldesigner.org/) and PyCml (https://chaste.cs.ox.ac.uk/cellml/). Until 
recently, it was necessary to learn how to programme competently to construct a 
computational model, which made the discipline inaccessible to many bioscience re-
searchers. Recently, significant progress has been made, and many tools now come 
with a graphical user interface (GUI), for instance Copasi  [40] and CellDesigner have 
intuitive GUIs. If the model is kinetic based, setting the initial conditions and param-
eters involves establishing the initial concentrations of the various biological species 
and giving each rate law a value. There are many online resources which can be uti-
lized to help with this process. For example, BRENDA (http://www.brenda-enzymes.
org/) and SABIO-RK (http://sabio.h-its.org/) archive the details of a wide variety of 
kinetic data including V max and K cat values which can be used to inform model pa-
rameterization. 
 Step 7: Model Simulation, and Step 8: Model Validation/Parameter Inference 
 The output from a simulation will depend on the type of mathematical framework 
that underpins the model. For example, a deterministic solution will always have the 
same output for a given set of initial conditions and parameters. A stochastic simula-
tion will not produce the same output given a set of initial conditions and parameters. 
Output from the model can be compared with appropriate time course data to com-
pare the dynamics of the system with its biological counterpart. The sensitivity of the 
model can also be explored by making adjustments to the model parameters/initial 
species concentrations. If the model does not compare well to the behaviour of the 
biological system, it will be necessary to ‘fine tune’ the parameters to ensure the be-
haviour of the model is consistent with the dynamics of the biological system. Certain 
software tools are capable of optimizing a parameter set (or sets) which is consistent 
with the experimental output. For example, the software tool Copasi has a number of 
inbuilt statistical techniques to facilitate parameter optimization. 
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 Step 9: Hypothesis Examination, and Step 10: Further Wet Lab Experimentation 
 If the output of the model appears to be a realistic interpretation of the dynamical be-
haviour of the system, the model can be used as a predictive tool. If the model does 
not appear to be a realistic interpretation, one can refine the research question/mod-
el; thus, model building is a cyclic process that involves continual revalidation and 
re-evaluation of the model. If satisfied with the model it can be coded in an exchange 
format and several exist for computational models, including the Cell Markup Lan-
guage (Cell-ML; http://www.cellml.org/) and SBML (http://sbml.org/Main_Page). 
Presently, SBML is the leading exchange format in systems biology and has been 
evolving since 2000 thanks to an international community of software developers and 
users. 
 Computational Systems Models of Aging – From Cell to Whole Body 
 As outlined, the aging process is inherently complex with a multitude of overlapping 
relationships that communicate over several different levels. This complexity is a direct 
result of the underlying multi-scale interconnectivity and interplay of a diverse range of 
molecular, biochemical and physiological processes. There is no doubt that aging and 
age-related diseases are a manifestation of the dysregulation and dysfunction of these 
systems. As a result of the multi-scale nature of biological systems, various different lev-
els of abstraction have been used to create models of a diverse array of processes relating 
to aging. In the main, systems computational models are cellular in nature; however, 
recently several aging researchers have come to the conclusion that cellular models, al-
though important are an insufficient means of representing the holistic nature of the 
aging process and its interaction with age-related pathologies. Consequently, several 
whole-body computational systems models have been developed. It is not possible to 
discuss every model; therefore, selections have been restricted to those that illustrate 
eloquently the diversity and utility of whole-body systems models which have been ap-
plied to aging research. For instance, a recent whole-body systems model of cholesterol 
metabolism was used to explore the interaction of this system with intrinsic aging. The 
model was able to show that changes to intestinal cholesterol absorption due to the ag-
ing process could result in a rise in low-density lipoprotein cholesterol (LDL-C), a key 
pathological signature of CVD. Moreover, the model also showed that decreasing the 
rate of hepatic clearance of LDL-C from half its initial value by age 65 years can result 
in the significant elevation of LDL-C  [18] . Other age-related whole-body models have 
focused on brain aging and dementia. For example, a novel whole-body computational 
model integrated specific brain regions associated with AD together with the physio-
logical regulation of the stress hormone cortisol. The rationale underpinning the mod-
el was to investigate the possible role elevated levels of cortisol have in damaging the 
hippocampus, the brain region which is the core pathological substrate for AD. The 
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model was able to replicate the in vivo aging of the hippocampus. Moreover, both acute 
and chronic elevations in cortisol increased aging-associated hippocampal atrophy and 
concomitant loss in the activity of the hippocampus. The model was also used to inves-
tigate potential interventions such as physical activity which could be used to mitigate 
the effects of aging and cortisol damage to the hippocampus  [41] . 
 Conclusions 
 Computational systems modelling is a novel integrated approach that provides a pow-
erful foundation for gaining an in-depth understanding of how human metabolism is 
perturbed by aging. This chapter has highlighted the rationale for using computation-
al systems models. The steps involved in the model building process were also outlined, 
and a wide variety of models from cellular to whole body were discussed that empha-
sized the utility of modelling to aging research. It is highly probable that in future years 
computation systems modelling will be further embedded within systems biology. This 
is something that the aging research community will benefit from as coming years of-
fer the possibility of models being connected together to create a holistic picture of the 
aging process from genes through to whole organ systems. Such models could focus 
on multi-scale responses to nutrients or physical activity over extended time frames. 
In order to achieve this goal, there is little doubt innovative collaborations are a neces-
sity. As this chapter has highlighted, building computational models is a highly collab-
orative effort that requires considerable interaction between several disciplines. Thus, 
it is not a process that should occur in isolation as it needs to be firmly integrated 
within the systems biology paradigm. Working together mathematicians, computer 
scientists and experimental biologists will be able to provide valuable insights into how 
robust biological systems break down due to the aging process. Such insights will no 
doubt contribute to the development of strategies which help to prolong healthy life 
and delay age-related diseases such as CVD and dementia. 
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 Abstract 
 Animals and plants have biological clocks that help to regulate circadian cycles, seasonal rhythms, 
growth, development and sexual maturity. If aging is not a stochastic process of attrition but is cen-
trally orchestrated, it is reasonable to suspect that the timing of senescence is also influenced by one 
or more biological clocks. Evolutionary reasoning first articulated by G. Williams suggests that mul-
tiple, redundant clocks might influence organismal aging. Some aging clocks that have been pro-
posed include the suprachiasmatic nucleus, the hypothalamus, involution of the thymus, and cel-
lular senescence. Cellular senescence, mediated by telomere attrition, is in a class by itself, having 
recently been validated as a primary regulator of aging. Gene expression is known to change in 
characteristic ways with age, and in particular DNA methylation changes in age-related ways. Here-
in, I propose a new candidate for an aging clock, based on epigenetics and the state of chromosome 
methylation, particularly in stem cells. If validated, this mechanism would present a challenging but 
not impossible target for medical intervention.  © 2015 S. Karger AG, Basel 
 To many readers, it will seem like a strange idea that aging proceeds under control of 
a biological clock. If you think in terms of the body accumulating damage over time, 
then there is no master clock, no separate record of the state of the body’s age – there 
are only the various parts of the body in various states of disrepair at any given time. 
 A recurring theme from research in animal models over the past two decades is 
that aging is not a passive accumulation of cellular damage, but is actively regulated 
at the level of the whole organism. However, even this regulation need not imply the 
existence of a biological clock; it may be merely that the activity of the body’s repair 
mechanisms is modulated by an internal calculation based on external cues, so that 
the damage might accumulate at a variable rate without the body having to follow a 
scheduled program.
 How Does the Body Know How Old It Is? 
Introducing the Epigenetic Clock Hypothesis 
 Joshua Mitteldorf  
 Department of EAPS, Massachusetts Institute of Technology,  Cambridge, Mass. , USA 
This chapter is adapted from an article of the same title published in Biochemistry (Mosc) [2013;78:1048–1053].
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 One motivation for thinking about a clock is a kind of Pascal’s Wager 1  for the ger-
ontologist: If there is an aging clock, then it suggests a convenient target for medical 
intervention that will have a highly leveraged effect on aging and disease. Speculation 
about the existence of an aging clock is interesting because, if such a thing does exist, 
it might be possible not just to slow the rate of aging, but to act directly on the clock, 
to set it back.
 But Pascal’s Wager (concerning the existence of God) appears to modern sensi-
bilities to be a form of wishful thinking and an inversion of causal logic. We need a 
better reason for exploring the premise of an aging clock than the fact that it would 
be a boon for gerontologists if it turns out to be true.
 Reasons to Believe in an Aging Clock 
 Here are four arguments in favor of an aging clock, which we shall explore in some 
detail presently. (1) In some animal models, interventions are known that do not sim-
ply slow the pace of decline, but actually cause reversion to a younger, more robust 
state. (2) Gene expression is known to change with age, including characteristic pro-
files that seem to be associated with senescence. (3) Attrition of telomeres seems in 
some ways to act like an aging clock. (4) Evidence that aging is an adaptive evolution-
ary program implies the existence of an aging clock. 
 (1) Many experimental interventions are known, for a given species, that cause the 
individual to revert to a younger state. Carrion beetles can be starved until they regress 
to a larval stage. Renewal of feeding causes them to mature again, and starvation can 
induce a repetition of the cycle through multiple ‘lifetimes’  [1] . The coelenterate  Tur-
ritopsis has been observed to perform a similar feat outside the lab, in a natural setting 
 [2, 3] . Lab mice have been rejuvenated with telomerase  [4, 5] and with blood factors 
 [6, 7] . In experiments with flies that are switched from a fully fed diet to caloric restric-
tion (CR) in mid-life  [8] , it is found that the flies’ mortality curve jumps quickly from 
the fully fed curve to the CR curve, as if they had been on CR from an early age. This 
suggests that, at least concerning those traits involved in mortality, CR does not mere-
ly slow the pace of future decline, but induces a change to a younger metabolic state.
 Fahy  [9] describes several more intriguing examples. Some of these might be con-
ceived simply as upregulation of repair mechanisms, such that damage is temporarily 
being repaired faster than it accumulates. But even this conservative interpretation 
suggests that the body repairs itself more efficiently at younger ages, and this implies 
that the body ‘knows how old it is’ and chooses an age-appropriate efficiency of repair.
 (2) Gene expression is now routinely profiled with DNA microarrays. Differences 
between late-life and early-life gene expression have been catalogued in several differ-
 1   Blaise Pascal (1523–1562) argued that we ought to believe in God for the following reason: If we believe in God 
and it turns out that our belief is erroneous, the consequence is trivial, but if we fail to believe in God and it turns 
out that God really exists, then the consequence is eternal damnation. 
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ent species  [10–12] . In theory, these differences might be accounted for as the body’s 
response to different levels of damage, rather than an age-dependent program; how-
ever, the nature of the changes with age suggests that they may be a cause of aging rath-
er than a response to aging  [12, 13] . For example, inflammation seems to be upregu-
lated and immune function suppressed (in mice) by genes expressed late in life  [12] .
 Early expositions of the pleiotropic theories for evolution of aging  [14] were formu-
lated before anything was known about the cell’s and the body’s elaborate controls over 
gene expression. In Williams’s early conceptions of the fundamental pleiotropic mecha-
nism, he imagined that if a gene was beneficial early in life, the body was stuck with it, 
even if its operation became detrimental to fitness later in life. We now know that this 
naïve version of pleiotropy is inconsistent with fundamentals of biochemistry. In par-
ticular, there is far more DNA devoted to transcription controls than there is genetic 
material that codes directly for proteins; and timing of gene expression is a fundamental 
element of all biological systems. All of development and maturation is controlled by 
biological clocks, so it is completely plausible that biological clocks are  available for con-
trol of aging if we believe it possible that natural selection could have led in that direction.
 (3) Short telomeres are associated with higher mortality and shorter life expectan-
cy in many species, and the correlations persist when age is statistically factored out. 
Since telomeres shorten throughout the life span, and telomerase expression seems to 
be modulated in a manner consistent with regulation of life span, the idea of telomeres 
as an aging clock has been attractive to a number of authors  [15–18] . A full section of 
the present chapter will be devoted to this hypothesis.
 (4) I have collected evidence elsewhere  [19, 20] that aging is a group-selected Dar-
winian adaptation, selected for its own sake. Others who have advocated this position 
explicitly include Skulachev  [21] , Bredesen  [22] , Goldsmith  [23] , Longo  [24] , Clark 
 [25] , Travis  [26] , Martins  [27] , Libertini  [28] and Bowles  [29] . Kenyon and Barja have 
indicated to me privately that sections of their submitted articles concerning pro-
grammed aging have been deleted by peer reviewers as a condition of publication. 
Many more scientists routinely adopt an implicit assumption that aging is pro-
grammed. But most evolutionists find this proposition implausible because the indi-
vidual fitness cost of aging is high and the group-selected benefit is not confined to 
genetic kin. A brief summary of the reasons to believe that aging is an explicit evolu-
tionary adaptation follows, and the reader is referred to my chapter in  The Future of 
Aging  [20] for details:
 • Many of the genes that regulate aging (TOR, IGF, DAF/FOXO) have been 
conserved since the dawn of eukaryotic life  [30] . All other such highly conserved 
genes have been protected by natural selection because they form an essential core 
to life processes. Natural selection has evidently treated aging as a core life process. 
 • Hormesis: The fact that life span can be readily extended under genetic control 
when conditions are most harsh and challenging (e.g., starvation) indicates that 
the body is ‘holding back’ on life span at times when the environment is more 
favorable  [31, 32] . 
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 • Breeding animals for longevity does not necessarily impair fertility, as is 
demanded by popular theories based on pleiotropy or trade-offs  [33] . In fact, 
many single-gene mutations are known to extend life (especially in worms), for 
which no major cost has yet been identified  [34] . 
 • One-celled eukaryotes are subject to two modes of programmed death: apoptosis 
 [35] and replicative senescence  [25, 36, 37] . This fact in itself vitiates the classical 
theoretical contention that it is impossible for programmed death to evolve, 
requiring as it would an implausible triumph of group selection over individual 
selection. Both apoptosis and replicative senescence have been conserved, so that 
they continue to play a role in the aging of higher organisms, including humans 
 [38, 39] . 
 • Many semelparous plants and animals exhibit manifestly programmed death 
 [40–42] , providing further counter-examples to the claim that affirmative 
selection for death is excluded on theoretical grounds. 
 Once we accept the premise that aging is programmed, it follows that the body 
must actively track its age (in a manner flexibly responsive to environmental cues) in 
order to initiate senescence at a characteristic age. The process must be governed by 
one or more master clocks.
 Modulation of the Aging Clock Suggests a Demographic Purpose 
 The aging clock does not measure strict time, but is flexible in response to environ-
mental conditions. The way in which the aging clock responds to the environment is 
highly suggestive of an adaptive purpose that helps us to understand the evolution of 
aging generally. 
 It is not possible to make sense of this picture if we imagine that life histories have 
been shaped only by natural selection for individual fitness. For the individual, living 
longer is always better. Theory predicts that all life histories should emulate the lobster 
or the sequoia tree, growing larger and more fertile and more robust against major 
causes of mortality with each passing year.
 Instead, in iteroparous animals, we see a fixed life span, and the length of life vary-
ing  inversely with hardship and environmental challenge, especially hunger. When 
the death rate from starvation is high, the death rate from aging is low, and vice versa. 
This is the well-known CR effect, but the same is also true of other environmental 
challenges: physical duress, infections, temperature extremes, and toxins in small 
amounts all lead paradoxically to longer life spans. The phenomenon is called  horme-
sis  [31, 32] and its reality has been established over the last two decades, after facing 
substantial skepticism of the initial accounts  [43] .
 The demographic impact of senescence is thus to level the death rate in good 
times and bad, by imposing a higher mortality burden when the body is least stressed 
and lower just when it would appear to be metabolically most difficult to preserve 
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the soma and avoid aging – under conditions of physical stress and starvation. By 
damping the most extreme variations in death rate, senescence makes possible the 
persistence and stability of ecosystems. Without aging, we might imagine a Tragedy 
of the Commons  [44] , with predator species competing viciously for their prey, and 
predator/prey population cycling much deeper than is actually observed in nature 
 [45, 46] .
 The variability of the aging clock, and the existence of the clock itself, might be 
understood in terms of natural selection at the level of ecosystems. Ecosystems 
built on species that have a programmed life span are less likely to suffer over-
shoot, instability and collapse than if the species have indeterminate life span, lim-
ited only by starvation, predation, and epidemic infections. I have argued else-
where  [45, 46] that ecological homeostasis is a major target of natural selection, 
tempering and counterbalancing the pressure toward higher individual reproduc-
tive fitness.
 Aging Clocks 
 If a program for aging were designed by a human engineer, it would be based on a 
central (flexible) time-keeping mechanism; but this is not necessarily the system that 
natural selection has bequeathed us. In particular, there is long-term group selection 
in favor of aging, but strong short-term individual selection against it. In order to 
shield affirmative aging mechanisms from dismantlement at the hand of individual 
selection, it is likely that evolution has embedded them below the surface, and de-
ployed redundant time-keeping  [14, 46] . A single master clock would be easily hi-
jacked by individual selection. We might expect to find several interdependent and 
redundant clocks for aging. 
 Under the paradigm of programmed aging, senescence may be a continuation of 
development, and we might suspect that whatever controls the timing of development 
has been extended to regulate the timing of aging. But neither a developmental clock 
nor an aging clock has yet been discovered. The closest thing we know of is cellular 
senescence, based on telomere length  [47] . But there are some organisms that age, in 
which telomerase is freely expressed, telomeres remain long, and thus the telomere 
clock is not operating. Examples include some rodents  [48] , bats  [49] and pigs  [50] . 
These considerations make it more likely that there is another clock and that it is 
somehow ‘hidden in the works’ of metabolism, so that it would not have been obvious 
to investigators thus far.
 My hypothesis, proposed below, is that gene expression itself forms a kind of ag-
ing clock. Time is maintained within the signal networks of metabolism, and a run-
ning record of the organism’s age is imprinted in the methylation state of the ge-
nome, as well as transcription factors and other regulators of gene expression. Gene 
expression products are part of a signal cascade that affects all aspects of metabo-
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lism, but that also feeds back (e.g. through methyl transferases) to increment the 
clock.
 I will first briefly survey known biological clocks, including aging clocks, and 
discuss prospects for medical interventions that might manipulate them. These 
include thymic involution, the suprachiasmatic nucleus, the hypothalamus, and 
replicative senescence. The latter, based on telomere attrition, has been the subject 
of intense research in the past decade, with promising developments ongoing. Fi-
nally, I argue based on evidence and logic that the methylation state of the ge-
nome, within stem cells in particular, may be a promising place to look for a 
stored record of organismic age that informs the body’s growth, development and 
senescence.
 Cellular Senescence and the Telomere Clock 
 Telomeres in stem cells (and hence in their somatic progeny) suffer attrition over a 
human lifetime because they lose a few hundred base pairs with each cell division. The 
primary means by which telomere length might be restored is through the enzyme 
 telomerase , which includes an enzyme which crawls along a chromosome end, and 
also an RNA template for copying the repetitive sequence. Telomerase is expressed 
copiously during early stages of an embryo’s development, but very little telomerase 
is expressed after the individual passes beyond embryonic development. Hence, telo-
meres are permitted to shorten with age, even though the gene for telomerase remains 
(unexpressed) in the nucleus of every cell in the body. 
 The hypothesis that cellular senescence represents a primary aging clock was 
promoted by West, culminating in a popular book published in 2003  [17] . That 
same year saw Cawthon’s actuarial study  [39] , associating leukocyte telomere length 
with mortality in humans. In the years since then, evidence has accumulated for the 
importance of telomere length in aging of birds and mammals including humans, 
and several herbal extracts that are claimed to address telomeric aging have reached 
the market. Meanwhile, several companies are researching more potent telomerase 
activators in the belief that this is a path to substantial extension of the human life 
span.
 The Cawthon results forced many researchers to consider for the first time the pos-
sibility that people could be dying for lack of telomerase. Association between telo-
mere length and life expectancy was confirmed in 3 studies of animals in the wild 
 [51–53] . The question remained open whether longer telomeres were a marker or a 
cause of life expectancy. This question has been addressed with animal studies. Telo-
meres have been extended by adding ectopic copies of the telomerase gene, by genet-
ically programming the expression of telomerase via a tamoxifen switch, and by oral 
administration of a plant-derived compound that promotes telomerase expression. 
Life span extension has been detected in worms, mice and rats.
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 Joeng et al.  [54] created a strain of  Caenorhabditis elegans  worms with longer telo-
meres using not telomerase, but a telomere-binding protein called HRP-1. Life span 
was extended by 19% by this intervention. The result was unexpected because telo-
meres do not erode over the life span of  C. elegans . In fact, the adult worms are post-
mitotic: there are no stem cells, no replenishment of tissues during a single worm’s 
lifetime. It should not be possible for telomeres to function as an aging clock. Life ex-
tension of the HRP-1 worms was dependent on the presence of DAF-16, an upstream 
modifier of aging that is thought to be a master regulator of dauer formation in re-
sponse to environmental hardships.
 Tomás-Loba  [55] first demonstrated life extension in mice using a strain that was 
engineered with extra copies of the telomerase (TERT) gene. Because it was widely 
believed that telomerase expression could cause cancer, they used mice that were can-
cer resistant via modified  p53 . These mice lived 40% longer than controls, and mark-
ers of senescence such as inflammation, glucose tolerance and neurological measures 
appeared on a delayed schedule. This result was unexpected because wild-type mice 
express telomerase copiously, and their telomeres are long enough to last through 
several lifetimes without obvious effects on health and longevity  [56–58] .
 There have also been some negative indications, casting doubt on the hypothesis 
that telomeres are an aging clock. Telomere length is widely variable in newborns  [59] , 
with a standard deviation about 7% of the mean. Telomere length predicts mortality 
and life expectancy less well with advancing age, with correlation disappearing for 
ages >80  [60, 61] . A few studies  [62, 63] have reported a tumorigenic effect of telom-
erase, suggesting that the evolutionary purpose for rationing telomerase is the oppo-
site of an aging clock.
 There are two known mechanisms by which telomeric aging might lead to senes-
cence of the organism and greater risk of mortality. First, as stem cells suffer from 
telomere attrition, they slow down in replacing the skin and blood and immune cells 
that are constantly turning over. Second, cells with short telomeres enter a senescent 
phase where they emit toxic signals, including proinflammatory cytokines  [64, 65] . 
Hence, it is not surprising to see cellular senescence emerge as a primary driver of se-
nescent phenotypes.
 The role of telomere length as a cellular aging clock recapitulates a similar function 
in some  protoctista . In paramecia, for example, telomerase is not expressed during 
mitosis, but only during conjugation. Hence, paramecia may reproduce clonally 
through a few hundred generations before their telomeres become shortened and they 
enter a senescent state, losing viability. They are compelled to conjugate, blending 
their genomes sexually with a partner cell, or they cease to be able to reproduce. 
Hence, the rationing of telomerase serves to enforce an imperative to share genes, and 
helps to assure that the local population remains diverse, and thus robust. Telomeric 
senescence serves to damp a winner-take-all form of individual selection, and en-
hanced diversity is insurance against excessive specialization, which might offer tem-
porary advantage  [25] .
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 Other Known Biological Clocks 
 Circadian biological clocks have been widely studied and are partially understood. 
There is evidence for an annual clock that contributes, along with environmental cues, 
to patterns of migration and hibernation; but mechanisms have not been identified. 
And the timing of growth, reproductive maturity, and senescence remain more mys-
terious yet. 
 The mammalian circadian rhythm is known to be regulated from the suprachias-
matic nucleus, a small structure in the middle of the brain  [66] . A chemical mecha-
nism (based on peroxiredoxins) has recently been discovered that might underlie all 
circadian clocks  [67] . The cycle is responsive to light and dark, and the intrinsic pe-
riod is close enough to 24 h that circadian timing becomes entrained with diurnal 
cycles.
 It has been proposed that seasonal cycles in mammals are mediated through a re-
sponse to light in the pineal gland. The mechanism is thought to be independent of 
the circadian clock  [68] . Again, there is an intrinsic cycle time that is modulated by 
temperature and duration of daylight.
 In female mammals, onset of puberty is controlled by a single chemical signal: 
gonadotropin-releasing hormone (GnRH). But the timing of this trigger is controlled 
in turn by a complex calculation, based in neural as well as hormonal mechanisms. 
‘The anatomical development of the GnRH secretory system occurs relatively early 
in life, and the synthetic capacity is present well before puberty in that GnRH mRNA 
expression reaches adult levels’  [69] . Timing responds to olfactory cues, stress, fat 
reserve, activity, season of the year, and other stimuli. The workings of this clock re-
main mysterious.
 Aging responds to these same cues, and perhaps others. There is reason to believe 
that the aging clock mechanism is at least as complex as the developmental clock. 
Though aging is programmed, it may not be programmed in a simple way. This ac-
counts for the challenge that aging has posed for research and medical intervention. 
The fact that aging progresses under genetic control suggests a promising approach 
to anti-aging interventions, and yet the complexity of the timing mechanism has 
slowed the pace of progress.
 Although relationships between the circadian clock and the aging clock have been 
documented, these are not such as to suggest that the aging clock depends directly on 
a count of circadian cycles. For example, dysregulation of the circadian clock  in either 
direction leads to accelerated aging in flies  [70, 71] .
 The Neuroendocrine Theory of Aging was proposed by Vladimir Dilman in 
1954  [72] . Homeostatic control of hormone secretions is supported by the hypo-
thalamus, and different hormonal levels are maintained as is appropriate for dif-
ferent stages of growth and development. Dilman’s hypothesis was that the trajec-
tory of changes in the hypothalamus has a kind of momentum (‘hyperadaptosis’) 
that carries forward after maturity and results in ‘dysregulation’ that character-
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izes the aging phenotype. The Neuroendocrine Theory is an early precedent for 
the Epigenetic Theory described below. ‘The life span, as one of the cyclic body 
functions regulated by “biological clocks”, would undergo a continuum of se-
quential stages driven by nervous and endocrine signals’  [73] . But Dilman did not 
frame this theory within the context of an adaptive program shaped by natural 
selection, and therefore the concept of a biological clock sits uncomfortably with-
in its narrative.
 The Immunologic Theory was proposed by Roy Walford in 1962  [74, 75] . The pro-
liferation of immune cells in the blood constitutes a kind of clock, which becomes 
dysfunctional as the number of cells multiply. The body’s cells are mutating as the 
number of different immune memory cells is multiplying. Chance coincidences result 
in the immune system attacking self with increasing frequency over time. Walford 
noted how many diseases of old age have a relationship to autoimmunity, but never 
connected this to programmed aging. He saw thymic involution as an independent 
cause of immune failure, and perhaps another aging clock.
 Epigenetic Clock Hypothesis 
 In the fall of 2012, an article  [13] appeared by Adiv Johnson and a diverse team of sci-
entists from the US and Europe pulling together evidence that the methylation state 
of the genome is related to the body’s age, and proposing methylation as an appropri-
ate target for anti-aging research. I would extend their proposal to argue that, if we 
believe there is an aging clock, the methylation state of the genome (especially in stem 
cells, because of their persistence) is logically the first place to look for its ‘clock dial’. 
Seeking a system of global signals that affects the metabolic state of the entire body, 
we would look as far upstream as possible. Upstream takes us to gene expression. Fur-
ther up, there may be signals that affect gene expression globally, but these, too, are 
products of genes, and hence they can be regarded as part of a self-modifying program 
for gene expression. If there is not in evidence another separate clock which feeds 
down to affect gene expression, then it is logical to assume that this self-modifying 
program functions as a clock in its own right. 
 We know that gene expression changes with age, and that this has the potential to 
affect all aspects of the metabolism and the aging phenotype. If there is an aging clock, 
then its output must be transduced so as to affect gene transcription. Merging the 
clock into the transcription state of the genome would be the most economical imple-
mentation of a clock mechanism, obviating the need for a separate record of the age 
state of the body. Gene transcription is affected by transient signaling, and also by 
more persistent epigenetic markers. The most important of these persistent markers 
is the genome’s methylation pattern. The ‘methylome’ contains information that is 
both programmable and persistent. Cytosine (the ‘C’ in ACGT) is one of the four 
nucleic acid residues that form chromosomal DNA. Within the DNA molecule, cyto-
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sine can accept a methyl group to form 5-methylcytosine, and this suppresses tran-
scription locally where methylation has occurred in gene promoters  [76] . Methylation 
patterns tend to be copied along with DNA replication, and they can even last through 
several generations as a form of epigenetic inheritance  [77] .
 An epigenetic clock has the potential to regulate growth, development and sexual 
maturity, as well as aging. If no other clock has been discovered that controls the tim-
ing of both development and aging, then our default hypothesis ought to be that the 
epigenetic state of the genome is its own clock.
 The methylation state of the genome is also self-modifying in the sense that tran-
scription of methyl transferases and related enzymes creates the mechanism for feed-
ing back upon the methylation state. This feedback implies the basis for a clock mech-
anism. Genes that are transcribed today create the metabolic environment that cas-
cades into signals that reconfigure the methylation state and program the genes that 
will be transcribed tomorrow.
 The above constitutes a general, theoretical argument for epigenetic state as an ag-
ing clock. There are also specific experimental results that point in this direction:
 • Gene expression profiles change substantially with age. There is reason to believe 
that an individual with youthful gene expression is functionally a youthful 
individual  [13] . 
 • Methylation has about the right degree of persistence. We know that methylation 
contains epigenetic information that is passed on in a soft way when DNA is 
replicated. 
 • In general, methylation decreases with age (though there are characteristic 
regions that become hypermethylated). Hypomethylation has been associated 
with ‘frailty’ and markers of biological age  [78] . 
 • Fruit flies with an extra copy of the methyl transferase  dnmt2 in their genome 
lived 58% longer than control flies. Conversely, flies engineered to be +/– for 
 dnmt2 had lifespans 25% shorter  [79] . 
 • Similar experiments with mice yield more nuanced results. Early, unreproduced 
studies reported that methylation was actually higher in  dnmt1  +/– mice than in 
+/+ controls  [80, 81] . More recently, neural deficiencies and low bone densities, 
increasing with age, have been reported associated with engineered  dnmt1 
deficiencies  [82] . 
 • In monozygotic twins, methylation patterns are similar when young, but diverge 
over time  [83] . This suggests a stochastic component that may account for 
diverse dysregulations associated with aging. 
 Age is determined almost certainly by the detailed pattern of methylation and oth-
er epigenetic markers, not simply the crude quantity of methylation. And yet there is 
evidence that senescing cells are characterized by progressive demethylation, so that 
chromosomes in younger cells tend to be more methylated than older cells  [84, 85] . 
The possibility that demethylation may be an aging clock was first proposed by Bowles 
 [29] , based on the fact that ‘aging is accompanied by DNA demethylation  [86–88] . In 
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fact, the animal genome loses practically all 5-methylcytosines during the life, the rate 
of the loss being inversely proportional to maximal lifespan of the species  [88] . The 
same occurs in cell cultures, again the rate being inversely proportional to the cell 
lifespan (Hayflick limit)  [88–90] .’
 Skulachev also notes a connection between oxidation, which has often been recog-
nized as a stochastic marker for aging, and methylation. In his schema, oxidation is a 
more fundamental aging clock (rather than demethylation leading to oxidation, as I ar-
gue here). ‘[O]xidation by ROS of the guanine DNA residues to 8-hydroxyguanine 
strongly inhibits methylation of adjacent cytosines  [91] . Antioxidants, on the other 
hand, cause DNA hypermethylation  [92] . According to Panning and Jaenisch  [93] , 
DNA hypomethylation activates Xist gene expression in X chromosome, which corre-
lates with a dramatic stimulation of apoptosis. All these observations may be summa-
rized by the following chain of age-related events: ROS  → DNA de-methylation  → apop-
tosis  → aging  [90] .’
 Drugs targeted to sirtuins  [94] have found some early success in extending lifespan 
by indiscriminate silencing of gene expression. Sirtuins’ mechanism is mediated via 
histone deacetylation rather than methylation, but the ease with which simple silenc-
ing of genes could extend lifespan is suggestive. Also, protein-restricted and methio-
nine-restricted diets retard aging  [95] , presumably by dialing down expression of 
many genes indiscriminately. Methionine is the ‘start codon’, essential to the initia-
tion of all gene transcription.
 Testing the Hypothesis: Medical Implications 
 This hypothesis – that the body’s age is stored within the cell nucleus as a methylation 
pattern – suggests a program of research, and an anti-aging strategy. Interventions based 
on methylation will require both a detailed automated reading of the methylation state 
of the genome, and a means of transcribing a youthful profile into chromosomes in vitro. 
 The former is already fairly well developed. Heyn et al.  [85] report transcription of 
the methylome using microarrays. The latter may be far more challenging. Methyl 
transferases are able to methylate targeted genes, but details of the biochemistry that 
guides the transferases to their target is not yet understood  [13] .
 More accessible might be interventions to increase methylation broadly. This is a life 
extension strategy that has been made to work in flies  [79] but not yet in mammals. 
 S-adenosyl methionine (SAMe) is the basic methyl donor of all eukaryotes. Simple 
supplementation with SAMe has been found to relieve arthritis and depression 
 symptoms  [96] , and SAMe has been shown to protect methylation levels in radiation- 
challenged mice  [97] , but SAMe has not been found to extend life span in rodents. 
 Johnson et al.  [13] catalogue some nutrients that have been associated with reduced 
methylation, but none with enhanced methylation. They stress that we are yet at an 
early stage of knowledge concerning the relationship between methylation and aging, 
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and it is not yet proven even that alterations of the methylation state are a cause and 
not simply a product of aging. Nevertheless, they propose methylation as a promising 
avenue for foundational and clinical research, and I concur. Since this article was writ-
ten,  CRISPR technology (Clustered, Regularly Interspaced, Short Palindromic Repeats) 
has advanced rapidly. Just a few years ago, the technique was developed to target a place 
in the genome for gene editing. It is now expected that CRISPR will also provide a handle 
for dictating epigenetics [98], turning genes on [99] and off [100] at will. If this comes to 
pass,  CRISPR may provide a dramatic shortcut, cutting through the complex biochem-
istry of gene expression and permitting us to target genes for promotion or repression. 
There are already several known genes with presumptive anti-aging benefits (e.g. GDF11, 
Klotho, possibly oxytocin, melatonin), and others that are overexpressed late in life with 
detrimental consequences (e.g. NFκB, TGF-β, possibly LH and FSH). 
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 Abstract 
 There is not one systems biology of aging, but two. Though aging can evolve in either sexual or 
asexual species when there is asymmetric reproduction, the evolutionary genetics of aging in spe-
cies with frequent sexual recombination are quite different from those arising when sex is rare or 
absent. When recombination is rare, selection is expected to act chiefly on rare large-effect muta-
tions, which purge genetic variation due to genome-wide hitchhiking. In such species, the systems 
biology of aging can focus on the effects of large-effect mutants, transgenics, and combinations of 
such genetic manipulations. By contrast, sexually outbreeding species maintain abundant genetic 
polymorphism within populations. In such species, the systems biology of aging can examine the 
genome-wide effects of selection and genetic drift on the numerous polymorphic loci that respond 
to laboratory selection for different patterns of aging. An important question of medical relevance 
is to what extent insights derived from the systems biology of aging in model species can be applied 
to human aging.  © 2015 S. Karger AG, Basel 
 With the advent of whole-genome DNA sequencing and other genomic technologies, 
biology is now revealing much about the genetic foundations of life that were once 
obscure. Here, we discuss the relevance of some of these early genomic findings for 
the systems biology of aging, as well as the design and interpretation of experimental 
research on aging. 
 We structure our discussion of these issues in terms of two distinct kinds of popu-
lation genetic systems: largely asexual reproduction or sexual reproduction with lim-
ited outcrossing (system 1), and sexual reproduction with consistent outbreeding 
(system 2). These two systems have very different consequences for genomes, par-
ticularly the relationship between genetic variation and organismal function, includ-
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ing aging. Their differing patterns of genetic variation and adaptation produce strik-
ing differences in the relationship between genetic variation and aging, with profound 
consequences for the theoretical explanation and experimental analysis of the genom-
ic foundations for the systems biology of aging.
 Rarely Sexual Evolutionary Genetics: Theoretical Expectations for Aging Genomics 
 Complete asexuality is evolutionarily exceptional. The prokaryotes, for example, may 
lack frequent mendelian recombination, but nonetheless have parasexual mecha-
nisms of recombination: conjugation, transduction, and transformation. Such para-
sexual genetic exchange can be largely or wholly removed from laboratory evolution 
paradigms that use well-understood prokaryotes such as  Escherichia coli  [1] . But in 
nature, parasexuality doubtless occurs with enough frequency to produce novel geno-
types at a greater frequency than mutation within clonal lineages can achieve. Early 
work showed that bacterial genetic diversity is higher than previously thought, sug-
gesting infectious transfer of genes brings in new genetic variants which are not nec-
essarily purged by directional selection  [2] . Indeed, when there is frequency-depen-
dent selection as well as transposable, phage, and plasmid elements, even bacterial 
populations can maintain significant genetic variation  [3] . 
 However, if parasexuality introduces new genetic variation into a population at a 
sufficiently low rate, then it is roughly like mutation with respect to its impact on func-
tional genetics. That is, if mendelian segregation and recombination among variant 
alleles do not usually occur in each generation, then conventional theory for clonal 
selection can address the evolutionary effects of the favorable genetic variants by ge-
netic exchange which is sufficiently rare. Note that this does  not mean that the genom-
ics of non-mendelian populations would not be significantly different with parasexu-
al genetic exchange. Compared to wholly asexual populations, there should be more 
genetic variation within parasexual or infrequently outcrossing sexual populations. 
But if we assume that beneficial genetic variation is only introduced rarely by para-
sexual recombination or amphimixis, then the low frequency at which genetic varia-
tion is introduced over time gives rise to an evolutionary process of adaptation math-
ematically comparable to that of adaptation sustained by rare favorable mutations 
subject to clonal selection.
 Thus, it is reasonable to examine the scenarios for adaptation and for aging that 
arise with this evolutionary genetic ‘system 1’ in terms of the formal theory and ex-
perimental findings already available for asexual systems with intermittent favorable 
mutations. The theory of such evolutionary systems is relatively powerful  [4] . Small-
effect beneficial variants will often be lost because of genetic drift effects near the fix-
ation boundary, as they will in mendelian populations. Large-effect beneficial variants 
are much more likely to escape from such sampling effects and sweep to fixation, 
purging genetic variation along the way due to a genome-wide, rather than local, 
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hitchhiking effect [cf.  5 ]. Thus, the process of adaptation itself will tend to purge ge-
netic variation from such systems, genome-wide. The chief exceptions to this genom-
ic purging arise in cases where selection is frequency-dependent, such as arises with 
micro-niche partitioning among genotypes [e.g.  6 ]. It is unclear how often such fre-
quency-dependent balancing selection leads to the maintenance of genetic variation 
in asexual or parasexual populations in nature [but see  3 ].
 The effects of this evolutionary genetic system 1 on the genomics of aging can be 
interpreted in terms of standard hamiltonian theory for age-specific selection  [7, 8] . 
If there is strictly symmetrical division of the organism during reproduction, then 
aging is not expected to evolve. It is important to note that the common asexual re-
productive system of fission does not ensure such strict symmetry. In both bacteria 
and eukaryotes, cytologically asymmetrical fission is well known to allow the evolu-
tion of aging  [9] . Even when cytological asymmetry is not obvious, bacteria like  E. 
coli  nevertheless have asymmetrical partitioning of waste products after fission, which 
can lead to the evolution of aging  [10] . Nonetheless, under good conditions strictly 
fissile single-cell species like  Schizosaccharomyces pombe  are known to be free of ag-
ing  [11] , as are Hydra kept under good conditions  [12] , as expected by hamiltonian 
theory  [7–9] .
 But when there is sufficient asymmetry between products of asexual reproduction, 
the problem of declining age-specific forces of natural selection is expected to always 
lead to the evolution of aging in hamiltonian evolutionary theory  [7–9] . Dissent from 
this view has been offered  [13] , but numerical simulations of asexual evolution suggest 
that such alternative theory for the evolution of aging in age-structured populations is 
incorrect  [8] . Only the formalism of Hamilton has been shown to be intimately tied 
with fitness in an age-structured population under some well-defined conditions  [8, 
14] . No such connection has been made for alternative non-hamiltonian analyses  [13] .
 At the genomic level, mutations with solely deleterious effects at later ages might 
drift to fixation, a process commonly called mutation accumulation  [8, 9, 14] . But be-
cause of the intermittent purging of genetic variation by selective sweeps, such drift 
effects are particularly unlikely for asexual systems. A more likely genetic mechanism 
for the evolution of aging in asexual species is antagonistic pleiotropy  [8, 9, 14, 15] , in 
which mutations that have early life benefits sweep to fixation despite deleterious 
later-life effects, because the latter will have little effect on fitness compared to the 
former.
 There are some significant issues that arise with evolutionary genomic system 1 for 
aging which are too often neglected: genotype-by-environment interaction (‘GxE’), 
rate of approach to evolutionary equilibrium, and age-independent beneficial substi-
tutions. Furthermore, these issues potentially interact with each other. Both adapta-
tion and aging are environment specific, thanks to GxE. That is, a mutant that is ben-
eficial in one environment can be deleterious in another environment. This is well 
understood for adaptation in evolutionary research, but less appreciated for aging, 
even though aging is nothing more or less than age-dependent loss of adaptation. 
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When mutants have beneficial effects that are age-independent, they foster the evolu-
tion of indefinitely sustained survival and reproduction, producing the phenomenon 
of post-aging plateaus after the cessation of aging  [8] . But such evolutionary effects 
are dependent on the number of generations that a population has spent in a particu-
lar environment. The approach to mutation-selection equilibrium in asexual popula-
tions decelerates over evolutionary time, with some evidence of continuing adapta-
tion as late in evolution as 50,000 generations  [16] , despite assiduous maintenance of 
a stable culture regime. This means that asexual populations with age structure will 
be subject to a protracted process of adaptation with later ages particularly subject to 
a lack of beneficial effects, which produces aging.
 Rarely Sexual Evolutionary Genetics: Implications for the Systems Biology of Aging 
 The forgoing general theoretical and experimental points have great salience for the 
design and interpretation of gerontological systems biology research using rarely 
outcrossing species like  Saccharomyces cerevisiae  and  Caenorhabditis elegans.  In 
these species, longevity mutants can be isolated by random mutational screens or by 
screening extant mutant stocks isolated for other purposes. It is not difficult to find 
mutants with greatly increased longevities in rarely outcrossing species [e.g.  17] . 
There are several evolutionary genetic mechanisms by which such increased longev-
ity can arise. 
 First, since these longevity mutants are not generally isolated from asexual stocks 
that have long adapted to laboratory conditions, unlike those of Lenski  [16] , they may 
be mutants that enhance survival and reproduction generally in the evolutionarily 
novel environment supplied in a particular laboratory. In effect, then, these mutants 
may be generally beneficial in the specific lab environments in which they are screened. 
That is, they are broadly adaptive. As such, they are not specifically ‘aging mutants’, 
even if they increase longevity. There is nothing wrong with the careful study of such 
genetic mechanisms of adaptation, so long as the experimenters doing so understand 
that they are studying the genomic foundations of adaptation in general, not some-
thing that is notably specific to aging. Evolutionary biologists welcome new recruits 
to the study of the evolutionary genetics of adaptation, particularly when those new 
recruits are aware of the strong evolutionary theory that pertains to adaptation.
 Second, other longevity mutants might involve cases of striking antagonistic plei-
otropy, in which early reproduction or competitive ability are sacrificed in the mutant 
in exchange for a striking gain in adult longevity, at least in the particular laboratory 
environment employed by the experimenter. Van Voorhies et al.  [18] have argued 
that this is the case for a number of  C. elegans  longevity mutants. However, the abil-
ity to obtain such antagonistic pleiotropy mutants does not demonstrate that aging 
evolved in such species specifically  because of the ‘wild-type’ sequences that have been 
altered in these longevity mutants.
Yashin AI, Jazwinski SM (eds): Aging and Health – A Systems Biology Perspective.
Interdiscipl Top Gerontol. Basel, Karger, 2015, vol 40, pp 63–73 ( DOI: 10.1159/000364930 )
 The Great Divide: Two Genomic Systems Biologies of Aging 67
 Evolutionary Genetics of Outcrossing Mendelian Populations: General Genomic 
Findings 
 Over the last 30 years, research on the evolutionary genetics of mendelian popula-
tions that usually outbreed has been dominated by a ‘neoclassical’ consensus. Clas-
sical evolutionary genetic theory presumed there was very little segregating mende-
lian variation  [19] , with rare beneficial mutations that sweep through the genomes 
of such populations providing the foundation of adaptation. With the discovery of 
massive genetic variation in outbred mendelian populations beginning in the late 
1960s, classical theory was replaced by a neoclassical variant with the following as-
sumptions: (a) a great deal of strictly neutral genetic variation evolves by genetic 
drift; (b) deleterious genetic variation arises by mutation but is kept at a low frequen-
cy by purifying selection, and (c) rare beneficial mutations arise and sweep to fixation 
 [20] . Like the classical theory of evolutionary genetics, neoclassical theories imply 
that there will be very little segregating genetic variation genome-wide that can read-
ily respond evolutionarily to novel forms of selection. Instead, rare beneficial muta-
tions of large effect are expected to dominate the process of adaptation in outbred 
mendelian populations, as they are supposed to in the evolution of strictly asexual 
populations  [1] . 
 Long opposed to both classical and neoclassical theories, balance and neobalance 
theories for evolutionary genetics have hypothesized that there is abundant genetic 
variation affecting components of fitness. The difference between balance and neobal-
ance theories is analogous to the difference between classical and neoclassical theo-
ries. Like neoclassical theory, present-day neobalance theory adds to traditional bal-
ance theory the possibility that there is a significant amount of neutral or weakly del-
eterious genetic variation across the genome. The key difference is that neobalance 
theory supposes that balancing mechanisms of selection, such as frequency-depen-
dent selection and antagonistic pleiotropy, frequently allow the maintenance of func-
tional genetic variants at high frequencies. Such abundant functional genetic variation 
is then expected to allow immediate responses to selection at many sites across the 
genome.
 Recent experimental studies of the genome-wide response to selection in labora-
tory mendelian populations suggest that the neobalance theory has much more valid-
ity than has been supposed heretofore. For example, Burke et al.  [21] found numerous 
sites in the genome that respond strikingly to selection for earlier reproduction and 
faster aging in  Drosophila melanogaster . Our recent unpublished research has found 
even more numerous sites in the  Drosophila  genome that respond to selection on ag-
ing, thanks to superior replication to that of earlier studies of the genomics of the re-
sponse to selection in mendelian populations. Thus, there can be a very large number 
of sites in the genome of a sexual species that respond to selection, implicating the 
action of widespread balancing selection which sustains functional genetic diversity 
in outbred populations of species like those of  Drosophila. 
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 Evolutionary Genetics of Outcrossing Mendelian Populations: Implications for 
Their Systems Biology of Aging 
 From a hamiltonian standpoint, aging is the decline in age-specific adaptation due to 
the declining forces of natural selection, as illustrated by, among other things, the 
cessation of aging after these forces stop declining  [8] . But the genomic machinery 
that underlies this decline in age-specific adaptation is evidently very different be-
tween largely asexual and sexual species, if the neobalance view of the evolutionary 
genetics of outbred sexual species is correct. If the neoclassical view is correct, there 
is  no  such differentiation between the genomics of aging in asexual and sexual spe-
cies: aging in both would depend primarily on selective sweeps of alleles with antag-
onistic pleiotropic effects that force aging as a price of improved adaptation at earlier 
ages. The neoclassical theory chiefly has different implications for outbred mendelian 
populations compared to rarely sexual species with respect to mutation accumula-
tion, because the purging of genetic variation that occurs with selective sweeps is ex-
pected to be localized across the genome in outbred species, rather than global  [5, 20] . 
Our view, however, is that this neoclassical view of the evolution of aging in sexual 
populations is unlikely to be correct, given the observed genomics of the evolution of 
aging in  Drosophila  [21] . 
 There is thus a clear divide in the genomic underpinnings of aging between large-
ly asexual species and outbreeding mendelian species, a division of great significance 
for the systems biology of aging. In particular, the kinds of mutants that are generated 
by mutagenesis and then identified in screens for increased life span do not generally 
correspond to those identified by us when resequencing outbred laboratory-evolved 
 D. melanogaster  populations with increased longevity.
 This type of finding is apparently not confined to aging research. The prosaic but 
much studied character of  Drosophila  bristle number likewise shows little correspon-
dence between loci identified by mutagenesis and those identified from studies of ge-
netic variation in wild populations [e.g.  22 ]. Thus, the functional genomics of outbred 
system 2 populations are not expected to correspond to the genetics of large-effect 
mutants on theoretical grounds, and they do not appear to correspond so far in stud-
ies of  Drosophila  where a direct comparison can be made. Naturally, this conclusion 
can only be offered for  Drosophila  at this point, but the history of genetics suggests 
that many  Drosophila  findings are likely to generalize.
 The Two Kinds of Evolutionary Genomics and the Systems Biology of Aging 
 Systems Biology of Aging in Largely Asexual or Inbred Populations 
 Considered in, of, and for themselves, evolutionary genetic system 1 species like  E. coli 
 or S. cerevisiae  can be usefully studied using large-effect mutants, as shown in  figure 1 . 
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It is exactly such large-effect mutations which will be important determinants of the 
evolution of aging in such species, because when they are sufficiently beneficial for 
fitness they will sweep rapidly toward fixation, purging genetic variation across the 
rest of the genome. Once they have swept through a population from a largely asexu-
al species, such substitution will change the activity of at least some, and potentially 
many, gene products from elsewhere in the genome. Such effects on gene activity 
should be identifiable from gene expression assays, from microarray characterization 
of translated proteins or from genome-wide transcriptomic assays. Furthermore, such 
substitutions could then pave the way for further, now beneficial, epistatic substitu-
tions elsewhere in the genome. And such epistatic combinations of substitutions 
could likewise be studied usefully, whether by direct genetic manipulation or experi-
mental evolution  [23] . 
 From data concerning both mutants and the alleles fixed by selective sweeps, in-
cluding gene expression and other downstream phenotypic effects, it should be pos-
sible to build a systems biological model for how some large-effect DNA sequence 
changes work their way through complex molecular networks to produce specific 
patterns of adaptation and aging in inbreeding or asexual organisms. In particular, 
the specific details of the antagonistic pleiotropy likely to be involved in natural selec-
tion against most longevity mutants would be a natural theme of such research, as 
well as any genotype-by-environment dependence in the appearance and disappear-
ance of such effects [see  18 ]. Overall, this seems like an eminently feasible research 
project.
Wild
sample
Time in lab
Baseline
Natural
mutants
Transgenic
Mutagenized
Genetic cross
 Fig. 1. In largely asexual or inbred species, the systems biology of aging is appropriately analyzed 
using large-effect mutants, transgenics, etc. This research focus arises naturally from the way aging 
evolves in such species. In the figure, genetic strains of little heterozygosity are indicated by thin 
lines, with the different types of genetic manipulation indicated by different line fonts. 
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 Systems Biology of Aging in Outcrossing Mendelian Populations 
 Significant challenges face the systems biology of aging in outcrossing mendelian spe-
cies. Many of these challenges have already arisen in the study of chronic diseases in 
human GWAS research. It has proven very difficult to identify the majority of spe-
cific SNP changes that are responsible for the heritability of such chronic disorders as 
type 2 diabetes, Crohn’s disease, or Alzheimer’s disease, although the impact of ApoE 
and ACE variants on longevity stands out as a notable exception  [24] . But the total 
amount of genetic variation for longevity that is explained by such loci is very small. 
 As we have already argued in more general terms  [25] , experimental evolutionary 
genomics offers a powerful way to begin developing a systems biology for aging in 
outbreeding mendelian species. Since there are many sites in the genome with se-
quence variation that affect aging, such variation can be teased out using experimen-
tal evolution with resequencing. Experimental evolution can readily change the rate 
of aging, and even the age of onset of late-life aging plateaus  [8–9] . With enough rep-
lication of selection lines and enough generations of selection, it is possible to probe 
the entire genomes of organisms like  D. melanogaster  for the genomic sites that affect 
aging [cf.  21 ]. Furthermore, it is then straightforward to use orthology to identify cor-
responding loci in other outbred mendelian species that affect aging or chronic dis-
ease in those species. Figure 2 provides a schematic for this research strategy.
 In this sense, the systems biology of aging is easier to probe genome-wide in outbred 
mendelian populations than it is in inbred or asexual species. It requires much less ex-
perimental effort to rapidly screen entire genomes to find a large number of genomic 
regions that are involved in the response to selection for different patterns of aging. 
However, recently Tenaillon et al.  [23] have shown that very large-scale experimental 
evolution in asexual populations can come up with comparable genome-wide screen-
ing. In their case, they applied high-temperature selection to more than 100 distinct 
populations for 2,000 generations. By resequencing samples from this huge collection 
of populations after selection, they were able to identify genomic regions that were re-
peatedly subject to sequence change as a result of their specific selection protocol. But 
sustaining longevity or later-life fertility selection among some hundred or more clon-
al lines over thousands of generations seems like a prohibitively difficult task.
 In any case, we already know that this strategy of genomic-site identification works 
in studies of the experimental evolution of aging in outbred mendelian populations 
with much less replication  [21] . The question is then what to do with information 
about the many genomic sites that evidently play a role in the system 2 genetics of ag-
ing, with respect to the systems biology of aging.
 An obvious next step is the use of genome-wide gene expression assays of popula-
tions with different patterns of aging over a range of different ages and different en-
vironments in order to infer the regulatory interconnections across the numerous 
sites in the genome. For further resolution, tissue-specific gene expression could also 
be used, particularly in conjunction with the kind of functional physiological differ-
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entiation associated with the evolution of aging in  Drosophila . Then there is the pos-
sibility of metabolomic analysis of whole organisms and specific tissues or organs. 
Such downstream genomic and functional data would naturally be extremely com-
plex, requiring advanced machine learning software to parse. Any viable systems bio-
logical model for aging obtained by this experimental methodology would naturally 
be extremely complex in turn, a model that would be opaque to human intuition at 
the detailed level. Nonetheless, it is possible to parse even very complex numerical 
models using well-developed bioinformatics tools like sensitivity analysis, in which 
model parameters are systematically varied in simulations for their quantitative im-
pact on model predictions.
 This in turn raises the question of how to test such a systems biological model. In 
our laboratory, we have a number of populations of  D. melanogaster  that have evolved 
a wide range of differences in DNA sequence, gene expression, and downstream phe-
notypes. If we were to assemble a systems biological model for aging based on ge-
nome-wide changes in sequence and gene expression among a subset of our popula-
tions, then we could test the validity of the analysis of such a model by determining 
whether corresponding variation in populations that were  not  used to construct the 
initial systems biology model nonetheless shows the predicted patterns of parametric 
sensitivity.
Wild
sample Domestication Replication Selection
Age of
reproduction
Late life
Baseline
Early life
Time in lab
 Fig. 2. Experimental evolution readily shifts patterns of aging when Hamilton’s forces of natural se-
lection have their declining phases shifted by changing the time at which outbred sexual laboratory 
populations are cultured  [8] . Such populations are differentiated at many sites across the genome 
 [21] . The systems biological analysis of aging in such settings needs to proceed along very different 
lines from that which is appropriate for asexual or inbred species. 
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 Application to the Systems Biology of Aging in Humans 
 Many scientists who work on aging are chiefly interested in patterns of aging in the 
particular taxonomic group(s) that they study, but most people are more interested in 
the application of such research to the biomedical problem of aging, as illustrated by 
the articulate declamations of figures like Aubrey de Grey. 
 Thus, the question of applying systems biological insights into the genomics of ag-
ing among model organisms to the human case is a natural concern. Surprisingly, a 
large fraction of the loci identified as relevant to aging in  D. melanogaster  have ortho-
logs in the human genome, and some of those loci in turn have been associated with 
human chronic disease, particularly when human GWAS databases are probed in 
light of genomic results  [26] . Likewise, the various longevity loci identified in studies 
of largely asexual species can be tested for their relevance to human genomic data-
bases for aging-associated diseases and disorders.
 In the end, the question of the medical merit of the systems biology of aging in 
model species for human aging is empirically answerable with orthology. We are al-
ready confident that genomic data from similarly outbreeding mendelian species are, 
at a minimum, relevant to  understanding the systems biology of aging in our species, 
but it has not yet been determined how useful such understanding will be for develop-
ing interventions that might  ameliorate human aging.
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 Abstract 
Aging is a consequence of an organism’s evolution, where specific traits that lead to the organism’s 
development eventually promote aged phenotypes or could lead to age-related diseases. In this 
sense, one theory that broadly explored development and its association to aging is the develop-
mental aging theory (DevAge), which also encompasses most known age-associated theories. Thus, 
we employed different systems biology tools to prospect developmental and aging-associated net-
works for human and murine models for evolutionary comparison. The gathered data suggest a 
model where proteins related to inflammation, development, epigenetic mechanisms and oxygen 
homeostasis coordinate the interplay between development and aging. Moreover, the mechanism 
also appears to be evolutionary conserved in both mammalian models, further corroborating the 
DevAge molecular model.  © 2015 S. Karger AG, Basel 
 A Brief View of the Two Sides of Life 
 Aging is accepted as a universal and irreversible process that gradually promotes 
physiological cellular decay and occurs in almost all living beings, from prokaryotes 
to eukaryotes. With aging as one of the main causes of disease development and tissue 
functionality impairment in mammals, different theories have been devised to de-
scribe and understand the causes and consequences of aging, including the generation 
of free radicals, the accumulation of DNA mutations, and the shortening of telomeres. 
 Nevertheless, understanding aging and its associated biological processes requires 
an answer to the question, ‘why do we age?’. The antagonistic pleiotropic theory, 
which was first proposed by Williams in 1957  [1] , provided the following first glimpse 
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of a satisfactory explanation: aging is a consequence, a declining force of natural selec-
tion, where the same specific molecular mechanisms and traits that can benefit young 
organisms can also be deleterious during the course of life, ultimately leading to aged 
phenotypes. These traits can arise during early development, providing advantages in 
terms of organogenesis, morphogenesis and embryo survival, but they can also pro-
mote aging. This scenario can be exemplified by the oxidative stress induced by reac-
tive oxygen species. Oxygen is necessary for proper tissue functionality, but long-term 
exposure is correlated with aging-associated diseases and cancer development that are 
attributed to the oxidation of proteins, lipids and nucleic acids  [2] . Another example 
is insulin, which ensures proper fetal growth by regulating several metabolic process-
es, such as the formation of adipose tissue. When deregulated, however, the insulin-
mediated signaling pathway also correlates with diabetes, which is commonly associ-
ated with aging and will be discussed further.
 When and how an organism ages remains inconclusive, although it has been pro-
posed that the aging process begins after an organism reaches its maximal reproduc-
tive capability. Nevertheless, several aging-associated pathologies are thought to re-
sult from genetic predisposition combined with specific environmental factors that 
become evident during the life span of an organism (e.g. Alzheimer’s disease  [3] ). In 
addition, it is important to consider that environmental changes during pregnancy 
can induce differential developmental outcomes by altering the epigenome via chang-
es in the methylation and acetylation of DNA and histones, irreversibly modifying 
gene expression patterns  [4] . Thus, we need to advance our understanding of aging 
by analyzing other theories that encompass the above conditions, such as ‘how are 
developmental outcomes connected to aging?’. In this sense, the following three theo-
ries/hypotheses fit into the criteria detailed above: the thrifty phenotype hypothesis 
(TPH) proposed by Hales and Barker  [5, 6] , the developmental origins of health and 
disease (DOHaD) theory proposed by Langley-Evans  [4] , and the developmental-
aging (DevAge) theory proposed by Dilman in 1971  [7] .
 The first two hypotheses are complementary and are derived from the same prin-
ciple. Aging results from genetic changes that occur during embryonic development 
and that are driven by environmental alterations, such as malnutrition of the mother 
or abnormalities in the placenta or in other maternal physiologies  [4–6] . These al-
terations can significantly alter fetal growth and tissue development  [4–6] . On the 
other hand, DevAge theory expands the scenarios encompassed by the TPH and 
 DOHaD hypotheses and suggests that aging is part of the same molecular mechanism 
that promotes tissue development and embryonic maturation during development, 
continuing throughout adult life  [3] .
 In summary, aging is a programmed molecular mechanism – a tradeoff per se – 
and is essential for the embryonic maturation that results in deleterious effects and 
aging phenotypes. Nonetheless, those theories, although supported by numerous 
trustworthy observations, still require more profound observations at the molecular 
level.
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 Common Mechanisms between Development and Aging Outcomes 
 Understanding complex molecular mechanisms, such as development and aging, and 
verifying their interconnectivity and how they are coordinated represent ideal chal-
lenges for computational modeling, where the use of networks can be applied for dy-
namic and global views of molecular interactions. Thus, our group developed a sys-
tems biology study to understand such mechanisms. 
 The Essential Understanding of Topological Parameters 
 To understand the relation between aging and development, we prospected two dif-
ferent protein-protein (PPI) networks, using the data available for  Homo sapiens and 
 Mus musculus . As expected, the networks ( fig. 1 ) displayed nodes (proteins) related 
to development and aging (e.g. HOX, PAX, histone deacetylases, DNA methyltrans-
ferases, and sirtuins). The topology of each network was subsequently analyzed. We 
first calculated the following two major parameters: clustering and centralities 
( fig. 1 ).
 Clustering is subject to the principle of a union between individual parts of a sys-
tem that are directly or indirectly connected. This principle of organization is com-
monly observed in daily life, either in the way that we organize objects by function or 
resemblance or in our tendency to organize social life by affinity groups of beliefs or 
mentalities. In a biological network, clusters are characterized by high-density regions 
that normally act on a specific biological function or biochemical pathway  [8] .
 Centralities are commonly used to analyze the most topologically relevant nodes 
in a given network  [9] . The following two parameters were used: node degree and be-
tweenness.
 The first parameter (node degree) refers to nodes exhibiting node degree values 
above the average node degree value as hubs, which are defined as nodes with several 
 Fig. 1. A representation based on interatomic data illustrating how aged phenotypes are driven by 
programmed molecular mechanisms during development. Environmental conditions, such as the 
exposure to different pollutants and climate fluctuations contribute together with nutritional habits 
and/or substance abuse (e.g. tobacco smoke, and alcohol), to changes in maternal health and pla-
cental status, which affects different molecular mechanisms. The data gathered from the PPI net-
works illustrate the major altered mechanisms that include (but are not limited to) inflammation, 
glucose metabolism, epigenetic programming (e.g. CpG island methylation and histone modifica-
tions) and changes in O 2 status. The DevAge and DOHaD hypotheses are derived from the principle 
that the overstimulation or inhibition of those mechanisms can significantly alter fetal development 
and terminally promote age-associated diseases. Notably, proinflammatory cytokines are necessary 
for the initial signaling events that promote the formation of the embryo stem cell niche and the 
establishment of the maternal-fetal interface. However, these are the same mechanisms that are re-
sponsible for the development of various diseases. SC = Stem cell. 
(For figure see next page.)
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connections  [9] . In contrast, betweenness is correlated with the flow of information 
that passes through a given node, including the number of connections (edges) that 
pass through a node, which are required for the connection of clusters and other 
nodes to the network  [9] . Thus, proteins with a betweenness score above the network 
average betweenness value are named bottlenecks. The union of the two parameters 
results in so-called hub-bottleneck nodes that are crucial for network integrity  [10] 
( fig. 1 ). These nodes were the main focus of our study in terms of centralities.
 Finally, we prospect the associated biological processes present in our network.
 Decoding the Networks: New Insights into DevAge and Its Relationship to 
Inflammation 
 As predicted, the networks ( fig. 1 ) exhibited similar topologies, indicating their con-
servation among the two species, as well as the following similarly associated biopro-
cesses: inflammatory and immune system processes, and the regulation of develop-
ment and glycolysis. Among the bioprocesses present, the  H. sapiens network dis-
played chromatin remodeling, whereas the  M. musculus network displayed aerobic 
respiration ( fig. 1 ). 
 The fact that both of the networks displayed a close relationship with inflammation 
is interesting. Inflammation has been demonstrated to be intimately correlated with 
aging diseases such as Parkinson’s, Alzheimer’s, sarcopenia, osteoporosis and athero-
sclerosis  [11] . The relationship between aging and inflammation is thought to repre-
sent one of the many causes of age-related phenotypes that characterize the so-called 
inflammaging theory (IT). The IT posits that the chronic inflammation that an organ-
isms suffers over the course of its life span as a result of constant exposure to innumer-
ous antigens results in reduced efficiency of the immune system (immunosenescence), 
which promotes the development of aging-associated and autoimmune diseases  [11] . 
These diseases are predominantly caused by the overexpression of proinflammatory 
cytokines and inflammatory mediators  [11] . Our centrality analysis ( fig. 1 ) revealed 
that the hub-bottleneck subnetworks of both model networks contained several pro-
inflammatory proteins, including interferon-γ (IFNG), tumor necrosis factor, and nu-
clear factor-κB. The  H. sapiens network displayed even more inflammatory-related 
factors, such as interleukins (ILs) -2, -4, -6, -8, -10, -18 and -1β, which are crucial me-
diators of pro- and anti-inflammatory cascades, whereas the  M. musculus network 
showed the presence of IL-2, -4, -6, -10, -18, -1a, -1b, -1r1, -10ra, -17a, -2ra, -2rb, -2rg 
 [12] . Our networks ( H. sapiens and  M. musculus ) also identified the caudal type ho-
meobox 2 (CDX2), which is a predominant regulatory protein in intestinal develop-
ment  [12] . This protein contains a binding site for nuclear factor-κB, indicating a close 
relationship between the immune system, inflammatory response and development 
 [12] . These observations reflect the significant conservation of the inflammation-asso-
ciated nodes of both networks that were initially queried for development and aging.
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 Moreover, in adults, wound healing is a continual process that involves the follow-
ing three distinct phases: inflammation, proliferation and tissue remodeling  [13] . Ac-
tive wounds are characterized by anoxic or hypoxic environments and anaerobic me-
tabolism, which represent a possible stem cell niche  [13] . Additionally, lymphatic 
circulation facilitates the infiltration of the interstitial space by inflammatory compo-
nents and the production of inflammatory mediators such as IL-1, IL-6 and tumor 
necrosis factor-α, proteins which were present in our PPI network ( fig. 1 )  [12, 13] . 
Finally, blood circulation is regenerated, reestablishing oxygen transport and nutrient 
supply, promoting tissue remodeling  [13] . Thus, Aller et al. [13] argued that the tissue 
repair of the body of injuries during postnatal life might occur according to embry-
onic biochemical patterning in a manner similar to gastrulation, which recapitulates 
an ancestral biochemical mechanism. This process might also recapitulate embryon-
ic ontogeny in injured tissues via a hypothetical trophic axis, which comprises the 
amniotic and yolk sacs  [13] .
 The amniotic and yolk sacs are extraembryonic tissues that surround the embryo, 
which represent the amniotic and vitelline axes, respectively, and which contribute 
to the maintenance of the mesoderm that localizes within the interstitial space be-
tween them. Furthermore, the amniotic sac is responsible for the secretion of amni-
on-derived cellular growth factors and cytokines, which promotes mesenchymal and 
epithelial communication  [13] . In addition, the amniotic fluid acts as an extracellu-
lar extension of the fetus by regulating changes in interstitial hydroelectrolytic po-
tential  [13] . Accordingly, the yolk sac is a membranous structure that is formed dur-
ing gastrulation and contains hematopoietic progenitors called blood islands, which 
contain associated endothelial cells  [13] . The differentiation of the yolk sac promotes 
hematopoiesis and the development of a primitive circulatory network  [13] . Addi-
tionally, the yolk sac has the major function of embryo nutrition by accumulating 
amino acids, carbohydrates and lipids  [13] . Thus, Aller et al. [13] argue that the re-
pair of tissues in the body after injuries during postnatal life occurs according to 
embryonic biochemical patterns in a similar manner as gastrulation by utilizing an 
ancestral biochemical mechanism. This process could recapitulate embryonic on-
togeny via a hypothetical trophic axis that consists of the amniotic and yolk sac in 
injured tissues  [13] .
 Therefore, both the amniotic and yolk sac contribute to normal development and 
are essential for organogenesis. Their functions are integrated during intraembryonic 
mesoderm formation and are maintained as mesoderm-derived cells in the form of 
fibroblasts, which can be identified within postnatal connective tissues  [13] . Thus, the 
inflammatory responses in injured tissues recapitulate an amniotic-vitelline pheno-
type; a hypoxic environment can provide the ideal conditions for the expansion and 
differentiation of stem cells, in addition to the recruitment of immune cells and the 
regeneration of circulation  [13] . However, the overstimulation of inflammatory cyto-
kines can impair embryo implantation, compromise proper maternal-fetus vascular 
interface, and prevent optimal nutritional inflow  [12] .
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 These observations are consistent with the TPH, DOHaD and DevAge theories, 
where such maternal alterations can alter embryonic development. Thus, the IT 
 hypothesis could fall into DevAge theory context.
 Decoding the Networks: DevAge and Its Relation to Epigenetics 
 Studies have demonstrated that during the 20th century, newborns with low birth-
weights also exhibited high blood pressure, a predisposition for coronary heart disease 
and the development of type 2 diabetes during adult life  [14] . Such observations cor-
roborate the TPH, which proposes that occasional changes in intrauterine conditions 
during embryonic development might induce fetal adaptations during nutrient defi-
ciency by optimizing fetal energetic supplies  [15] . However, organ development can 
be restricted during nutrient deprivation, impairing fetal growth  [15] . Certain tissues 
(e.g. cardiac and neural tissues) are crucial for proper body functions, whereas others 
(e.g. osteogenic and muscular tissues) can display specific plasticities, exhibiting ab-
normal functions without affecting the short-term survival of the fetus  [15] . 
 In contrast to Barker’s group, the predictive adaptive response (PAR) hypothesis 
proposed by Bateson and Gluckman  [16] argues that a fetus exhibits the inherent abil-
ity to promote metabolic reorganization and to adapt to environmental stresses, such 
as nutrient deficiency  [17] . Thus, environmental stresses during early life can provide 
a ‘forecast’ by dictating the environment conditions in which the organism will grow, 
promoting the development of an adequate phenotype for the stressors present in that 
environment  [17] . Both the PAR and TPH hypotheses are associated with develop-
mental plasticity in response to environment changes and with how this plasticity is 
correlated with adult health and disease. Developmental plasticity appears as an adap-
tive mechanism that is governed by a set of underlying molecular processes, such as 
epigenetic programming  [18] . The association of these molecular mechanisms, how 
they are trigged during development, and how they affect adult life are explained by 
the DevAge and DOHaD theories.
 Our PPI networks for both organisms ( fig. 1 ) displayed several of the following 
proteins that are related to epigenetics: (a) the DNA methyltransferase (DNMT1), 
DNMT3A, DNMT3B; (b) class I histone deacetylase 1 (HDAC1), HDAC2 and 
HDAC3; (c) class III HDACs named sirtuin 1 (SIRT1) and SIRT2, and (d) p300, a 
histone acetyltransferase. All the proteins listed above are crucial for the maintenance 
of chromatin structure. Epigenetic studies have aimed to determine heritable changes 
in chromatin structure by analyzing histones and CpG island modifications, which 
induce conformational changes in chromatin, facilitating the binding of transcription 
machinery at specific promoter regions in different tissues. This phenomenon is com-
monly referred to as the ‘on’ (relaxed chromatin, available for the binding of tran-
scription factors) or ‘off’ (condensed chromatin, unavailable for transcriptional ma-
chinery) state of a gene  [18] .
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 Moreover, it has been suggested that DNA methylation patterns (controlled by 
DNMTs during development) are modulated by the nutritional status of an organism, 
representing a potential regulator of phenotypes and tissue plasticity  [18] . The  DOHaD 
hypothesis supports all of these ideas and is consistent with the DevAge theory, which 
describes the interpolation of development and aging mechanisms and which assumes 
that fetal development is ruled by a set of key genes that are turned ‘on’ or ‘off’ by epi-
genetic mechanisms to induce phenotypic changes in response to the intrauterine en-
vironment and the maternal state. These changes might have pathophysiological rel-
evance, contributing to the predisposition to disease or, in the less aggressive cases, to 
phenotypes that would only manifest during adulthood. Major epidemiological impli-
cations can include cardiovascular disease, type 2 diabetes, depression, osteoporosis 
and impaired cognitive functions  [19] . Thus, developmental mechanisms are suscep-
tible to natural selection of a regulatory set of genes that are essential for proper body 
and axis patterning and progenitor tissue specification  [12, 20] .
 Decoding the Networks: Glucose Metabolism and Developmental Changes 
 In the PPI networks, we observed several proteins in both networks that are related to 
glucose and aerobic metabolism (in  M. musculus ), such as succinate dehydrogenase 
(SDHA and SDHB), aconitase (ACO1 and ACO2), and glycerol-3-phosphate dehy-
drogenase 1 and 2 (GPD1/GPD2). We also identified the insulin growth factor 1 in 
our analysis (IGF1, which was present in both model organisms). 
 Glucose metabolism and aerobic respiration are essential for appropriate fetal 
growth and normal adult metabolism  [21] . Glucose utilization within the fetus is 
more dramatic than during late gestation, when the developing pancreas produces 
insulin upon glucose stimulation  [21] . Aberrant fetal insulin secretion occurs in re-
sponse to oscillating glucose concentrations. Interestingly, chronic hyper- and hypo-
glycemic conditions can alter glucose transporter concentrations  [21] , indicating that 
glucose transporters are altered to reduce glucose uptake during hyperglycemia, 
which can correlate with the development of insulin resistance  [21] . In addition, al-
tered insulin and glucose pathways can induce glucose uptake during hypoglycemic 
states, which is associated with intrauterine growth restriction (IUGR)  [21] . Further-
more, IUGR is generally related to fetal hypoglycemia, which involves decreased in-
sulin secretion and fetal pancreatic development  [21] . These findings are related to 
B-cell dysfunction and reduced pancreatic endocrine tissue mass, which, over the long 
term, might increase the incidence of noninsulin-dependent diabetes mellitus  [21] . In 
contrast, hyperglycemia is associated with protein glycation and increased production 
of oxygen-derived free radicals that target several molecules, including DNA and col-
lagen  [22] . During embryonic development, the fetus might also be exposed to a high-
glucose environment during contexts such as diabetic embryopathy, which can cause 
excessive damage to multiple organs (e.g. the central nervous system and cardiovas-
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cular system)  [22] . In addition, increased glucose availability can induce altered levels 
of prostaglandins and DNA biosynthesis, as well as differential expression of morpho-
genetic regulatory genes  [22] . Thus, DNA damage can be induced by reactive oxygen 
species, resulting in the production of advanced glycation end products (AGEs)  [23] 
that can lead to oxidative stress mediated by AGE receptors. This is observed in dif-
ferent organisms and is associated with several congenital abnormalities, such as gen-
itourinary defects  [12, 22] . Thus, metabolic perturbations can lead to cumulative 
damage in several tissues, such as blood vessels, nerves, muscles and eyes, which alters 
metabolic capacity and can be responsible for postnatal metabolic disorders, such as 
insulin resistance, diabetes mellitus and obesity  [21, 22] .
 As discussed previously, our network presented proteins that are related to aerobic 
respiration. During embryogenesis, the establishment of the maternal-fetal interface 
facilitates vascular connections among placental tissues and the embryo, promoting 
an environment with an ambient O 2 supply that was previously hypoxic. This phe-
nomenon induces angiogenesis and a gradually increasing O 2 supply.
 The effects of low O 2 concentrations have been shown to promote the development 
of the morula and blastocyst when O 2 oscillations can modulate the gene expression 
of different lineages  [24] . Additionally, appropriate levels of O 2 and aerobic metabo-
lism can regulate a set of proteins that are related to epigenetic mechanisms, as well 
as the progression of cell fate decisions and cell cycle  [12] . Thus, perturbations in 
aerobic respiration-related genes can promote prolonged hypoxic conditions, which 
can alter epigenetic mechanisms.
 These relationships are consistent with the DevAge and DOHaD hypotheses, link-
ing one more common regulatory network that begins during embryogenesis and is 
related to different phenotypes in aged individuals.
 Summary of the Observed Mechanisms and Further Considerations 
 In this systems biology analysis, the major biological processes identified were im-
mune system/inflammation, development, epigenetics and aerobic respiration/glu-
cose metabolism. These processes are modulated during early development and are 
stringently subjected to selective pressure, which ensures successful development  [12] 
( fig. 1 ). Richardson in 1999  [20] proposed the role of natural selection during various 
stages of development, which can act on regulatory networks and regulate adult mor-
phologies. Thus, selective pressure is more predominant in the context of develop-
mental mechanisms and adult trait specification, and small changes in either that oc-
cur during early development might result in significant morphological alterations 
during later stages  [20] . 
 In addition, the establishment of the maternal-fetal interface is dictated by the de-
velopmental conditions (e.g. mother’s health and habits). Studies have shown that 
newborns are subject to maternal under- or overnutrition, and smoking during preg-
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nancy has been implicated in morphological anomalies  [19, 25] . Epigenetic program-
ming is responsive to perturbations or imbalances of intrinsic and/or extrinsic factors 
experienced in utero. This can promote an adaptive response and influence gene ex-
pression patterns, leading to age-associated diseases, such as cancer, osteoporosis and 
the decline of the immune system  [26] . In addition, noncoding RNAs have been im-
plicated in chromosomal dynamics, highlighting its important role in the epigenetic 
regulatory control that has been implicated in developmental stages and cellular dif-
ferentiation  [27] . Studies have shown oscillations of miRNA expression in the brain 
during development, as well as during neurodegenerative conditions and age-associ-
ated disease, such as Alzheimer’s disease. For example, the miRNA miR-107 is in-
volved in the progression of Alzheimer’s disease, but is underexpressed during the 
early pathogenesis of Alzheimer’s disease  [26] .
 In summary, aging is a programmed mechanism that is driven by a multifactorial 
developmental process. During development, these processes are crucial for the es-
tablishment of the placental environment, and they further culminate in tissue differ-
entiation and embryonic survival. To overcome environmental challenges, the em-
bryo needs to adapt its metabolism in response to environmental fluctuations, and 
such adaptations appear to be closely related to glucose metabolism, O 2 supply, the 
activation of a broad range of pro- and anti-inflammatory cytokines, and epigenetic 
modifications in chromatin structure.
 It is possible to conclude that all of the hypotheses that link development and aging 
or that attempt to explain aging itself (e.g.  DOHaD, TPH, IT, and antagonist pleiotro-
pic theory) can all be linked to the DevAge theory. Lastly, our interactomic analysis 
corroborates the DevAge theory and aids in the understanding of the molecular 
mechanisms underlying aging and development. 
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 Abstract 
 Individuals of the same age differ greatly with respect to their health status and life span. We have 
suggested that the health status of individuals can be represented by the number of health deficits 
that they accumulate during their life. We have suggested that this can be measured by a fitness-
frailty index (or just a frailty index), which is the ratio of the deficits present in a person to the total 
number of deficits considered (e.g. available in a given database or experimental procedure). Fur-
ther, we have proposed that the frailty index represents the biological age of the individual, and 
suggested an algorithm for its estimation. In investigations by many groups, the frailty index has 
shown reproducible properties such as: age-specific, nonlinear increase, higher values in women, 
strong association with mortality and other adverse outcomes, and universal limit to its increase. At 
the level of individual, the frailty index shows complex stochastic dynamics, reflecting both stochas-
ticity of the environment and the ability to recover from various illnesses. Most recently, we have 
proposed that the origin of deficit accumulation lies in the interaction between the environment, 
the organism and its ability to recover. We apply a stochastic dynamics framework to illustrate that 
the average recovery time increases with age, mimicking the age-associated increase in deficit ac-
cumulation.  © 2015 S. Karger AG, Basel 
 People age at different rates. Even so, everyone ages, and to an end: the mortality rate 
is characteristic, rising exponentially with age. This is the case even though not every-
one dies from the same illness. Despite the remarkable progress that has been made 
by studying how each individual illness arises, and how each contributes to mortality, 
there remains a strong rationale to consider illnesses in their totality. Multiple aging 
processes can be studied with profit by employing a systems biology approach  [1–3] . 
Mathematical modeling, at the heart of systems biology, allows the useful insights and 
apparatus developed in other scientific fields to be brought to bear on understanding 
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ageing. Here, we discuss how ageing can be understood as a process of deficit accu-
mulation, which likely scales from the molecular level to produce macroscopically 
visible deficits  [4] . After briefly reviewing major facts about the deficit accumulation 
approach to quantifying aging, we discuss a very general stochastic framework to ex-
plain how the origin of deficit accumulation stems from the interaction between the 
environment and the organism. Because the deficit accumulation approach to aging 
has many reproducible characteristics, we suggest that the biological age of an indi-
vidual can be estimated in relation to how many deficits they have accumulated, com-
pared with how many are accumulated, on average at their chronological age. We also 
discuss how this approach can be applicable in understanding differences in health 
status not only in individuals, but also between countries with differing socioeconom-
ic status. 
 The Accumulation of Deficits as a Proxy Measure of Aging 
 However aging is defined, it should be measured. The simplest measure of aging is 
chronological age, not least because mortality rate increases exponentially with age, 
in accordance with the Gompertz law of mortality  [5] . Even so, the mortality rate is a 
population characteristic, and its application to individuals is quite limited. That is 
because individuals at the same age differ from each other not only because of differ-
ences in their genetic profile, but also reflecting how the external environment affects 
the multiple biological pathways of damage control and repair. This variability in 
damage potential and control leads to variable changes in physiological functions, loss 
of homeostatic regulation, shrinkage of the homeodynamic space, and flexibility, and 
vulnerability to stressors  [6] . In these ways, subcellular processes scale up to affect life 
expectancy and health span. This variability in the vulnerability to adverse outcomes 
(worsening health, mortality) is often referred to as  frailty  [7, 8] . In short, different 
people age at different rates, making the idea of biological age (which is intrinsically 
individual) quite attractive; even so, how to estimate biological age remains a matter 
of dispute. Despite great individual variability in how aging manifests, there is a uni-
versal characteristic – the number of health problems increases with age  [9, 10] . In 
2001, we suggested a method for appraising health status in older adults  [9] later ex-
tended to younger ages  [11] . We demonstrated how to use a simple count of deficits 
(symptoms, signs, functional impairment, and laboratory abnormalities), and in or-
der to make the deficit count comparable across different datasets, we defined the 
 frailty index as a ratio of the number of deficits that individuals accumulated to the 
total number of deficits available in the database. Remarkably, from this simple mea-
sure, it is possible to predict mortality and other adverse outcomes  [7] . Since then, our 
group and many others have investigated the properties of the frailty index in multiple 
databases ( ∼ 300,000 cases) from different countries including Canada, the United 
States, Australia, Mexico, China and most European countries. Together, the results 
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are similar across databases that use different data collection methods (e.g. clinical vs. 
self-reported data), different designs (e.g. cross-sectional vs. longitudinal) and differ-
ent numbers of variables. Specifically, the frailty index robustly shows that: (a) the 
average rate of deficit accumulation has a narrow range (in community-dwelling peo-
ple between 2.5 and 4% per year, on a log scale)  [7] ; (b) men have lower mean frailty 
index values than do women of the same age; (c) women show better mean survival 
than do men who have the same frailty index value; (d) there is an empirically deter-
mined limit to the frailty index value close to 0.7; (e) the frailty index is a strong pre-
dictor of adverse outcomes; (f) the frailty index outperforms chronological age in all 
survival models. 
 The statistical distribution of the frailty index for older adults shows typically 
skewed pattern (fitted by the gamma density function). Of some note, people from 
institutions or with severe illnesses show bell-shaped patterns approximated by the 
normal distribution  [9] . The frailty index can be regarded as a  clinical state vari-
able , in that it characterizes the whole health of individuals  [7] and validly classifies 
risk across a wide range of people. In short, the frailty index, although nonspecific 
(but note, aging itself is  nonspecific ), is a very sensitive measure of health in older 
adults.
 Remarkably, the values and age trajectories of frailty indices are not sensitive to the 
exact nature of the variables that might be included in the frailty index. Indeed, when 
some dozens or more variables are included, individual variables can be selected at 
random and still yield comparable results  [12] . For this reason, and usefully for epi-
demiological inquires, the frailty index can be created from virtually any set of health-
related variables if they cover a range of systems, are associated with adverse outcomes 
and increase with age  [13] . The reason that the frailty index characterizes individuals’ 
health independently of the variables it comprises can be understood if we recognize 
that the variables (health deficits) are not independent, even though this typically is 
assumed in the various risk factor models. Indeed, whatever statistical techniques 
might be employed to suggest otherwise, in any pragmatic sense the deficits are pre-
dominantly interdependent; each of them is linked with many others, i.e. each of them 
contains information about many others  [9, 14] .
 One property of the frailty index is of considerable practical and theoretical inter-
est. Each new deficit decreases the probability of surviving. There is an empirical lim-
it to the frailty index around 0.7, beyond which further deficit accumulation is incom-
patible with life independently on their age  [15] . A frailty index can also be construct-
ed from clinical data using a Comprehensive Geriatric Assessment (CGA) from the 
items available in typical CGA forms  [14] . This so-called FI-CGA has the usual prop-
erties of other versions of the frailty index – i.e. it is correlated with age, shows a 
skewed distribution, is higher in women, and correlates with several adverse out-
comes, including institutionalization and health care use. It could aid clinical deci-
sion-making by indicating the  degree of frailty , and thus the likelihood of an adverse 
outcome.
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 Individual Frailty Trajectories: Stochastic Patterns 
 On average, health tends to decline with age, but in individuals, including older adults, 
health status can improve. In confirmation of such behavior, we have found that the in-
dividual values of frailty index do not monotonically increase over time; their changes 
are highly dynamic such that individuals may show significant change from a higher 
frailty index value (higher number of deficits) to a lower value reflecting a possibility of 
health improvement  [14, 16] . This is illustrated in  figure 1 A, where individual courses 
typically show highly irregular patterns, including a few cases of ‘big jumps’ against a 
background of relatively small changes. Individual trajectories showing irregular behav-
ior mark a stochastic process of changes in frailty states in relation to aging. Although 
highly irregular at the level of individuals, the process is nevertheless summarizable at a 
group level ( fig. 1 B). To reflect the complex nature of these changes, we introduced a 
stochastic model of health transitions between two fixed time points  [16] . 
 According to that model, the probability of transition from  n to  k deficits for the 
fixed time interval can be approximated by the following equation  [16] :
 (1)
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 Fig. 1.  A Examples of individual trajectories of the deficit count in 12 randomly selected participants 
of the NPHS. Individual trajectories are represented by dots connected by dashed lines. The age-
specific deficit count (the average cross-sectional trajectory) is shown by the dashed line. Of note, 
the values of the individual numbers of deficits were changed to satisfy Statistics Canada privacy 
requirements, but the patterns have been preserved. From Mitnitski et al.  [30] .  B The probability of 
transition (y-axis) from a given deficit state  n (shown in each subplot cell) to  k deficits (x-axis). Circles 
represent observed transitions between two consecutive cycles. The lines show the model’s fit ac-
cording to equation 1. The solid line is for 2-year transitions. The data are truncated at 12 deficits for 
presentation; fewer than 5% of people show 12 or more deficits. From Mitnitski et al.  [31] . 
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 where  P nd  is the probability of death and  ρ n is the Poisson mean which is state,  n , de-
pendent. It is usually well represented by the linear function on  n :  ρ n  =  β 0 +  β 1 n , and 
the probability of death is well represented by the logistic function,  logit ( P nd ) =  α 0 + 
 α 1 n . 
 In many settings and with many different measures, this model fits the observed 
data with very high precision as can also be seen in  figure 1 B, with the goodness of fit 
typically accounting for more than 90% of ‘explained’ variability. The major results 
are: (a) the model allows changes in health to be represented in all directions (includ-
ing worsening and improvement) and at any degree (both gradual and in ‘jumps’); (b) 
the model considers these changes and death simultaneously as competing events; (c) 
the model has a few interpretable parameters that depend on baseline conditions (i.e. 
the number of deficits at baseline); (d) the model is applicable not only to general 
health status (represented by the number of deficits) but also to other functions such 
as cognition. Note that the model illustrates dynamic aspects of how aging occurs 
through the accumulation of deficits; dynamics arise because of the possibility of re-
pair and recuperation. Note that there is often fluctuation, and that changes in frailty 
status occur in both directions, i.e. even though, on average, decline predominates, an 
important proportion of people experience other trajectories.
 As noted, an individual’s likelihood of changing his/her health status is largely con-
ditioned by his/her health at baseline (i.e. at the current evaluation). Most transitions, 
in either direction, are gradual, so that going from having no deficits to having many 
deficits, for example, is not common (and same for vice versa). From both clinical and 
public health standpoints, it is important to note two factors. First, this is a probabi-
listic model: for any individual, the model shows the chance of a series of outcomes, 
not simply the relative risk of a given outcome. Second, and relatedly, the model al-
lows for the possibility of the real world phenomenon and clinical/public health goal 
of improvement. In other words, the model shows not just deficit accumulation, but 
deficit diminution (i.e. improvement).
 Health Changes in the Fittest (The Zero State of Frailty) 
 The stochastic transition model considered above has an interesting characteristic 
that has potential in describing population health. Among the four parameters in 
equation 1, two ( α 0 and  β 0 ) characterize those people who had no deficits at baseline. 
People with no baseline deficits are said to be in the ‘zero state’,  n  = 0. People can be 
in the zero state at any age, although the older they are, the less likely this is to be the 
case. An example of how people transit from a baseline state  (n) to any follow-up state 
 (k) is illustrated in  figure 1 B, where cell (a) represents transitions from the zero state. 
We have evaluated the outcomes of people in the zero state at baseline in relation to 
their so-called social vulnerability index. Even in Canada, with a universal health care 
system and average Western indices of economic inequality, the 5-year mortality of 
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those with the highest social vulnerability was more than twice that of those with the 
lowest social vulnerability  [17] . The transitions of the fittest (i.e. the average number 
of deficits that they accumulate) are quantitative estimates of these background ef-
fects, and thereby appear to be a means of quantifying the health hazard of a given 
environment. 
 The Origin of Deficit Accumulation – A Stochastic Framework 
 Characterizing aging as a process of deficit accumulation gives us an opportunity to 
represent aging in an individual by the changes in the number of deficits this indi-
vidual has. If so, the question can be posed: what is the cause of such accumulation? 
We will show that the origin of deficit accumulation can be understood by consider-
ing a very general process of interaction of the environment, which causes damage, 
and the ability of the organism to sustain/repair the damage. This can be considered 
under the framework of stochastic processes. To illustrate this, we assume that the 
process of environmental challenges imposing stresses on the organism can be con-
sidered as a stochastic process, with average intensity (rate) λ. The average time inter-
val between the consecutive stresses is thus 1/λ. Such challenges will be of many dif-
ferent sorts, arising from individual exposures to perturbations in the weather, solar 
activity, pollution, stressful social events, disease outbreaks, etc. The interval between 
the challenges (1/λ) varies from minutes to months; most cannot be measured. Let R 
be the average time of recovery from such environmental stresses in people of the 
same chronological age. The ability of the organism to recover depends on the indi-
vidual’s genetic profile  [18] , health status, living conditions, and access to modern 
health care  [19] . Most importantly, the time of recovery is age dependent, presumably 
reflecting subclinical (even microscopic) tissue, cellular and subcellular damage  [4] . 
 Queuing Theory and Little’s Law 
 There is a structural similarity between the process described above and the process-
es governing the formation of a queue described in stochastic queuing theory. Queu-
ing theory is a mathematical discipline that aims to explain how the length of a queue 
is related to the intensity of the stream of arrivals to the system, and to the service and 
waiting times  [20] , e.g. how long it takes to service the people in the queue. Queuing 
theory is widely employed across multiple applications in communications, comput-
er architecture, operation management, etc. The statistical mechanics of the queuing 
system can be complex, and even in simplest cases is described by the Kolmogorov 
differential equations. Although the specific details of these equations depend on the 
assumptions of the model (e.g. single server or a network of servers; stationary or non-
stationary arrivals, different priory schedules, etc.), as outlined above, there is a gen-
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eral and simple relationship between the average number of items in a queuing system 
(N), the average arrival rate (λ) and the average waiting time of an item in the system, 
R, known as Little’s Law  [21] (here we use the different notation from the original 
 [21] ): 
 N = λR (2)
 By exact analogy, we suggest that the average number of deficits present in an indi-
vidual (N) equals the rate of environmental stresses λ (the amount of damage arriving 
to the queue), multiplied by the average recovery time R (analogous to waiting time) 
 [22] . 
 Damage occurs at the different levels of the organism, including DNA, epigenetics, 
cells, and organ tissues: each of these levels has its own repair mechanism; the latter 
are not isolated from each other but organized in complex networks, so the elimina-
tion of damage does not go through one isolated system with a queue but through 
many such subsystems. In some circumstances, repeated damage may happen at the 
same place and create a ‘local’ queue. It could also be some other reasons for the queue. 
Independent of the detailed mechanisms of these processes, equation 2 imposes fun-
damental constraint on them.
 Age-Related Deficit Accumulation Reflects the Increase of Age-Related Time of 
Recovery 
 Equation 2 states that the average recovery time is proportional to the average number 
of deficits that the individual has. The coefficient of proportionality (λ) which is the 
intensity of the environmental stresses is an average characteristic of the environ-
ment. Let us assume that during the life course this average intensity does not change. 
As we know, deficits accumulate with age. According to equation 2, this means that 
the average recovery time changes proportionally to the increase in the number of 
deficits, i.e. the kinetics of the deficit accumulation with age is the same as the kinetics 
of recovery time. It has been demonstrated that the kinetics of deficit accumulation 
can be fitted by an exponential function  [7, 9, 22] with the exponent parameter typi-
cally close to 0.03.  Figure 2 A shows age-specific (cross-sectional) average trajectories 
for the 9 waves of the National Population Health Survey (NPHS) of Canadians aged 
20+ years, over 16 years of follow-up, repeated every 2 years. There is about a 3-fold 
increase in the number of deficits during 3 decades after the age of retirement (65 
years) and about an order of magnitude increase from early adulthood to 100 years. 
Given the exponential increase in the number of deficits with age, according to equa-
tion 4 we can say that the  average  recovery time increases exponentially with age, and 
with the same parameter k = 0.035  [22] : 
 dR/dt = kR (3)
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 Even though the time it takes to recover from illness is age dependent  [23, 24] , the 
most severe conditions contribute to a greater extent to the average recovery time than 
relatively benign conditions. 
 Changes in the Distribution of the Number of Deficits Indicates Change in Recovery 
Potential 
 An important limitation of Little’s Law is that it describes relationships only between 
the average characteristics. The stochastic dynamical model of deficit accumulation is 
needed to explain the changes in the distributions of the deficit accumulation over 
time. Note that these distributions change characteristically from being highly asym-
metrical in younger people (most of whom have few deficits) to the gamma-like dis-
tributions seen in older people  [22] . These patterns now can be understood from our 
model. When the recovery time is low, the damage caused by the environmental 
stresses is quickly repaired, which explains why most of young people have no or a 
few deficits. The length of the queue in a system with ‘light traffic’ shows the same 
highly asymmetrical density distributions as we see in younger people. As can be seen 
in  figure 2 B, in younger people (20–35 years old), the distribution of the number of 
deficits is highly asymmetrical (see a similar figure in Rockwood et al.  [25] ). The same 
figure also shows the density distribution of the number of deficits in an older group 
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 Fig. 2.  A Age trajectories of the mean number of deficits. Thin lines are the cross-sectional data for 
the 9 consecutive 2-year cycles plotted against age. The solid line is the best exponential fit with the 
exponent of 0.035 ± 0.02. Two individuals A and B have the same chronological age of 65 years old: 
their biological ages, indicated by the arrows, correspond to those averages of the population rep-
resented by the calibration curve. From Mitnitski et al.  [22] .  B Distribution of the number of deficits 
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exponential fit with the exponent –0.6) and 75–100 years old (circles are the observational data and 
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Mitnitski et al.  [22] . 
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of individuals aged 75–100 years also fitted by the gamma density function typical for 
‘heavy traffic’ models  [22] . 
 The age-related increase in recovery time can be related to the decreasing vitality 
first suggested in 1960 by Strehler and Mildvan  [26] . The difference is that in their 
model vitality declines linearly while the rate of recovery changes exponentially. Here, 
too, increasing the recovery time with age appears also be related to a very general 
systems biology mechanism of critical slowing  [27] . Finally, the origin of these chang-
es can be related to the fact that the organism is not in equilibrium with the environ-
ment. The entropy of the organism is lower than the entropy of the environment, so 
that maintaining and keeping the structure of the organism requires permanent ef-
forts for compensatory adaptation, repair and elimination of damage. The mainte-
nance of such nonequilibrium causes increasing metabolic cost  [2] .
 Estimating Biological Age 
 Although an important and desirable goal, the characterization of biological ageing 
has proven to be difficult, and for a long time was unsuccessful in tackling interin-
dividual variability  [1] . By long convention, the assessment of biological aging has 
translated into an often controversial search for  biomarkers of aging – i.e. a search 
for specific nondisease traits which change over a life span. According to the usual 
terms of engagement in the debate, any biomarker should predict the outcome of a 
wide range of age-sensitive tests in multiple physiological domains in an age-coher-
ent way, and do so better than chronological age. The many candidates considered 
as biomarkers of ageing have particularly included endocrine system/immune re-
sponses, those associated with caloric restriction, and cell membrane viscosity, the 
concentration of prostacyclin in fibroblasts, alterations of DNA methylation, com-
pliance of the cardiovascular system and a host of several others. The chief challenge 
in finding any single biomarker is how to integrate across organ systems in a unified 
way so as to allow the estimation of biological age at the level of the whole organism. 
A standard response to this challenge is to evaluate many biomarkers using some 
form of multivariate regression analysis. Although common, this approach strikes 
us as deeply flawed. That is because as discussed above, candidate variables in such 
analyses, although held to be independent on statistical grounds can hardly be con-
sidered to be so: in biological systems, exactly the opposite generally holds. That is 
why results from any multivariate model typically do not prove to be generalizable; 
the output of these statistical exercises is contingent on the particular samples from 
which they are drawn. What should be evident, however, is that their application in 
other datasets will require recalculation of the weights which they employ; this level 
of precision is unlikely to be generalizable. Unless the model shows stable parameter 
estimates across databases, any theoretical understanding of biological age will be 
restricted. 
Yashin AI, Jazwinski SM (eds): Aging and Health – A Systems Biology Perspective.
Interdiscipl Top Gerontol. Basel, Karger, 2015, vol 40, pp 85–98 ( DOI: 10.1159/000364933 )
94  Mitnitski · Rockwood 
 The consistency of the relationship between the frailty index, age and health out-
comes made it possible to suggest that it can be used as a basis for approximation of 
personal biological age  [14, 28] . As an illustrative example ( fig. 2 A), consider 2 people, 
A and B, of the same chronologic age, for example, 65 years with their frailty index 
values deviated from the average. At 65 years, the mean value of the frailty index is 
0.12. Person A has a frailty index value of 0.24, which is 0.12 higher than the mean 
value of the frailty index at 65 years (0.12), and rather corresponds to the mean value 
of the frailty index at age 80 years. In essence, person A has the health of an 85-years-
old: although chronologically 65 years old, person A can be considered to be biologi-
cally 20 years older than chronologically. By contrast, person B has a frailty index 
value of 0.07, which is 0.05 lower than the mean frailty index value at age 50 years. In 
essence, person B has the health of a 50-year-old: although chronologically 65 years 
old, person B can be considered to be biologically 50 years old, i.e. 15 years younger 
than chronologically.
 In other words, we used the relationships between the average frailty index and age 
as a calibration curve ( fig. 2 A).
 ln( FI ̂ ) =  a +  b · CA (4)
 Where  FI ^ is the mean frailty index estimated as a function of age from the equation 
above that we can call a  calibration equation . CA is the chronological age and  a  and  b 
are empirical parameters that can be estimated from the data, using for example a least 
squares regression technique. Note that in general, the slope parameter  b has been 
estimated in several databases to be about 0.03  [7] . For example, the most recent esti-
mates obtained from the NPHS for people aged 15–105 years gave the estimates of  a  = 
–4.16 ± 0.08 and  b  = 0.035 ± 0.001  [22] . 
 The biological age of an individual can be estimated from inversing equation 4, 
given the value of the FI of the individual:
 BA  = [ln( FI ) –  a ]/ b  (5)
 It can be seen that the difference between biological age and chronological age can be 
found from the following equation: 
 BA –  CA  = ln ( FI/FI ̂ )/ b  (6)
 In other words, biological age could be equal, greater or lower than chronological age. 
This approach therefore gives a ready metric for estimating by how many years an 
individual is younger or older than the average person of his/her chronological age in 
a given population. In that specific sense, people can be considered as biologically 
older compared to those who are in a better health who can be considered as biologi-
cally younger compared to those who are in worse health. 
 Equation 6 contains only one parameter, slope  b , which has a narrow range of val-
ues  [14] . For those individuals who had no reported deficits (i.e. the fittest people) 
biological age can be calculated by substituting FI = 0 by its next minimal value, which 
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corresponds to one deficit present. The corresponding FI could be calculated accord-
ingly: e.g. where 40 deficits are being considered, FI = 0.025, with 100 deficits FI = 
0.01, etc.
 Note too that the theoretical limit to BA (when FI = 1) is –  a/b.  For the NPHS data, 
max BA = 126 years. As maximally observed empirical limit of the FI = 0.7, the limit 
to BA according to equation 5 is 116 years, which is close to max life span observed in 
human.
 The frailty index is fundamental to this method of calculating biological age; it 
is based on a simple count of deficits that are broadly defined, but biologically/
clinically meaningful. The outcomes using predictive models based on this ap-
proach are highly generalizable – they typically show superior performance of the 
frailty index compared to chronological age  [7, 11] . Biological age calculated based 
on the frailty index can become a useful means of assessing and monitoring health 
status in individuals.
 Aging, Health, Wealth and Life Expectancy Worldwide 
 The numerous indicators of population health include health risk factors, disabilities, 
chronic disease and conditions, maternal and infant health, social determinants of 
health, etc. The deficit accumulation approach was evaluated in relation to national 
income and healthcare spending as well as their relationship with mortality. By as-
sessing over 35,000 people from 15 European countries who participated in the Sur-
vey of Health Aging and Retirement in Europe (SHARE), we demonstrated that the 
frailty index constructed from 70 deficits showed significant inverse relationships 
with gross domestic product, health expenditures and mortality. Survival of frail peo-
ple was higher in higher-income countries: the higher level of the frailty index gener-
ally corresponds to the lower level of gross domestic product  [19] . Perhaps higher 
health expenditures in more developed countries can contribute to recovery from 
major illnesses and decrease the average recovery time. Similarly, the decrease in the 
intensity of the environmental stresses in countries with more developed social poli-
cies would also accord with our model with decreasing λ in equation 2. This is an-
other large area of inquiry where the use of deficit accumulation approach can be 
promising. 
 Conclusions and Perspectives 
 Aging can be conceptualized as a process of the accumulation of deficits, taking 
place in different individuals in different ways, with a variety of rates for different 
organ systems. Deficit accumulation depends on the interplay of intrinsic and ex-
trinsic factors. Deficits are indicators of physiological deregulation and therefore, 
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by counting them, it is possible to quantify the level of such deregulation. This ap-
proach offers a simple and justifiable way of assessing health in individuals and 
populations. 
 Note that this approach to health deficits is silent on the nature of the deficit (e.g. 
disease, disability, symptoms, sign, laboratory or imaging or electrodiagnostic ab-
normality). The point merits further comments. First, it has proven to be surpris-
ingly controversial, especially in the clinical literature. This is understandable for 
two reasons. Clinical training traditionally emphasizes diagnostic parsimony. A sin-
gle cause for a large number of abnormalities is more likely to be correct than is an 
explanation that invokes multiple causes. (It is certainly more psychologically satis-
fying to the person who recognizes it.) Clinical training also emphasizes diagnostic 
precision: what works for condition A might be harmful for similarly looking condi-
tion B. (Confusion in a diabetic is a trivial example: giving insulin will help the pa-
tient whose confusion is due to blood sugar being too high, but be harmful to the 
diabetic in whom confusion reflects blood sugar being too low.) The disciple of pre-
cision and parsimony is not readily overcome, for good reason. Even so, it is less well 
suited to the reality of the nature of ageing, especially as the number of deficits in-
creases. Attempts to ‘disentangle disability and comorbidity for frailty’ are rooted in 
this approach.
 A second reason that the nature of the deficit being less important than the number 
of deficits has proven controversial is that at first glance it seems counter-intuitive. 
How can a skin problem and a heart attack be equivalent, in the sense of each simply 
being a single deficit? But the truth is that they can be. Not every heart attack is fatal. 
Not every rash is benign. To the extent that they impair function or induce a spiral of 
other diagnoses, they will add to the deficit count, and in that way the frailty index will 
capture their unequal nature in relation to prognosis.
 Considering deficits in relation to age and not just diseases – i.e. adopting more a 
systems perspective – also appear to have implications for understanding the epide-
miology of late life illness. An interesting report in this regard was published in  Neu-
rology in 2011, in the same issue as two other papers that reported ‘novel risk factors 
for Alzheimer’s disease’  [29] . Instead, the third paper combined 19 so-called ‘non-
traditional dementia risk factors’ in an index variable. The index variable (composed 
of items such as a history of diarrhea, dentures or foot problems) was a stronger risk 
for predicting all causes of late-life cognitive decline than was any traditional risk fac-
tor. The perspective offered here, that deficit accumulation reflects impaired recovery 
time, and that age-related recovery processes in the brain will not be unrelated to 
those in other parts of the body gives some broad insight into why deficits are so pow-
erful, even if they are not known to be specific risk factors for the disease in question. 
Recent work by our group has replicated this observation in another cohort, and for 
both heart disease and osteoporosis.
 To advance our understanding of age-related, multiply determined illnesses, the 
development of the statistical mechanics of deficit accumulations involving interac-
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tion between different subsystems of the human organism is the next natural step, and 
one that we are pursuing. This will allow better understanding of the processes of 
deficit accumulation, and their relationships with long- and short-term changes in the 
environment. This approach fits comfortably into overall agenda of extending the 
healthy life span. 
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 Abstract 
 Aging is associated with immunosenescence and accompanied by a chronic inflammatory state 
which contributes to metabolic syndrome, diabetes and their cardiovascular consequences. Risk fac-
tors for cardiovascular diseases (CVDs) and diabetes overlap, leading to the hypothesis that both 
share an inflammatory basis. Obesity is increased in the elderly population, and adipose tissue in-
duces a state of systemic inflammation partially induced by adipokines. The liver plays a pivotal role 
in the metabolism of nutrients and exhibits alterations in the expression of genes associated with 
inflammation, cellular stress and fibrosis. Hepatic steatosis and its related inflammatory state (ste-
atohepatitis) are the main hepatic complications of obesity and metabolic diseases. Aging-linked 
declines in expression and activity of endoplasmic reticulum molecular chaperones and folding en-
zymes compromise proper protein folding and the adaptive response of the unfolded protein re-
sponse. These changes predispose aged individuals to CVDs. CVDs and endothelial dysfunction are 
characterized by a chronic alteration of inflammatory function and markers of inflammation and the 
innate immune response, including C-reactive protein, interleukin-6, TNF-α, and several cell adhe-
sion molecules are linked to the occurrence of myocardial infarction and stroke in healthy elderly 
populations and patients with metabolic diseases.  © 2015 S. Karger AG, Basel 
 Aging is defined as a series of morphological and functional changes which take place 
over time. The term also refers to the deterioration of biological functions after an 
organism has attained its maximum reproductive potential  [1, 2] . Aging is accompa-
nied by a chronic inflammatory state which may contribute to metabolic syndrome 
(MS) and diabetes and their cardiovascular consequences. Inflammation accompa-
nied by a proinflammatory cytokine production during aging is associated with pre-
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disposing factors that include increased oxidative stress, a decrease in ovarian func-
tion, a decrease in stress-induced glucocorticoid sensitivity and an increased inci-
dence of asymptomatic bacteriuria. Indeed, when compared with young subjects, 
healthy elders are more stressed and show activation of the hypothalamus-hypophy-
sis-adrenal axis  [3] . 
 MS is a number of criteria reflecting abnormalities in lipid and glucose metabo-
lism. These abnormalities are considered to be a cause for atherosclerosis, cardiovas-
cular disease (CVD) and type 2 diabetes mellitus. The prevalence of CVD among pa-
tients with diabetes is 3- to 5-fold higher than in patients without it. MS demonstrates 
ethnic and gender variants, its frequency depends on the lifestyle and age. MS in an 
elderly population is a proven risk factor for cardiovascular morbidity, especially 
stroke and coronary heart disease and mortality. The high prevalence of MS, heart at-
tacks and diabetes in the elderly population evidences that age is an independent risk 
factor for the development of metabolic abnormalities  [4] .
 CVDs appear as a consequence of both insulin resistance and inflammatory re-
sponses which are increased during aging. Risk factors for atherosclerosis and diabe-
tes overlap, and there is a propensity of diabetic patients to have premature athero-
sclerosis leading to the hypothesis that both share an inflammatory and perhaps ge-
netic basis  [5] . Low-grade inflammation caused by the secretion by adipocytes of 
proinflammatory cytokines due to our thrifty genotypes and alterations in the innate 
immune system due to our proinflammatory genotype are linked to insulin resistance, 
diabetes and CVD  [6–8] .
 Aging, Diseases and the Regulation of Energy Allocation 
 Stress response genes and nutrient sensors regulate energy directed to cell protection, 
maintenance and longevity; when food is plentiful and stress levels are low, genes sup-
port growth and reproduction; in contrast, harsh conditions favor a shift in gene ac-
tivity towards cell protection and maintenance extending life span. Therefore, chang-
es in diet that lead to obesity, MS and diabetes determine longevity and alter the aging 
process. Important genes in extending life span include kinase mammalian target of 
rapamycin, AMP-activated protein kinase, sirtuins and insulin/insulin like growth 
factor 1 (IGF-1) signaling. These genes integrate longevity pathways and metabolic 
signals in a complex interplay in which life span appears to be strictly dependent on 
substrate and energy bioavailability  [9] . 
 IGF-1-mediated signaling is determining for longevity. Abnormalities in the insu-
lin signaling pathway generate age-related diseases and increased mortality, whereas 
the growth hormone/IGF-1 axis could potentially modulate longevity in many spe-
cies. Moreover in humans, an age-related decline in IGF-1 levels occurs, and at old 
age, low IGF-1 levels are associated with frailty, poor nutrition and cognitive decline 
and an increased risk of death  [10, 11] .
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 The aging process is altered or accelerated when inflammation increases the 
propensity of metabolic diseases and CVD and the risk of diseases increases with 
age.
 Aging and the Immune System 
 Aging has been associated with immunological changes, denominated immunosenes-
cence. An elderly immune system becomes more and more predisposed to chronic 
inflammatory reactions and is less able to respond to acute and massive challenges by 
new antigens. A young immune system has to cope quickly and efficiently with acute 
immunological challenges to assure survival and the reaching of reproductive age. 
Such reaction capability gradually burns out because of lifelong antigenic attrition. 
Moreover, lifelong antigenic challenges and the increasing antigenic burden deter-
mine a condition of chronic inflammation, with increased lymphocyte activation and 
proinflammatory cytokines  [12] . 
 Polymorphisms in the promoter regions of pro- and anti-inflammatory cytokine 
genes influence the level of cytokine production and the aging process. Nutrients with 
anti-inflammatory properties, such as vitamin E and n-3 polyunsaturated fatty acid, 
may reduce the level of chronic inflammation and thereby ameliorate tissue and func-
tional loss during aging. New evidence suggests that, for the latter nutrient, gene-nu-
trient interactions occur that alter the effectiveness of dietary therapy  [13] .
 Inflammation in Obesity and Metabolic Syndrome during Aging 
 Obesity is increased in the elderly population. Obesity is the result of a complex inter-
action of factors in each individual including: genetic predisposition, diet, metabolism 
and physical activity. The increase in the mass of adipose tissue induces a state of sys-
temic inflammation due to an increase in secretory factors (adipokines) derived from 
pre-adipocytes and from macrophages constituting this tissue ( fig. 1 ). This inflamma-
tion significantly contributes to endothelial dysfunction present in the CVD devel-
oped as a consequence of MS and diabetes  [14] . 
 Adipose tissue also provides energy for the immune system, which has a significant 
energy cost. The contribution of energy stores to immune function became clear from 
early studies noting reduced survival in subjects of low relative weight  [15, 16] . Infec-
tion imposes a metabolic burden on account of the need to synthesize immunoglobu-
lins and acute-phase proteins and other processes such as inflammation and fever. To 
meet these costs of infection, lipolytic factors such as cortisol, glucagon and various 
hormones release energy from adipose tissue  [17, 18] .
 The immune system represents a priority function of adipose tissue during malnu-
trition. Adipose tissue has been previously considered as a toxic substance, but it may 
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be more appropriate to consider it as an activator of the immune function to increase 
protection against infectious diseases.
 Adipocytes from old mice induce a higher inflammatory response in other cells. 
Sphingolipid ceramide is higher in old than in young adipocytes. Reducing ceramide 
levels or inhibiting NF-κB activation decreases cytokine production, whereas the ad-
dition of ceramide increases cytokine production in young adipocytes to a level com-
parable to that seen in old adipocytes, suggesting that ceramide-induced activation of 
NF-κB plays a key role in inflammation  [19] ( fig. 1 ).
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 Fig. 1. Diagram of the 
 pathophysiology of MS 
 associated with low-grade 
 systemic inflammation. Aging 
is accompanied by a chronic 
inflammatory state which may 
contribute to MS. The figure 
indicates the involvement of 
inflammatory factors derived 
from adipose tissue, liver and 
immune system cells leading 
to endothelial dysfunction 
and contributing to the 
 development of CVDs. FFA = 
Free fatty acids. 
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 The Immune System and Type 2 Diabetes 
 There is increasing evidence that an ongoing cytokine-induced acute-phase response 
is closely involved in the pathogenesis of type 2 diabetes mellitus and associated com-
plications such as dyslipidemia and atherosclerosis. Elevated circulating inflamma-
tory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) predict the 
development of type 2 diabetes mellitus, and several drugs with anti-inflammatory 
properties (aspirin and thiazolidinediones) lower both acute-phase reactants and gly-
cemia and possibly decrease the risk of developing type 2 diabetes mellitus (statins). 
Among the risk factors for type 2 diabetes mellitus, which are also known to be asso-
ciated with activated innate immunity, are age, inactivity, certain dietary components, 
smoking, psychological stress, and low birthweight. Other features of type 2 diabetes 
mellitus, such as fatigue, sleep disturbance and depression, are likely to be at least 
partly due to hypercytokinemia and activated innate immunity  [20] . 
 The Liver and Inflammation in Metabolic Syndrome 
 The liver plays a pivotal role in the metabolism of nutrients, drugs, hormones, and 
metabolic waste products, thereby maintaining body homeostasis. The liver is central 
to glucose and lipid homeostasis as well as steroid biosynthesis and degradation. This 
organ also has a major impact on health and homeostasis through its control of serum 
protein composition. Concomitant with morphological changes, the liver exhibits 
important alterations in global gene expression profiles with age. In mice, aging is ac-
companied by changes in expression of genes associated with increased inflamma-
tion, cellular stress, fibrosis, altered capacity for apoptosis, xenobiotic metabolism, 
normal cell-cycle control, and DNA replication. These changes predispose aged indi-
viduals to CVD  [21] . 
 Hepatic steatosis and its related inflammatory state (steatohepatitis) are the main 
hepatic complications of obesity and metabolic diseases. Hepatic steatosis is a disor-
der characterized by fat infiltration and excessive accumulation of lipids such as tri-
glycerides in the liver (nonalcoholic fatty liver, NAFLD). The accumulation of fat in 
hepatocytes is a consequence of three principle sources: de novo lipogenesis in the 
liver; nutritional uptake from the small intestine; and free fatty acid release from vis-
ceral white adipose tissue.
 Hepatic steatosis is accompanied by an increased liver/body weight ratio and high-
er plasma levels of enzyme markers of liver damage (alanine aminotransferase, 
γ-glutamyltransferase, and alkaline phosphatase). This pathology, which is often as-
sociated with obesity, hyperinsulinemia, and insulin resistance, shows an inflamma-
tory state, characterized by increased hepatic and plasma levels of several proinflam-
matory cytokines, particularly TNF-α, which may play a crucial role in the progress 
of steatohepatitis to hepatic necrosis, fibrosis, cirrhosis and cancer ( fig. 1 ).
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 It has been observed that 70% of the adult patients and 25.5% of the pediatric pa-
tients with MS have NAFLD. The prevalence of NAFLD increases with age, but the 
underlying molecular mechanisms need to be further investigated. Indeed, aged mice 
both under standard diet conditions or a high-fat diet will develop hepatic steatosis.
 Hepatocytes, like other secretory cells, are rich in endoplasmic reticulum (ER). The 
ER is a highly dynamic organelle that has essential roles in multiple cellular processes 
that are required for cell survival and normal cellular functions. ER stress contributes 
to the pathology of many human diseases. Cell death, a physiological consequence of 
chronic ER stress, is key to the pathogenesis of many diseases including obesity, insulin 
resistance, hepatic steatosis, inflammation, neurodegenerative disorders and cancer.
 The ER responds to environmental stress such as hyperlipidemia, hyperhomocys-
teinemia, hyperglycemia, and inflammatory cytokines, triggering a series of signaling 
cascades known as the unfolded protein response (UPR). The primary signal that ac-
tivates the UPR is the accumulation of misfolded proteins in the ER lumen. As a con-
sequence, the UPR regulates the size, shape and components of the ER to accommo-
date fluctuating demands on protein folding, as well as other ER functions in coordi-
nation with different physiological and pathological conditions. ER stress activates 
NF-κB and JNK, with downstream effects on inflammatory recruitment, phosphory-
lation of insulin receptor signaling intermediates (to worsen insulin resistance), lipo-
genesis, and oxidative stress. Hence, it is important to seek strategies to improve the 
antioxidant capacity in subjects who suffer from NAFLD as a consequence of MS.
 Aging-linked declines in expression and activity of key ER molecular chaperones 
and folding enzymes compromise proper protein folding and the adaptive response 
of the UPR  [22] .
 Fatty acids acting through toll-like receptors (TLR) in hepatocytes increase inflam-
mation. TLR receptors are important pattern recognition receptors in the immune 
system that identify bacterial pathogens, but recently their participation in hyperten-
sion and insulin resistance has been recognized. Eight TLRs are expressed in mam-
malian liver (TLRs 1, 2, 4, 6–10). Individual TLRs interact with different combinations 
of adapter proteins and activate transcription factors such as NF-κB and JNK/activa-
tor protein 1. JNK activation is a key injury and inflammatory pathway in MS-related 
NAFLD  [23] .
 Inflammatory Function, Atherosclerosis and Other Cardiovascular Consequences 
 Inflammation is one of the main mechanisms underlying endothelial dysfunction, and 
therefore it plays an important role in atherosclerosis and other CVDs such as hyper-
tension. Recent investigations of atherosclerosis have focused on inflammation, pro-
viding new insight into mechanisms of the disease. Atherosclerosis is a disorder char-
acterized by a chronic alteration of inflammatory function, and key markers of inflam-
mation and the innate immune response, including CRP, IL-6, TNF-α, and several cell 
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adhesion molecules are linked to the occurrence of myocardial infarction and stroke in 
both healthy populations and among those with known coronary disease  [24] ( fig. 1 ). 
 Inflammatory cytokines involved in vascular inflammation stimulate the genera-
tion of endothelial adhesion molecules, proteases, and other mediators, which may 
enter the circulation in soluble form. The concept of the involvement of inflammation 
in atherosclerosis has spurred the discovery and adoption of inflammatory biomark-
ers for cardiovascular risk prediction. CRP is currently the best validated inflamma-
tory biomarker; in addition, soluble CD40 ligand, adiponectin, IL-18, and matrix me-
talloproteinase 9 may provide additional information for cardiovascular risk stratifi-
cation and prediction.
 An enhanced immune response also increases plaque vulnerability. Enhanced in-
flammation might prove to be an evolutionary determinant of atherogenesis, plaque 
rupture, platelet aggregation, and acute thrombosis.
 Aging and hyperglycemia contribute to reduced mitochondrial biogenesis and mi-
tochondrial dysfunction. These mitochondrial abnormalities can predispose a meta-
bolic cardiomyopathy characterized by diastolic dysfunction. Mitochondrial dysfunc-
tion and resulting lipid accumulation in skeletal muscle, liver, and pancreas also im-
pede insulin metabolic signaling and glucose metabolism, ultimately leading to a 
further increase in mitochondrial dysfunction  [25] .
 Free oxygen radicals are involved in alcoholic cardiomyopathy, ischemia-reperfu-
sion injury and aging. The myocardial cells are an important source of free radicals. 
When this organ suffers from diminished blood supply to an area as a result of diverse 
conditions such as a stroke, ischemia produces oxidative stress and structural damage, 
and the affected tissues die due to necrosis. Reperfusion may reverse the lethal pro-
cess, but often not without taking its toll in the form of injury to the tissues. This is 
due to calcium re-entry to the cell, and this also generates an important amount of 
free radicals which are linked to alterations in mitochondrial function. There are spe-
cific alterations in heart mitochondrial function which occur as a result of ischemia 
and reperfusion and they involve the electron transport complexes, ATP concentra-
tion, ADP/ATP translocase, permeability transition and uncoupling  [26] .
 Conclusion 
 Aging is associated with immunological changes, denominated immunosenescence, 
and is accompanied by a chronic inflammatory state which may contribute to MS and 
diabetes and their cardiovascular consequences. Inflammation is enhanced in the el-
derly population since there is increased obesity that increases fat-produced cytokines 
and alterations in hepatic function that lead to inflammation. Risk factors for CVDs 
and metabolic diseases overlap, and therefore the hypothesis that they share an in-
flammatory basis has been proposed, suggesting that low-grade systemic inflamma-
tion connects aging, MS and CVD.  
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 Abstract 
The physiological responses to nutrient availability play a central role in aging and disease. Genetic 
and pharmacological studies have identified highly conserved cellular signaling pathways that influ-
ence aging by regulating the interface between nutrient and hormone cues and cellular growth and 
maintenance. Among these pathways, the mechanistic target of rapamycin (mTOR) has been most 
reproducibly shown to modulate aging in evolutionarily diverse organisms as reduction in mTOR 
activity extends life span from yeast to rodents. mTOR has been shown to play a role in a broad range 
of diseases, and is of particular interest to human health and aging due to the availability of clini-
cally approved pharmacological agents targeting the mTOR complexes and other components of 
the mTOR signaling network. Characterizing the role of mTOR in aging and health promises to pro-
vide new avenues for intervention in human aging and disease through modulation of this signaling 
pathway.  © 2015 S. Karger AG, Basel 
 mTOR and Aging 
 The mechanistic target of rapamycin, mTOR, is a highly conserved serine/threonine 
kinase that plays a central role in sensing and responding to nutrient availability and 
growth signaling in eukaryotes. mTOR, encoded in mammals by  MTOR , is an essen-
tial component of two distinct multiprotein complexes, mTORC1 and mTORC2. 
These signaling complexes regulate a variety of basic cellular activities including 
growth rate, cell size, and metabolism, and act as critical signaling hubs at the interface 
between nutrient or hormonal cues and cell growth and maintenance. 
 mTOR was first identified in yeast in studies of the immune-suppressive com-
pound rapamycin. Rapamycin had previously been shown to act by forming a gain-
of-function complex with Fpr1p, with mutations in  FPR1 conferring recessive resis-
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tance to rapamycin, and expression of the human homolog FKBP12 (FK-506 binding 
protein 12) restoring drug sensitivity. Mutations in  TOR1  and  TOR2 , originally des-
ignated  DDR1 and  DDR2 (dominant rapamycin resistance), were found to confer re-
sistance to the antiproliferative effects of rapamycin in yeast. Wild-type Tor1 and 
Tor2 are bound and inhibited by the Fpr1/rapamycin complex  [1] . This mechanism 
was subsequently found to be conserved in mammals with the rapamycin-FKBP12 
complex binding to and inhibiting mTOR  [2] .
 A link between mTOR signaling and aging was first established in yeast when stud-
ies in  Saccharomyces cerevisiae demonstrated that deletion of Sch9, the yeast homolog 
of the mTORC1 substrate S6K (see ‘mTOR Downstream Signaling’), results in a sig-
nificant increase in chronological life span, defined as the duration of time that a yeast 
population retains viability when in a nondividing state  [3] . Studies in the nematode 
 Caenorhabditis elegans subsequently revealed that mTORC1 can negatively regulate 
longevity in multicellular organisms; knockdown of  daf-15 (the nematode homolog 
of Raptor, a component of mTORC1) or  let-363 (the nematode homolog of mTOR) 
by RNAi can extend life span in this model  [4] . Reports from  Drosophila melanogaster 
and yeast replicative aging studies further supported the role of mTOR in regulating 
longevity in lower eukaryotes.
 Direct evidence of a role for mTOR in mammalian life span has been provided by 
studies showing life span extension in mice resulting from deletion of S6K, by double 
heterozygosity for mTOR and mlst8 (a component of mTORC1), and by treatment 
with rapamycin  [5] . Intriguingly, life span extension in each of these studies was 
strongly sex-specific, with males receiving no longevity benefit from S6K deletion or 
double heterozygosity of mTORC1 components. Female mice also experienced a 
more robust response to treatment with rapamycin with an 18% increase in median 
life span, compared to a 10% increase in male animals  [5] . Notably, intervention with 
rapamycin resulted in an increase in life span even when rapamycin treatment began 
late in life, suggesting that mTOR inhibition may prove an attractive target for inter-
vening in human aging.
 mTOR Signaling 
 mTOR in Nutrient and Growth Factor Sensing 
 mTORC1 and mTORC2 both play essential roles in eukaryotic biology, as complete 
loss of either Raptor, an mTORC1 specific component, or Rictor, an mTORC2 com-
ponent, results in embryonic lethality. While both are essential for development, the 
two mTOR complexes differ in their components, relative regulatory roles, and up-
stream regulation of their activity. The upstream regulators and downstream effectors 
of mTORC1 are generally better characterized than those related to mTORC2. Al-
though mTOR signaling is affected by numerous intra- and extracellular growth cues 
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and conditions, and it affects numerous downstream pathways and processes, only 
the best characterized of these pathways, in terms of aging and disease, are described 
below. 
 Insulin/Insulin-Like Growth Factor/Phosphoinositide/AKT  
 mTOR is activated by a variety of growth factors and mitogens ( fig. 1 ). Among the 
canonical regulators of mTORC1 signaling in mammals are insulin and the insulin-
like growth factors (IGFs). Insulin and IGFs are recognized at the cell surface by tyro-
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 Fig. 1. Major mTORC1 and mTORC2 signaling pathways. mTORC1 and mTORC2 are major intracel-
lular signaling hubs that respond to a variety of stimuli and mediate an array of downstream re-
sponses. Major regulators of mTORC1 signaling through insulin and IGF, sensing of intracellular ami-
no acid levels at the lysosome via ragulator, and response to intracellular AMP:ATP levels through 
sensing by AMPK. mTORC2 is activated at assembled ribosomes and by Foxo1. Downstream path-
ways regulated by mTORC1 include mRNA translation, autophagy, metabolism, and vascularization. 
mTORC2 regulates actin/cytoskeletal assembly, inflammation, and stress resistance mediated by 
Foxo1 and Foxo3. 
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sine kinase receptors and provide the primary extracellular regulation of mTOR. Sig-
naling through insulin/IGF is partially through phosphoinositide (PI3)-mediated ac-
tivation PI3-dependent kinase (PDK) and subsequent activating phosphorylation of 
AKT on T308  [5] . IGF-1 signaling represents a longevity-regulating pathway in its 
own right, acting through both mTOR and through FoxO. IGF receptor loss has been 
shown to increase life span in mice and worms ( daf-12 is the IGF homolog in  C. ele-
gans ); serum IGF levels have been shown to correlate with life span among mouse 
strains, and FOXO gene variants are strongly associated with extreme longevity in 
humans  [6] . IGF-1 is the canonical and best characterized IGF activator of mTOR. 
AKT stimulates mTORC1 through phosphorylation of the mTORC1 inhibitor tuber-
ous sclerosis complex protein 2 (TSC2). In its active form, the TSC1/2 complex is a 
GTPase-activating factor for the small guanine nucleotide-binding protein Rheb. 
Stimulation of Rheb by active TSC1/2 results in a conversion of loaded GTP to GDP, 
inactivating the protein. Active GTP-bound Rheb is a necessary component of 
mTORC1; thus, inhibition of TSC1/2 results in downstream activation of mTORC1 
through an increase in active Rheb  [7] .
 Ribosome Capacity  
 While mTORC2 is not activated by insulin and growth factors through canonical 
signaling events, an intriguing mechanism has been described which couples reg-
ulation of mTORC2 activity by extracellular signals to intracellular ribosomal ca-
pacity  [8] . In this pathway, mTORC2 is activated by PI3K through increased phys-
ical association with ribosomes. Activated mTORC2 at the ribosome phosphory-
lates S473 on a hydrophobic motif of Akt, priming it for activation by PDK1. 
Ribosome-associated active mTORC2 also phosphorylates a hydrophobic motif of 
SGK and PKC. The relationship between mTORC2 and ribosome activity links 
cellular translation capacity to growth signaling. Simultaneously, ribosomal bio-
synthesis is also regulated by TORC1 activation of p70S6K and its target, the ri-
bosomal S6 subunit. This crosstalk between mTORC2 and mTORC1 provides an-
other link between intracellular growth capacity sensing and the regulation of 
growth by mTOR.
 mTORC2 thus lies both upstream and downstream of AKT, a relationship that 
may explain a variety of otherwise inexplicable observations related to mTOR biol-
ogy. One such case is the uncoupling of mTORC1 and AKT signaling by Foxo in-
duction. Foxo has been found to upregulate levels of Rictor, the mTORC2-specific 
binding partner of mTOR, and activate AKT while simultaneously causing a de-
crease in assembled mTORC1. This decrease has been shown to result from seques-
tration of mTOR to mTORC2, while increased activity of mTORC2 directly acti-
vates AKT. The downstream effects of mTORC2-specific signaling are not well 
characterized in the context of aging but this complex relationship with mTORC1 
and AKT demonstrates the importance of mTORC2 in the outcome of mTOR sig-
naling perturbations.
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 AMPK  
 mTOR activity is modulated not only through extracellular signaling, but also by mul-
tiple intracellular energy and nutrient-sensing pathways. One well-characterized reg-
ulator of mTOR activity is the highly conserved AMP-activated kinase, AMPK. AMPK 
is an ancient sensor of energy status that acts as an intracellular upstream regulator of 
mTOR. AMPK is sensitive to the AMP:ATP status in the cell and is activated as this 
ratio increases. Upon activation, AMPK drives catabolic processes, such as fatty acid 
metabolism, and inhibits anabolic reactions, such as lipid synthesis, for the purpose 
of balancing intracellular energy status. AMPK acts on mTOR through multiple in-
teractions. TSC2 is activated by AMPK through phosphorylation at T-1227 and 
S-1345. AMPK also appears to directly inhibit mTORC1 through phosphorylation of 
Raptor at serine 722 and serine 792  [9] .
 Multiple pharmaceutical agents that target AMPK signaling are available for re-
search use, and AMPK activators have been used clinically in the setting of type 2 
diabetes. Phenformin, a potent and direct AMPK activator, was used for the treatment 
of type 2 diabetics for decades before being removed from clinical use. This drug had 
strong beneficial effects for patients but was found to cause life-threatening, some-
times lethal, lactic acidosis following exercise  [10] . The less potent and less character-
ized drug metformin replaced phenformin in the clinic. Metformin appears to have 
many of the same biological effects as phenformin (primarily inhibition of glycolysis 
and regulation of blood glucose) with a much lower frequency of the life-threatening 
lactic acidosis. The exact mechanism of function for metformin is not well under-
stood, with some recent studies suggesting that the compound functions through in-
hibition of complex I of the electron transport chain, and others demonstrating an 
effect from the drug even in AMPK-deficient animals, together suggesting that met-
formin functions in large part through AMPK-independent pathways.
 Amino Acid Sensing at the Lysosome  
 mTORC1 is also directly activated by amino acids through an interaction at the surface 
of the lysosome, allowing for intracellular amino acid abundance to regulate growth 
and metabolism directly through mTOR  [11] . This sensing is facilitated by the recent-
ly discovered ragulator complex, a vacuolar ATPase binding complex that contains a 
guanine nucleotide exchange factor for Rheb and is regulated at the lysosomal surface 
by amino acids. Under conditions of high intracellular amino acids, mTORC1 and 
Rheb are recruited to the ragulator complex at the surface of the lysosome where Rheb 
activates mTORC1 as described above. Together, the regulatory interactions described 
above define mTORC1 as a central sensor of growth conditions and energy cues.
 Caloric Restriction  
 Caloric restriction (CR) is a well-documented life span-extending intervention that 
has been found to be effective in divergent species including yeast, flies, rodents, and 
nonhuman primates  [12] . Defined as a reduction in nutrient intake in the absence of 
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malnutrition, CR (also referred to as dietary restriction or DR) is simple in theory but 
is a complicated intervention in practice, and one that has not been rigorously stan-
dardized. CR strategies differ greatly between organisms, life span assay type, labora-
tory, and field of study  [13] . Even within the same organism, CR can be implemented 
in a variety of fashions. In nematodes, CR can be accomplished by titrating down the 
bacterial food available on solid plates or in media or by removing bacteria altogether 
(referred to as bacterial deprivation or BD). A variety of CR treatments exist in yeast 
including variable degrees of glucose deprivation or substitution of glucose (the stan-
dard carbon source for yeast on plates) with nonfermentable carbon sources. Murine 
studies of CR vary greatly in terms of food composition, percent CR (mass of food 
provided compared to ad libitum intake), and housing conditions, such as imple-
menting CR on singly versus multiply housed mice.
 Given that CR varies widely in implementation practices, it is almost surprising 
that CR generally works, suggesting that the downstream factors regulating this in-
tervention are robust, well conserved, and may hold real promise in human aging 
and disease. There has been a significant effort to identify downstream effectors of 
CR, and mTOR has been often identified as a pathway likely to regulate a portion of 
the CR response. Given the role of mTOR in nutrient signaling and response to 
growth cues, it makes sense that mTOR would be involved in the CR response. 
mTORC1 activity has been shown to be reduced by CR in invertebrate and mamma-
lian studies. Additional evidence implicating mTORC1 in CR comes from reports in 
which CR fails to additively extend yeast replicative life span in mutants for mTOR 
or S6K, as well as from studies in  C. elegans showing a similar lack of additive exten-
sion between a genetic model for CR (the eat-2 mutant) and RNAi against mTOR 
 [14] . S6K and translation initiation factors were, however, found to be additive with 
CR in this model.
 It has become clear over the past decade of aging research in invertebrates, and 
more recently in murine studies, that classical genetic complementation experiments 
are often difficult to interpret and are prone to overinterpretation when longevity is 
the phenotypic readout. Given that longevity is an extraordinarily complex trait and 
that the regulators of maximum longevity are still poorly understood, it has proven 
difficult to demonstrate true complementarity in life span studies. There always exists 
a possibility that some unrelated factor or process is limiting additive life span exten-
sion in experiments that appear to demonstrate complementation. Even considering 
this caveat, there is a large body of literature arising from multiple model organisms 
that link mTORC1-regulated processes, including autophagy and mRNA translation, 
to the beneficial effects of CR; together, these strongly suggest a role for mTOR in the 
CR response. Given the clear links of CR to processes downstream of mTOR, the ob-
served decrease in mTORC1 signaling on CR, and the role of mTOR in nutrient sig-
naling, there is a general consensus that altered mTOR signaling plays a significant 
role in CR, though additional pathways undoubtedly contribute to the overall effects 
of the intervention.
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 mTOR Downstream Signaling and Biological Relevance 
 As a major energy and growth signaling sensor, mTORC1 acts as a central coordina-
tor of proliferative and maintenance programs. mTORC1 activity drives growth 
through activation of mRNA translation, regulation of metabolic pathways including 
glycolysis and fatty acid metabolism, and repression of cellular catabolic pathways, 
primarily the autophagy/lysosomal degradation pathway. Inhibition of mTORC1 re-
sults in reduced mRNA translation, increased catabolic processes, and a shift in met-
abolic substrate preference. Many of the effects of mTORC1 activity or inhibition are 
mediated by activation or suppression of downstream transcriptional regulators and 
the complex crosstalk between these factors. This is particularly apparent in the effects 
of mTORC1 modulation on metabolism, with the outcomes being highly context de-
pendent on organism, tissue type, duration of intervention, type and severity of inter-
vention, and complex interactions with extracellular or extraorganismal environ-
ment. Thus, dissecting out the pathways and targets of key importance in aging and 
disease is a significant challenge. This is a context in which future work using systems 
biology approaches may play an especially important role. 
 While mTOR signaling is complex, some highly conserved and well-defined path-
ways have been identified downstream of mTORC1 and mTORC2. mTORC1 has 
been studied more extensively, and mTORC1-regulated processes are generally better 
described. The best-described mTOR-driven processes are briefly addressed below.
 mRNA Translation  
 Hormonal signaling and abundant nutrient availability promote mTORC1 activation 
which upregulate a variety of cellular processes necessary for growth. One critical pro-
cess driven by active mTORC1 signaling is mRNA translation, required for protein 
synthesis and cell growth. mTORC1 kinase activity is known to promote translation 
through at least two distinct substrates  [15] . mTORC1 phosphorylates p70S6K, the 
70-kDa ribosomal S6 kinase, which is an activator of ribosome biogenesis. The inter-
action of this level of regulation of translation with the control of ribosomal biogen-
esis by TORC2 has been previously mentioned. Eukaryotic translation initiation fac-
tor 4E-binding protein 1 (eIF4E-BP1 or 4E-BP1) is also directly phosphorylated by 
mTORC1. Phosphorylation of eIF4E-BP1 results in its release from the eukaryotic 
translation initiation factor 4E (eIF4E), allowing eIF4E to associate with mRNA cap 
binding proteins and form the cap-dependent translation initiation complex. The for-
mation of this cap-binding complex is a key translation initiation event in eukaryotes.
 Activation of mRNA translation is a critical function of mTORC1 and likely ac-
counts for many of the phenotypes associated with mTOR-driven disease, while de-
creased translation likely mediates many of the positive effects of mTOR inhibition. 
The antiproliferative effects of mTOR inhibitors in cancer and immune diseases may 
largely be attributed to decreased rates of protein synthesis due to reduced translation. 
Decreased mRNA translation has been identified as a major pro-longevity interven-
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tion in multiple organisms, and CR is thought to largely act through decreased trans-
lation. Deletion or knockdown of ribosomal components or translation initiation fac-
tors has been clearly demonstrated to increase life span in yeast, flies and nematodes. 
Furthermore, deletion of S6K extends life span and decreases body size in mice  [6] , 
though rates of translation have not yet been directly examined in these animals.
 While mRNA translation is globally decreased in the setting of CR, and in at least 
some reports of mTOR inhibition, multiple studies in model systems suggest that the 
beneficial effects of reduced translation may result from differential translation of a 
subset of mRNAs rather than simply being a consequence of reduced global transla-
tion. This model has been best established in budding yeast, where life span extension 
resulting from ribosomal protein subunit deletion has been linked to an increase in 
translation of the transcription factor Gcn4  [16] . Gcn4 regulates a variety of genes 
including genes coding for proteins necessary for response to low nutrient conditions 
and genes encoding proteins involved in stress response. In yeast, Gcn4 has been 
found to be necessary for life span extension by ribosomal mutants, and appears nec-
essary for full life span extension by mTOR or S6K deletion. Similar observations 
have been described in nematodes and flies, but this model has not yet found support 
in mammalian systems. A recent report using the mTORC1-specific catalytic inhibi-
tor Torin 1 in p53 –/– mouse embryonic fibroblasts suggested that differential effects 
on translation resulting from mTOR inhibition in mammalian cell culture could be 
largely explained by the presence of a 5 ′ terminal oligopyrimidine motif, though the 
study could not rule out the existence of less abundant differentially regulated 5 ′ or 
3 ′ elements  [17] . The interpretation of this study is complicated by the authors’ claim 
that all of the effects of mTOR inhibition were mediated through the 4E-BPs. Dele-
tion of individual 4E-BPs has not been reported to alter translation and has no obvi-
ous effect on body size in mice, although it does appear to alter adipose tissue mass 
 [18] , while deletion of S6K results in a marked reduction in body mass, demonstrat-
ing that S6K regulates growth rate (presumably through direct effects on translation) 
in vivo. These apparent discrepancies may be a result of the cell culture system or 
mode of mTOR inhibition – it may be that catalytic inhibition of mTORC1 by Torin 
1 does not accurately model mTOR inhibition by rapamycins or through genetic 
modulation.
 Global reductions in mRNA translation may directly contribute to the beneficial 
effects of mTOR inhibition on age-related diseases involving proteotoxic stress. The 
reduction of translation rates may directly enhance the fidelity of translation  [19] , and 
it is widely accepted that decreases in protein synthesis rates may allow for improved 
cellular proteostasis through a decreased workload on endogenous protein repair and 
degradation. A decreased steady state requirement for protein repair and degradation 
machinery may result in an increased capacity for cells to respond to transient stress-
es such as oxidative damage, protein aggregation, and heat or cold shock. Loss of pro-
teostasis is a critical component of a number of age-related diseases (see ‘mTOR and 
Age-Related Diseases’) and maintaining proteostasis is crucial for organism survival. 
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It seems that decreased mRNA translation may be promoting longevity at least par-
tially through improved proteostasis and increased protein degradation, though it is 
difficult to dissect this phenotype away from elevations in autophagy (see below), an-
tioxidant defense, or other biological effects of mTOR inhibition.
 Autophagy  
 In addition to promoting protein synthesis and cell growth, active mTOR inhibits 
the intracellular catabolic process of autophagy. As a major intracellular recycling 
pathway in eukaryotes, the autophagy-lysosomal pathway plays an essential role in 
degrading damaged organelles and macromolecules. Nutrient deprivation decreas-
es mTOR activity, relieving the inhibition of autophagy by active mTOR and result-
ing in an increase in the catabolism of proteins and organelles. This increased cata-
bolic activity provides amino acids and allows for cell survival when nutrients are 
limiting.
 The observed accumulation of damaged and aggregated proteins, oxidized lipids, 
and damaged organelles with age suggest that basal levels of autophagy decline or 
are insufficient to prevent the accumulation of damaged macromolecules associated 
with aging. Lipofuscin, the complex granular pigment that accumulates in aged tis-
sue, is a highly conserved phenotype of cellular aging that has been observed in all 
multicellular eukaryotes  [20] . While the exact composition and functional conse-
quences of lipofuscin remain to be determined, it has become clear that longevity-
promoting interventions also slow the rate of lipofuscin accumulation. Thus, lipo-
fuscin is often used as a biomarker of relative age. Given the close correlation be-
tween longevity and damaged macromolecule accumulation, the obvious prediction 
is that accumulated damaged macromolecules are a driving factor in aging and mod-
ulation of this accumulation could attenuate aging. While this hypothesis has prov-
en difficult to test directly given the challenges in selectively inducing the autophagy-
lysosomal system, a large body of evidence from yeast and  C. elegans supports the 
model that induction of autophagy is a necessary downstream effector of mTORC1 
inhibition in mediating life span extension  [21] . Induction of autophagy has also 
been shown to be necessary for CR-mediated longevity promotion, potentially 
through mTOR  [22] . While the necessity of autophagy for the success of these inter-
ventions is broadly accepted, it is not clear whether induction of autophagy alone is 
sufficient to increase life span.
 In addition to the role of autophagy in promoting longevity, dysfunction of this 
pathway has been implicated in a variety of pathologies, and activation of autophagy 
has been demonstrated to attenuate a variety of age-related diseases. The induction of 
autophagy has been directly implicated as a potential clinical target for treatment of 
cardiovascular disease, age-related macular degeneration, diabetes, and a variety of 
neurodegenerative disorders including Parkinson’s disease (PD) and Alzheimer’s dis-
ease (AD)  [23] . The nervous system appears particularly sensitive to the accumulation 
of damaged macromolecules and protein aggregates, and increasing autophagic deg-
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radation has been shown to prevent neurodegeneration in models of AD and PD as 
well as in models of Huntington’s disease (HD), a progressive neurodegenerative dis-
ease directly associated with proteotoxic insult.
 Mitochondrial Function and Metabolism  
 Mitochondria are key organelles in metabolism, disease, and aging. These organelles 
are the major producers of energy for most cell types, a primary site of metabolic re-
actions, a major source of toxic products (both reactive oxygen species and toxic in-
termediates of metabolism) and provide key cellular signaling regulators. Given the 
multifaceted role that mitochondria play in eukaryotic biology, it is unsurprising that 
mitochondria have been linked to a variety of pathological states, diseases, and aging 
 [24] . mTORC1 appears to influence mitochondrial function through multiple mech-
anisms and downstream regulatory factors.
 Hypoxia-inducible factor 1, Hif-1, is a transcription factor that promotes glyco-
lytic processes, and can be activated through mTOR signaling in mammals  [25] . This 
factor is linked to longevity in model organisms through somewhat unclear mecha-
nisms and to vascular tumor growth, ‘wet’ macular degeneration  [26] , and rheuma-
toid arthritis  [27] in mammals through its positive effects on the angiogenic factor 
VEGF. At the intracellular level, Hif-1 promotes glycolysis, downregulates mitochon-
drial oxygen consumption, and at least partially mediates the Warburg effect in mam-
malian neoplasia. Decreased mTOR signaling is thought, therefore, to directly influ-
ence tumor vascularization, tumor metabolism, and the Warburg effect at least par-
tially through decreased activation of Hif-1. This pathway may act independently of, 
or cooperatively with the general anti-proliferative effects of mTOR inhibition.
 Consistent with these effects, mTOR inhibition has been associated with increased 
mitochondrial respiration in yeast and worms, and CR has been associated with in-
creased mitochondrial content and respiration in a variety of organisms. This effect 
has been directly associated with longevity in yeast, with adaptive signaling resulting 
from increased mitochondrial superoxide production being implicated in this re-
sponse  [28] . Mice lacking mTORC1 components in white adipose tissue also show an 
increase in mitochondrial content and respiration, suggesting that this may be con-
served in mammals  [29] . Mitochondrial metabolism and cellular mitochondrial mass 
have also been reported to be increased by mTORC1 inhibition, at least in certain 
conditions, through a downstream activation of PGC-1α and the transcription factor 
Ying-Yang 1  [30] . The precise role of mitochondrial metabolism as a downstream 
mediator of mTOR is far from clear, but available data suggest that this is a critical 
component of aging and disease, and thus warrants further attention.
 In addition to the above, mTOR affects mitochondrial function through autopha-
gic degradation of mitochondria, a process termed mitophagy. The mitochondrial-
lysosomal axis theory of aging suggests that proper maintenance of a functional pool 
of mitochondria depends on continuous successful removal of damaged and dysfunc-
tional mitochondrial components through fission and mitophagy of fission products 
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 [31] . This theory predicts that reducing the rate of turnover of mitochondria, as may 
occur in aging, would result in an accumulation of dysfunctional mitochondria. This 
accumulation could lead to an increase in basal ROS production, damage accumula-
tion, loss of tissue homeostasis, and potentially cellular senescence or death. mTORC1 
inhibition increases basal autophagy, as described above, and would thus be predicted 
to preserve or restore mitochondrial function with age and thus potentially improve 
overall mitochondrial function. While this model remains to be directly addressed, it 
provides an attractive link between mitochondrial function and mTOR signaling in 
aging and disease.
 Stem Cell Maintenance  
 Stem cell loss and dysfunction are likely a significant factor in mammalian aging and 
age-related diseases. This is particularly likely in proliferative tissues such as dermis, the 
immune and gastrointestinal system, as well as in wound repair or response to ischemic 
injury in which proliferative capacity is required. While the exact role for stem cells in 
aging is currently unknown, evidence suggests that mTORC1 is central in the mainte-
nance of stem cells with age. As discussed below, mTOR inhibition has been shown to 
protect immune function with age in murine models of infection, and this has been at-
tributed to enhanced hematopoietic stem cell capacity. mTOR inhibition with rapamy-
cin has also been recently reported to improve intestinal stem cell function, although in 
this case the improvement was linked to alterations in mTOR signaling in the adjacent 
Paneth cells, which are responsible for maintaining the stem cell niche, rather than a 
direct effect on intestinal stem cells. CR has been shown to enhance the function of skel-
etal muscle stem cells, presumably related, at least in part, to the concomitant decrease 
in mTOR activity. The role of stem cells in aging and of mTOR in regulating their func-
tion remains an exciting and largely uncharted avenue of research.
 mTOR and Age-Related Disease 
 Longevity and Health Span 
 Extension of health span, defined as the duration of life for which an organism is free 
from major age-related disease or loss of function, is considered by many to be the 
critical goal of aging research. Longevity studies in model organisms can intrinsically 
include health span components.  C. elegans viability determination in standard plate 
or liquid-based life span studies is based on the ability of the animals to respond to 
mechanical stimulus. Yeast studies, both replicative and chronological, depend on the 
cell capacity to successfully produce progeny. In both cases, the individual organism 
may remain viable beyond the point that they are considered deceased by the assay 
standards. Thus, the nematode and yeast models are tied to neurological, muscular 
health, and reproductive capacity, respectively. In the murine model animal welfare 
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regulations generally prevent expiration of mice by natural causes, requiring eutha-
nasia if animals decline past a set cutoff in body mass, appear immobile, hunched, or 
in pain, or if they show signs of severe and untreatable diseases, such as ulcers or can-
cers. These restrictions may complicate accurate determination of life span in a lon-
gevity study but they also compel longevity-promoting interventions to be those that, 
at least in part, also protect health span. 
 Considering these restrictions, it is perhaps unsurprising that current data suggest 
longevity-enhancing interventions extend the health of populations and decrease or 
delay the incidence of age-related disease, rather than increase survival of unhealthy 
individuals. It appears that the regulation of health span and life span are at least 
closely linked. Concordantly, relatively few examples exist in the literature where 
health span is benefited in the absence of longevity benefits, perhaps a result of using 
life span as a primary end point. A noted exception is the recent (2013) NIA study of 
CR in rhesus monkeys, which observed a significant decrease in the appearance of 
age-related diseases without a change in survival  [32] . While this, and studies like it, 
show that it may be possible to uncouple health span and longevity, they are gener-
ally limited by a lack of positive controls and/or a clear definition of what constitutes 
baseline health span. The rhesus study, for example, stands in contrast to a prior study 
that reported an increase in both life span and health span  [33] . Differences in diet, 
housing conditions, and severity of the CR protocol may be factors distinguishing the 
two studies and the lack of a positive control limits the conclusions that can be drawn 
from this work. It is possible that longevity-promoting interventions may more sen-
sitively and broadly affect health span than life span.
 There has been a recent growth in emphasis on efforts to define and characterize the 
effects of longevity-promoting interventions on age-related health parameters. Each 
model used for aging studies has a set of health parameters that have been used to ex-
plore the relationship between life span, health span, and aging interventions. In yeast, 
the primary health span parameters are replicative capacity (in this case the actual read-
out for life span), mitochondrial function, and cell morphology. Nematodes have typi-
cally been used to study proteostasis and clearance of damaged macromolecules during 
the aging process as well as neurological decline, diseases of proteotoxicity, and age-
related changes in muscle function.  D. melanogaster has been useful in studying neuro-
logical function, muscle function, sensory function, stem cell function, and cardiac 
function with age. Mammalian systems have been used to examine a variety of age-re-
lated physiological and health parameters relevant to the biology of human aging.
 mTOR and Disease 
 Concurrent with demonstrations of a role for mTOR in regulating longevity, it be-
came increasingly apparent that mTOR signaling plays a central role in regulating 
health span and a variety of age-related and non-age-related pathologies ( table 1 ). 
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mTOR inhibition attenuates specific age-related changes in lower organisms, as not-
ed above. In addition, mTOR inhibition slows or delays many age-related and age-
associated changes that are broadly conserved from lower eukaryotes to mammals. 
Included among these are lipofuscin accumulation, DNA damage accumulation, 
age-related mitochondrial dysfunction, and loss of proteostasis. Cardiac, neuronal, 
and stem cell functions are also improved with age in multicellular invertebrates and 
mammals by inhibition of mTOR. While the efficacy of mTOR inhibitors in attenu-
Table 1.  mTOR inhibition in age-related diseases
Disease Observation
Neurodegenerative
PD Protection of dopaminergic neurons in fly and mouse models 
AD Delayed disease progression in mouse models
HD Induction of autophagy and reduction in htt toxicity in fly and mouse  models
Age-related cognitive decline Improved spatial learning and memory in old mice; antidepressive effects
Cancer Inhibition of growth of solid tumor cell lines; disappointing efficacy in 
 clinical trials with the exception of renal cell carcinoma and several rare 
 cancers that include those driven by TSC1 and TSC2 deficiency 
Heart disease
Restenosis following angioplasty Widespread use of stents that elute rapamycins 
Hypertrophy and failure Inhibition of hypertrophy and some regression of failure in the mouse 
aortic constriction model
Cardiomyopathy Zebrafish heterozygous for mTOR were protected in two different models of 
cardiomyopathy; rapamycin attenuated cardiomyopathy in LMNA–/– mice
Diabetes and obesity
Protection Mice lacking S6k1 in all tissues or lacking Raptor in adipose tissue are 
 resistant to diet-induced obesity and insulin insensitivity
Susceptibility Mice and rats chronically treated with rapamycin develop glucose 
 intolerance and insulin resistance, attributed to inhibition of mTORC2;  
associated with rapamycin in transplantation therapy in humans 
Immune function
Inhibition Use in clinical immunosuppression therapies 
Enhancement Enhanced immune function in tuberculosis and anti-tumor vaccine 
 responses in mice and vaccinia vaccination in nonhuman primates 
 Improved B cell and influenza vaccine responses in old mice
Kidney disease
Allografts and renal cancer Reduced rejection and nephrotoxicity with rapamycin therapy 
Polycystic kidney disease Improved outcome in animal models
Age-related macular degeneration Decreased the incidence and severity of retinopathy in rats; decreased need 
for anti-VEGF treatment in humans
Hutchinson-Gilford progeria Corrected the nuclear morphology defect, delayed onset of cellular 
 senescence, and enhanced clearance of progerin through autophagic 
 degradation in cell culture models
 Altered mTOR signaling has been investigated as a potential therapeutic strategy in a range of age-related and 
age-associated pathologies.
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ating age-related pathologies in humans is yet to be determined, there is an abun-
dance of literature suggesting that mTOR is a clear potential target for diseases of 
aging. 
 Heart Disease  
 There is evidence that mTOR inhibition may be generally protective against cardio-
myopathies, including age-related cardiomyopathy  [34] . Zebrafish heterozygous for 
mTOR were protected against two different models of cardiomyopathy. Administra-
tion of rapamycin markedly suppresses cardiac hypertrophy in the trans-aortic con-
striction model of pressure overload-induced heart failure, and rapamycin treatment 
has been shown to result in regression of established pressure overload-induced car-
diac hypertrophy, fibrosis, and dysfunction. Perhaps the greatest impact of mTOR-
targeted pharmacotherapy in cardiac disease has emerged through the widespread use 
of stents that elute rapamycin or rapamycin derivatives (e.g. everolimus, temsiroli-
mus, ridaforolimus, umirolimus, zotarolimus, collectively referred to as ‘rapamycins’) 
to inhibit cell proliferation and restenosis following angioplasty, with significant de-
creases in major adverse cardiovascular events during the first few years after implan-
tation  [35] .
 While decreased mTOR signaling has been clearly demonstrated to attenuate a va-
riety of cardiac myopathy and failure models, the precise mechanisms of importance 
are less clear  [34] . Decreased mRNA translation, inflammation, and hypertrophic 
growth signaling, increased autophagy, improved mitochondrial function or content, 
and altered metabolic preference have all been independently linked to improved out-
come resulting from mTOR inhibition in cardiac models making it difficult to parse 
out the key functions downstream of mTOR crucial to the benefits observed. The 
complex nature of the cardiac system and the multifaceted role of mTOR inhibition 
in attenuating cardiac dysfunction make age-related cardiac dysfunction a particu-
larly attractive model for a systems approach. Much of the recent and ongoing work 
in the cardiac aging field relies on systems biology techniques, such as shotgun pro-
teomics, RNA sequencing, and metabolomics, to demonstrate a shift in organ state in 
aging and an attenuation with treatment.
 These stand-alone systems analyses are proving highly informative for under-
standing the effects of interventions, but a full mechanistic picture of the role of 
mTOR in age-related cardiac disease and rescue will likely require a combination of 
multiple approaches. Systems analyses will likely reveal multiple distinct functional 
states in cardiac tissue where interventions affecting any of the individual down-
stream mediators of mTOR actually lead to a similar shift in the steady state through 
feedback. Decreased translation and increased autophagy could, in this scenario, con-
verge in their functional consequence by causing an overall shift in the functional, 
proteomic or metabolic state of cardiac cells. Thus, the cardiac aging paradigm seems 
particularly amenable to a systems biology perspective.
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 Neurodegenerative Disease  
 As noted above, it has been suggested that mTORC1 inhibition-mediated enhance-
ment of autophagy may lead to improved degradation of aberrant or misfolded pro-
teins and reduced proteotoxic stress in neurodegenerative diseases such as PD, AD, 
and HD  [36] . Thus, inhibition of mTOR could prove to be a successful therapeutic 
strategy in neurodegenerative disease. Evidence of such effects has been seen in fly and 
murine models of PD as well as in fly, murine, and cell culture models of HD. Positive 
effects of rapamycin on disease progression have been reported in two different mouse 
models of AD.
 The evidence of a benefit of rapamycin in neurodegenerative diseases raises the 
question of whether mTORC1 inhibition might also attenuate age-related declines in 
cognitive function in the absence of a more severe neurological disorder. Recent stud-
ies assessing the effects of chronic mTOR inhibition on cognitive function during ag-
ing in mice have reported that old animals treated with rapamycin performed sub-
stantially better on tasks measuring spatial learning and memory than did untreated, 
age-matched animals  [37] . Intriguingly, there were indications that rapamycin also 
enhanced cognitive function in young mice and had anti-anxiety and antidepressive 
effects at all ages. mTOR has also been identified as a potential target for treatment of 
seizures  [38] , suggesting that growth signaling inhibition may have broad neurologi-
cal benefits. The complexity of the central nervous system makes it a challenge to in-
vestigate the mechanisms underlying the beneficial effects of decreased mTOR signal-
ing, but the clear therapeutic potential make it a very attractive target for testing 
mTOR inhibitors in a clinical setting.
 Cancer  
 A majority of tumors show evidence for activation or upregulation of mTOR signal-
ing, and mTOR inhibition has been studied extensively as a potential therapy for a 
wide variety of cancers. Rapamycins potently inhibit growth of solid tumor cell lines 
but have shown disappointing efficacy in several clinical trials, though certain rare 
cancers, including renal cell carcinomas and glioblastomas, may respond to mTOR 
inhibition. Mutations in TSC1 and TSC2, which are upstream inhibitors of mTOR, 
cause a variety of hyperplastic diseases including tuberous sclerosis, directly linking 
hyperplasia to mTOR overactivity. Dysplasias driven by TSC1 or TSC2 loss are cur-
rently being evaluated as clinical targets for mTOR inhibitors  [39] . Rapamycin has 
been shown to delay or reduce deaths due to age-related and age-associated cancers 
in several studies in mice.
 Diabetes and Obesity  
 mTOR signaling has been implicated in the development of age-associated metabolic 
disorders such as obesity and type 2 diabetes. Inhibition of mTORC1 inhibits, while 
mTORC1 activation stimulates, adipogenesis in mice  [40] . Obesity results in chronic 
activation of mTOR in adipose tissue, a state that has been linked to obesity-associat-
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ed cancers, inflammation, β-cell adaptation preceding type 2 diabetes, nonalcoholic 
fatty liver disease, and many other complications  [41] . Multiple downstream effectors 
of mTOR signaling, such as S6K-1, 4EBP1, and SREBP, act as mediators between nu-
trient signaling and the development of obesity and type 2 diabetes. SREBP, a tran-
scription factor that induces the expression of lipogenic genes, is activated by mTORC1 
but not mTORC2  [41] . S6K-1 null mice display reduced body fat mass and resistance 
to diet-induced obesity, while mice lacking 4EBP1 show increased sensitivity to diet-
induced obesity and adipogenesis, possibly through hyperactivation of S6K-1  [41] . 
Mice lacking Raptor in adipose tissue are lean with fewer and smaller adipocytes, have 
increased insulin sensitivity, and show resistance to diet-induced obesity  [29] . Con-
versely, mice with adipose-specific knock out of Rictor have normal body fat mass and 
glucose tolerance but are hyperinsulinemic  [42] . Mice lacking S6K1 in all tissues or 
lacking RAPTOR specifically in adipose tissue show a profound resistance to diet-
induced obesity  [29] .
 The relationship between mTOR signaling and age-related metabolic disorders, 
including type 2 diabetes and obesity, is complicated. Rapamycin can protect mice 
from diet-induced obesity through the inhibition of adipocyte differentiation  [43] . 
However, mice and rats chronically treated with rapamycin demonstrate altered met-
abolic homeostasis, observed as altered insulin sensitivity and glucose tolerance  [44] . 
These effects of chronic rapamycin have recently been attributed to effects on 
mTORC2. Blood hyperlipidemia is also observed with chronic rapamycin treatment 
in mouse and human studies  [40] . The S6K1 knockout mice are also hypoinsulinemic 
and glucose intolerant, apparently due to a decrease in β-cell size and function. De-
spite these diabetes-like symptoms, both S6K1 knockout mice and rapamycin treated 
mice are long-lived, suggesting that these effects are not so detrimental as to limit sur-
vival. It has also been pointed out that the ‘starvation-induced diabetes’ associated 
with mTORC1 inhibition differs substantially from type 2 diabetes, which is caused 
by insulin resistance resulting from overnutrition in association with mTOR activa-
tion. Thus, additional study is needed to determine whether targeted inhibition of 
mTORC1 and the observed changes in lipid profile, insulin sensitivity, and glucose 
homeostasis represent a health risk or an altered metabolic state consistent with the 
promotion of longevity and health span.
 Immune Function  
 Rapamycins are used clinically as immunosuppressive or immunomodulatory drugs. 
There are, however, also reports that rapamycins can enhance immune system effi-
cacy in certain settings, including tuberculosis, anti-tumor vaccine responses in 
mice, and vaccinia vaccination in nonhuman primates  [45] . In the context of age-
related immune function, treating 22- to 24-month-old mice with rapamycin for 
only 6 weeks doubled the percentage and number of B (but not T) cells in the bone 
marrow, and restored the capacity of the aged animals’ immune system to mount an 
effective response to influenza vaccination, which was protective against subsequent 
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infection. The apparent contradiction between these observations and the use of ra-
pamycins as immunosuppressive drugs may be explained by observations that 
mTOR can exert divergent immunoregulatory functions during immune cell activa-
tion and differentiation, depending on the cell subset type. Furthermore, while ra-
pamycins may limit immune activation and proliferation in the setting of an immu-
nogenic insult, they appear to have a robust effect in preventing age-related declines 
in immune function, thus preserving immune function later in life. Thus, rapamy-
cins’ functions in immune biology are more complex than previously recognized, 
with outcomes depending on dose, duration of treatment, immune cell type, and 
specific immune challenge. Furthermore, the long-term effects of rapamycins on 
age-related declines in immune function stand in stark contrast to those of short-
term responses.
 Inflammation  
 Inflammation is strongly associated with aging and drives a multitude of age-associ-
ated disorders. Cardiovascular disease, obesity and metabolic disorders, cancer, and 
neurodegenerative diseases all include inflammatory components, and attenuation of 
inflammation has been implicated as a clinical target in each of these disease settings. 
Hyperactive mTOR has been linked to inflammation, and inhibition of mTOR by ra-
pamycins has been demonstrated to be anti-inflammatory in renal disease, lung infec-
tion, and in vascular inflammation in atherosclerosis and following angioplasty. Fur-
thermore, CR strongly attenuates age-related inflammatory signaling, and this effect 
appears to be at least partly mediated through mTOR. Reduced mTOR thus seems a 
good candidate for treating or preventing age-related inflammatory processes, while 
reduced inflammation seems to play significant mechanistic role in the pro-longevity 
effects of mTOR inhibitors.
 Renal Disease  
 Rapamycins are used clinically to reduce nephrotoxicity in chemotherapy, prevent al-
lograft rejection, and as a treatment for renal cell carcinoma. Activation of mTOR 
signaling has been associated with several common forms of kidney disease, suggest-
ing that inhibition of mTOR might have broad therapeutic benefits for renal health. 
Consistent with this, rapamycins have been shown to reduce kidney fibrosis, attenuate 
diabetic nephropathy, and improve outcome in animal models of polycystic kidney 
disease.
 Age-Related Macular Degeneration  
 Age-related macular degeneration is the leading cause of blindness in Western coun-
tries. Capillary overgrowth in the choroid layer of the eye, which is a contributing fac-
tor, has been attributed to excessive production of VEGF. Rapamycin has been shown 
to reduce VEGF expression in retinal pigment epithelium and inhibit angiogenesis in 
vitro  [46] . In a rat model of age-related macular degeneration, rapamycin decreased 
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the incidence and severity of retinopathy  [47] and in human patients rapamycin ap-
peared to decrease the need for anti-VEGF intravitreal injections by approximately 
half  [48] . Thus, age-related macular degeneration appears to be a promising clinical 
target for mTOR-inhibiting interventions.
 Hutchinson-Gilford Progeria and Laminopathies  
 Hutchinson-Gilford progeria syndrome (HGPS) is typically caused by a de novo 
mutation in the lamin A/C gene (LMNA) that activates a cryptic splice site, produc-
ing an abnormal lamin A protein termed progerin. Accumulation of progerin leads 
to aberrant nuclear morphology in vitro, and is believed to be the causal factor in 
the pathogenesis of disease. The precise mechanism linking progerin accumulation 
to the phenotypes associated with this disease is unclear, but it is generally thought 
to involve disruption of nuclear DNA binding proteins, including transcription fac-
tors and DNA repair components, as a result of aberrant nuclear scaffold structure. 
It has been reported that treatment of cells from HGPS patients with rapamycin 
corrects the nuclear morphology defect, delays the onset of cellular senescence, and 
enhances the clearance of progerin through autophagic degradation  [49] . No effec-
tive treatment for HGPS currently exists, and these data provide hope that rapamy-
cins might slow disease progression in HGPS patients. Any success in HGPS would 
strongly suggest that rapamycins might show efficacy in patients diagnosed with 
atypical Werners’ syndrome, often caused by non-HGPS mutations in LMNA, as 
well as in patients with muscular dystrophies resulting from lamin mutations or 
other laminopathies.
 Systems Biology Approaches to Studying mTOR 
 Genome-wide approaches, such as yeast single-gene mutant screens and RNAi screens 
in nematodes, have been critical to uncovering genes involved in the regulation of life 
span. The advent of proteomics, metabolomics, whole-genome sequencing, and 
RNAseq has fundamentally altered the way that aging studies are designed and exe-
cuted. As the accessibility of these high-throughput methods has improved, these 
techniques are being increasingly utilized. The study of mTOR in aging has histori-
cally been largely led by reductionist experiments, with researchers focusing primar-
ily on the use of single gene or small molecule perturbations to study mTOR and aging 
in model organisms. While these approaches have been, and continue to be, very fruit-
ful in defining the regulation of aging and age-related processes by mTOR, they are 
limited in their ability to model the complexities of aging. 
 As large datasets produced using these methods become more widely available, 
it becomes increasingly important that the systems biology paradigm is applied to 
produce a comprehensive picture of the information ( fig. 2 ). Modern aging research 
will greatly benefit from collaborations with bioinformatics experts that extend be-
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yond analysis of high-throughput data and into systems-based integration of di-
verse datasets into models that combine genetic, proteomic, transcriptomic, and 
metabolomics data into informative and approachable descriptions of aging pro-
cesses. These models should provide novel targets and strategies for intervention in 
the aging process as new nodes are described in genetic, proteomics, transcription-
al, and metabolic paradigms. In addition, the systems approach to aging research 
may provide clear answers to difficult scientific queries, such as the nature of the 
similarities and differences between CR and CR mimetics (such as rapamycin). 
Thus, while classic methods for studying aging are far from exhausted, it is clear that 
systems approaches have a role to play in our understanding of aging, the influence 
of genotype on aging, and the mechanisms of interventions, such as mTOR inhibi-
tion, on the aging process. 
A network of view of aging
ROS
degeneration
IGF
Nrf2
FOXO
Aging and
 Fig. 2. A network view of aging. A network approach to aging emphasizes the extensive crosstalk 
among and between the underlying causes of age-related changes, age-related diseases and dys-
function, and the cellular mechanisms and mediators that regulate longevity. This paradigm high-
lights the importance of systems biology approaches as a perturbation to any individual component 
in these networks is likely to affect many other components, and the overall outcome depends on 
the interactions between all players involved. 
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 Abstract 
 From the perspective of systems biology, melatonin is relevant to aging in multiple ways. As a high-
ly pleiotropic agent, it acts as a modulator and protectant of mitochondrial electron flux, a potent 
antioxidant that supports the redox balance and prevents excessive free radical formation, a coreg-
ulator of metabolic sensing and antagonist of insulin resistance, an immune modulator, a physiolog-
ical hypnotic and, importantly, an orchestrating chronobiotic. It entrains central and peripheral cir-
cadian clocks and is required for some high-amplitude rhythms. The circadian system, which controls 
countless functions, is composed of many cellular oscillators that involve various accessory clock 
proteins, some of which are modulated by melatonin, e.g. sirtuin 1, AMP-dependent protein kinase, 
and protein kinase Cα. Aging and age-related diseases are associated with losses in melatonin secre-
tion and rhythm amplitudes. The dynamic properties of aging processes deserve particular attention. 
This concerns especially two vicious cycles, one of peroxynitrite formation driven by inflammation 
or overexcitation, another one of inflammaging driven by the senescence-associated secretory phe-
notype, and additionally the loss of dynamics in a deteriorating circadian multioscillator system. 
 © 2015 S. Karger AG, Basel 
 Among scientific terms, ‘homeostasis’ is one of those which are very frequently used 
in an inappropriate manner. Of course, homeostasis reflects a concept of considerable 
value. Plasma levels of insulin and of Ca 2+ are classic examples of its usefulness. How-
ever, even basically homeostatically regulated parameters can be modulated by a mi-
nor but demonstrable circadian component, as known since long for the cases of both 
insulin  [1, 2] and Ca 2+  [3, 4] . From a cybernetic point of view, homeostasis is based 
on a negative feedback loop that allows the system to approach a setpoint value. How-
ever, with a sufficient delay time in the system, the feedback may result in an oscilla-
tion. Therefore, the existence of a negative feedback loop does not at all imply that this 
would lead to a near-constant level. Oscillations may also be superimposed from out-
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side the feedback circuit. An impressive example is the level of plasma cortisol  [5] , 
which exhibits a circadian rhythm with one of the highest amplitudes among blood 
parameters, despite a feedback to the upper instances in the hypothalamo-hypophy-
seal-adrenal axis. Contrary to the earlier belief that the delay time of the feedback may 
contribute to rhythmicity and that corresponding upstream rhythms in CRH and 
ACTH are causal to the glucocorticoid rhythm, the latter is meanwhile known to be 
generated by a peripheral circadian oscillator present in the adrenal cortex  [6] . At least 
in mice, this oscillator requires the presence of melatonin for generating robust 
rhythms  [7] . 
 The idea that the functioning of an organism is mainly based on the principle of 
homeostasis, i.e. a dynamic equilibrium attained by feedback mechanisms, turns out 
to be a misconception. A closer look reveals that countless processes in the body are 
rhythmic. The ‘circadian organization’ is apparent in functions as different as behav-
ior, mood, sleep/wakefulness, other neuronal activities, muscular strength, hormones, 
cytokines, intraorganismal distribution and actions of various immune cells, circula-
tion, vegetative functions, intracellular structure, chromatin remodeling, protein ex-
pression, enzyme activities, and many parameters more.
 Our growing insight into the significance of circadian oscillators and their output 
functions for health and healthy aging is currently increasingly perceived  [8, 9] . This 
includes the notion that genes of the cellular core oscillators act as tumor suppressors, 
that tumors suppress their intracellular circadian oscillators by epigenetic means, that 
an aging suppressor such as sirtuin 1 (SIRT1) and other metabolic sensors turn out to 
be accessory oscillator proteins that interact with the core oscillator, and that muta-
tions in core oscillator genes lead to increased formation of free radicals and to cancer.
 This perception is insofar of particular importance as the circadian oscillator sys-
tem, which is composed of numerous central and peripheral oscillators with a differ-
ent degree of autonomy and sensitivity to external time cues, controls a high number 
of physiological and cell biological processes. A specific aspect concerns melatonin, 
which is mainly secreted by the pineal gland, but is also synthesized in numerous 
other tissues and cells  [10] . The fraction released from the pineal gland exhibits a 
high-amplitude circadian rhythm with a prominent nocturnal peak. The actions of 
this indoleamine display an unusually high degree of pleiotropy  [10] . The melatonin 
receptors MT 1 and/or MT 2 are expressed in many cell types, not only in those with 
high receptor density such as the hypothalamic suprachiasmatic nucleus (SCN), the 
central circadian master clock. In mammals, a dual relationship between SCN and 
melatonin exists insofar as melatonin secretion is steered by the SCN, and melatonin 
feeds back to the SCN, thereby influencing the circadian phase and, in diurnally ac-
tive mammals such as the human, initiating sleep  [11] . In addition, melatonin effects 
have been demonstrated in several peripheral circadian oscillators, and are assumed 
in others  [8] .
 In relation to aging, both the SCN and melatonin levels exhibit changes presumed 
to be unfavorable and to accelerate processes of senescence  [9, 12] . Circadian ampli-
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tudes often decrease by age, which may lead, e.g., to sleep disturbances and nocturia. 
Typically, the spontaneous circadian period changes during aging, with the conse-
quence of phase advances under synchronized conditions. In the extreme, rhythms 
may decompose into separate, differently coupled components. In many but not all 
individuals, nocturnal melatonin levels decrease considerably, and the rhythm may 
almost disappear at advanced age. These changes are even more pronounced in a 
number of diseases and disorders, especially in neurodegenerative pathologies  [12] . 
With regard to the multiple connections of the circadian system and of melatonin to 
numerous functions, these alterations are of particular gerontological interest. Under 
the aspect of cyclicity, the significance of these changes can be only understood from 
a dynamical perspective.
 A Systemic View on the Interconnections of Major Aging Processes 
 From the perspective of systems biology, it is important to perceive the multiple con-
nections between aging processes. A selection of the most important causes of damage 
and alterations resulting hereof are depicted in  figure 1 . In particular, the various 
sources of reactive oxygen and nitrogen (RNS) species, their interaction in terms of 
peroxynitrite formation and the consequences for mitochondrial function, cell pro-
liferation and the immune system are emphasized in this overview. Of course, areas 
of high complexity such as immunosenescence can be touched in this scheme only 
superficially. Age-dependent changes in the immune system including immune re-
modeling, inflammaging and the new insights concerning the senescence-associated 
secretory phenotype (SASP) have been recently discussed in relation to melatonin and 
circadian rhythmicity  [9] . 
 Vicious Cycles 
 In addition to the circadian rhythmicity, which is involved in manifold ways in free 
radical formation, detoxification and avoidance, in mitochondrial metabolism and in 
the immune system, dynamic processes are also initiated and amplified by positive 
feedback loops, which can promote deteriorating changes during senescence. In  fig-
ure 2 a, the crucial role of peroxynitrite (OONO – ) and free radicals formed from this 
compound is outlined. As soon as ·NO, the free-radical congener of nitric oxide, is 
formed at higher rates, especially as a consequence of neuronal overexcitation or in-
flammation, a simultaneously occurring elevated generation of superoxide ( O 2 ·– ) un-
avoidably leads to peroxynitrite because superoxide has a similar affinity to ·NO and 
to the superoxide dismutases, the detoxificants of  O 2 ·– . Protonation of peroxynitrite 
leads to the unstable acid, which readily decomposes to the highly reactive, devastat-
ing hydroxyl radical (·OH) and ·NO 2 . An additional reaction exists, which is frequent-
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ly underrated in its importance. Peroxynitrite forms an adduct with CO 2 , which de-
composes in a corresponding way to a carbonate radical ( CO 3 ·– ) and · NO 2 . Although 
the carbonate radical has a lower reactivity than ·OH, it undergoes similar oxidative 
reactions and has, by virtue of resonance stabilization, a longer lifetime than the ex-
tremely rapidly decaying ·OH and is, thus, farther reaching. In conjunction with ei-
ther ·OH or  CO 3 ·– , ·NO 2 leads to nitration of aromates, including tyrosine residues in 
proteins  [13] . Further reactions are described in this reference. It seems important to 
be aware of the role of CO 2 in this context since it is highly available in mitochondria 
where it is formed as well as in tissues and in the circulation under conditions of hy-
poperfusion, a cause of enhanced tyrosine nitration, endothelial damage and vascular 
senescence. Notably, melatonin is an efficient scavenger of carbonate radicals  [14] and 
a mitochondrial protectant  [9, 13] . 
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Fig. 1. Simplified overview of some aging processes. DDR = DNA damage response; mtDNA = mito-
chondrial DNA; nDNA = nuclear DNA; Nox = NAD(P)H oxidase; ROS = reactive oxygen species.
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 The formation of peroxynitrite is part of a vicious cycle with relevance to aging 
( fig. 2 b). RNS are known to interrupt electron flux at different points of the mitochon-
drial electron transport chain (ETC). In the extreme of high-grade inflammation, it 
can completely block the entire pathway. Under conditions of low-grade inflamma-
tion, the damage by peroxynitrite-derived free radicals is crucial to the impairment of 
electron flux. The resulting bottlenecks cause an enhanced rate of electron leakage via 
electron back- and overflow mainly at complexes I and III [for further details, see 
Hardeland  15 ]. Dissipating electrons are transferred to molecular oxygen to give su-
peroxide. As long as ·NO formation takes place at an enhanced rate, the increased 
formation of superoxide and, therefore, peroxynitrite causes a steady amplification of 
ETC dysfunction and radical generation through this vicious cycle. ETC damage ul-
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 Fig. 2. Role of peroxynitrite and a vicious cycle driving progressive damage of the electron transport 
chain (ETC), apoptosis and mitophagy.  a Formation of free radicals from peroxynitrite.  b Vicious cy-
cle. The feedback loop that inhibits electron fluxes, in cybernetic terms, a positive one because it 
enhances electron leakage. iNOS = Inducible NO synthase; nNOS = neuronal NO synthase; eNOS = 
endothelial NO synthase. 
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timately leads to cardiolipin peroxidation by the peroxidase activity of the cytochrome 
c/cardiolipin complex  [16] , permeability transition and apoptosis. Interestingly, mel-
atonin acts in nontumor cells as an anti-apoptotic agent and a regulator of permeabil-
ity transition that allows short-term opening of the transition pore, but inhibits its 
persistent opening [for details, including discussion of superoxide flashes and differ-
ences to tumor cells, see Hardeland  9 ]. Alternately, mitochondrial damage can lead to 
mitophagy. On the one hand, this rescues cells from death, but, on the other hand, it 
can cause losses especially in the numbers of peripheral mitochondria, what is fre-
quently observed during aging and impairs neurotransmission at synapses insuffi-
ciently supplied with ATP.
 A second vicious cycle is also related to free radicals and inflammation, but in-
volves damage to the nuclear DNA ( fig. 3 ). This initiates the DNA damage response, 
which includes a proliferative arrest, a mechanism that prevents a carcinogenic fate 
of the affected cells. However, these senescent cells display the previously unexpected 
property of secreting, even as nonimmune cells, numerous factors including proin-
flammatory cytokines. This so-called SASP represents a driving force of aging-related 
inflammation. Even at low grade, this mechanism causes additional oxidative and ni-
trosative damage and can become an undesired source of carcinogenesis, although the 
primary action of arresting cells represents an anticarcinogenic action  [17, 18] . In 
conjunction with shifts from anti-inflammatory to proinflammatory cytokine secre-
tion that occur as a consequence of immune remodeling, SASP largely contributes to 
inflammaging.
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 It is important to be aware that vicious cycles behave in a highly dynamic way, 
far from homeostatic system properties. Because mitochondrial metabolism, com-
ponents of the antioxidative protection system including melatonin, neuronal ac-
tivities and many aspects of the immune system undergo circadian changes  [19, 20] , 
the vicious cycles are intertwined with a second dynamic system driven by cellular 
oscillators.
 Beneficial Cycles 
 Circadian rhythms are not only a means for structuring our day/night-related activi-
ties and for anticipating physiological requirements to come a few hours ahead, but 
are truly beneficial with regard to health and, thus, healthy aging. Some of these as-
pects had not been foreseen in the past. The important finding that mice carrying 
mutations in the core oscillator gene  Per2 are cancer prone  [21] has been later ex-
tended to other core oscillator genes, which have been identified as tumor suppressor 
genes  [8] . This role is, among other effects, related to circadian cycles of chromatin 
remodeling, which include histone acetylation by the CLOCK protein and deacety-
lation by SIRT1, by upregulation of other tumor suppressor genes such as  Wee-1 , and 
by suppression of protooncogenes such as  c-myc [summarized in Hardeland et al.  8 ]. 
Mutations in genes of the core oscillator and associated factors that cause deviations 
in period length or make the oscillator dysfunctional have been shown to increase the 
damage by free radicals, in organisms as different as hamsters and  Drosophila , to en-
hance the susceptibility to exogenously induced oxidative stress, and may be related 
to the observation that repeated experimental phase shifts reduce the lifetime of  Dro-
sophila [details in Hardeland et al.  8, 19 ]. These findings are believed to reflect the 
rhythmicities of both free radical formation and detoxification. 
 The cyclicity of the highly complex circadian system has manifold implications for 
the optimal functioning of a body, for health and aging. In  figure 4 , an overview is 
presented for some major roles of circadian oscillators. It combines findings obtained 
in different central and peripheral oscillators. The oscillators of different cells are not 
entirely identical, although they are operating on the basis of the same principle. Even 
in a single tissue, different clocks exist, which are acting in parallel and utilize differ-
ent orthologs or even paralogs of the core oscillator proteins. Moreover, the various 
accessory oscillator proteins are sometimes cell type specific. Finally, input pathways 
for synchronizing time cues as well as the degree of autonomy can differ. Some of 
them are more sensitive to the timing of food intake, whereas others strongly depend 
on the light/dark cycle. In  figure 4 , a selection of physiological or cell biological func-
tions is summarized that are relevant to health and aging. Some of the output func-
tions are feeding back to the respective oscillators and are capable of reentraining 
circadian rhythms. Among these, melatonin plays a particularly important role, be-
cause it modulates or synchronizes a plethora of circadian output functions including 
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those depicted in  figure 4 . A remarkable aspect concerns the numerous accessory os-
cillator proteins, among which all those have been incorporated that are also under 
control by melatonin.
 Pleiotropy of Melatonin in the Context of Aging 
 After the discovery of the antioxidant and cell protective properties of melatonin  [22] , 
the questions arose as to why a nocturnally peaking agent should be effective in diur-
nally active mammals such as the human, which generate more free radicals during 
the day, and whether results obtained in nocturnal laboratory rodents can be appli-
cable to man. Part of the answer is that direct scavenging of free radicals requires high 
melatonin concentrations for being efficacious and is only relevant where sufficient 
levels are attained, e.g. in melatonin-forming cells, perhaps in melatonin-accumulat-
ing organelles such as mitochondria  [9, 10] , and at pharmacological levels. The other 
part of the answer is related to the coordination and phasing of circadian rhythms, 
presumably also to a support of high-amplitude oscillations as observed, at least, in 
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several cases. In conjunction with other effects, such as prevention of neuronal over-
excitation and reduction of mitochondrial electron leakage, the concept of radical 
avoidance  [23] was proposed, assuming a higher significance of the prevention of en-
hanced radical generation compared to the detoxification of radicals already formed. 
 Melatonin exerts a number of effects of importance to aging, as summarized in 
 figure 5 . The support and coordination of rhythms is not only of relevance to the 
avoidance of excessive damage by free radicals, as observed under conditions of dis-
turbed rhythmicity in oscillator gene mutants. A sufficiently high and appropriately 
timed increase in melatonin is also implicated in sleep initiation  [12] . This involves 
an action at the SCN with a downstream effect on the hypothalamic sleep switch and 
an additional thalamic action that initiates, via a thalamocortical interplay, the forma-
tion of sleep spindles. Sleep disturbances represent a highly frequent change and com-
plaint associated with aging and can have a number of secondary consequences con-
cerning, e.g., nutrition, insulin resistance, and changes in the immune system.
 The actions of melatonin are also intertwined with the pathways of metabolic sens-
ing ( fig. 5 ). Effects on AMP-dependent protein kinase, phosphatidylinositol 3-kinase 
and Akt have been repeatedly described under various conditions, as recently sum-
marized  [9] . Upregulation of SIRT1, an aging suppressor, metabolic sensor and acces-
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 Fig. 5. Actions exerted by the highly pleiotropic regulator molecule melatonin, a selection with par-
ticular relevance to aging. CNS = Central nervous system; COX2 = cyclooxygenase 2; PI3K = phos-
phatidylinositol 3-kinase. 
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sory oscillator protein, have been reported in a few cases related to aging, but the re-
verse was found in tumor cells [cf.  9 ]. Effects on mitochondrial proliferation may be 
associated with metabolic sensors and downstream factors such as peroxisome pro-
liferator-activated receptor-γ coactivator-1α and peroxisome proliferator-activated 
receptor-γ  [9] . Beneficial effects by melatonin and synthetic melatonergic agonists on 
metabolic syndrome, insulin resistance and diabetes type 2 have been repeatedly de-
scribed and reviewed  [8, 9, 12] . Effects of melatonin on mitochondria exceed the as-
pect of their proliferation and intracellular distribution, as partially addressed in a 
preceding section. Further details have been elaborated in normally aging and senes-
cence-accelerated animals, as summarized elsewhere  [9, 12] . These findings obtained 
in mitochondria include the upregulation of antioxidant enzymes, improved forma-
tion and availability of reduced glutathione, and ·NO metabolism.
 Finally, melatonin formed by the pineal gland and by leukocytes is related to im-
mune functions in multiple ways. Actions of melatonin in the diverse subtypes of im-
mune cells and concerning the secretion of numerous cytokines have been described 
 [9, 10] and are relevant to immune remodeling during aging and the particularly im-
portant aspect of inflammaging  [9] . The problem of both anti- and proinflammatory 
actions exerted by melatonin is addressed in the next section.
 Controversial Results at First but Not at Second Glance: The Importance of 
Circadian Dynamics 
 Among the numerous actions of melatonin, several reports on seemingly opposite ef-
fects appear, at first glance, controversial or, as soon as they have been repeatedly con-
firmed, at least paradoxical. However, they may turn out to be less implausible when 
regarded from the perspective of systems biology and, where appropriate, under con-
sideration of dynamic changes as well as interventions that block dynamic processes. 
 One example for opposite effects concerns melatonin’s immunological actions. 
Both anti-inflammatory and proinflammatory effects of the methoxyindole have been 
described. In the majority of immune cells, melatonin has stimulatory properties  [10] . 
Therefore, it is not surprising that proinflammatory and, thus, pro-oxidant effects 
have also been described. However, what matters is the balance between pro- and 
anti-inflammatory actions and the conditions under which the balance is shifted. As 
a rule, anti-inflammatory actions are most evident under conditions of high-grade 
inflammation, especially endotoxemia and sepsis. The protective property of melato-
nin is largely related to suppression of excessive ·NO production, reduction of per-
oxynitrite formation, maintenance of glutathione levels and improvement of mito-
chondrial function. Proinflammatory effects are frequently observed under basal con-
ditions. Notably, melatonin does not suppress basal or moderately enhanced ·NO 
formation by inducible NO synthase or neuronal NO synthase and, therefore, does 
not prevent these stimulatory actions. The immunological role of melatonin may, 
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thus, be understood as that of a buffering agent  [24] , which allows moderate upregu-
lations but sets limits to excessive, damaging processes  [9] . However, this interpreta-
tion may not fully explain what is found under conditions of senescence. Especially 
with regard to concerns related to the promotion of inflammatory processes in auto-
immune diseases, which become more frequent in the course of immunosenescence, 
one might have expected a primarily detrimental role of melatonin as an immune 
stimulator during aging. However, the opposite is observed, in both normally aging 
and senescence-accelerated rodents, in which proinflammatory cytokines were down-
regulated and anti-inflammatory mediators upregulated [summarized in Hardeland 
 9 ]. In addition, reductions of oxidative damage and improvements of mitochondrial 
activity and efficiency were reported. Although the reasons for the predominantly 
anti-inflammatory actions may require further clarification, the interruption of vi-
cious cycles (cf.  fig. 2 ,  3 ) may be of particular importance. Improvements of mito-
chondrial function and antioxidative actions of melatonin may prevent an enhanced 
release of inflammatory mediators and, thus, normalize the system.
 Another area in which opposite effects of melatonin have been observed concerns 
apoptosis. Numerous publications have demonstrated anti-apoptotic effects of mela-
tonin in nontumor cells, in vivo and in culture. These comprise increases in anti-
apoptotic proteins such as Bcl-2 or Bcl-x L , decreases in their proapoptotic counter-
parts such as Bad and Bax, inhibition of Bad dephosphorylation and of poly-ADP 
ribose polymerase cleavage, prevention of cardiolipin peroxidation, of permanent mi-
tochondrial permeability transition, cytochrome c release and caspase-3 activation 
[summarized in Hardeland  9,  and Hardeland et al.  10 ]. However, several more recent 
reports have shown that melatonin can also behave in a proapoptotic way  [9, 25] . 
However, these surprising findings have been made, at reasonable melatonin concen-
trations, in tumor cells. This difference has been even observed by comparing a pseu-
do-tumorigenic tissue, the human primary villous trophoblast, in which melatonin 
remained antiapoptotic, with choriocarcinoma cells  [25] . Similarly contrasting find-
ings, with particular importance to aging, were obtained when effects of melatonin on 
SIRT1 expression were studied  [9] . Again, the sirtuin was found to be upregulated in 
normal cells, especially also in comparisons of young and aged neurons, and in senes-
cence-accelerated mice, but it was reported to be downregulated in tumor cells  [26; 
 for further literature see Hardeland  9 ]. Again, this melatonin effect in cancer cells was 
associated with the induction of apoptosis. The causes of these differences between 
tumor and nontumor cells require further clarification. However, it seems important 
to consider in this context their differences in circadian dynamics. As mentioned in 
the introductory section, tumors can suppress their cellular circadian oscillators epi-
genetically, by promoter hypermethylation in core oscillator genes, and thereby block 
the tumor suppressor function of oscillator proteins. Therefore, it would be of high 
relevance to know in which phase state the oscillator is trapped. This could imply that 
certain clock proteins are maintained at an expression minimum and others at their 
maximum. Since SIRT1 acts as an accessory oscillator protein, it may be fixed at a 
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certain relatively high expression level when the oscillator is stopped in a tumor cell. 
An agent like melatonin that interacts with circadian clocks may push the system into 
another phase position, e.g. by the known inhibition of  Rorα expression and subse-
quent downregulation of the core oscillator protein BMAL1, even if the oscillator is 
in total not yet sufficiently operating. In other words, effects of melatonin may be en-
tirely different depending on the circadian phase and can be completely divergent in 
operating and arrested oscillators. This interpretation may lead to other, more gen-
eral implications of relevance to experimental approaches. Overexpression of clock 
proteins may likewise lead to unphysiological states of oscillators that may not allow 
unambiguous conclusions.
 Conclusion 
 For the understanding of aging, the consideration of dynamic processes is required. This 
includes the circadian oscillator system and the melatonin rhythm in their aging- and 
disease-related deterioration and, moreover, vicious cycles of peroxynitrite formation 
driven by inflammation or overexcitation and of inflammaging driven by the SASP. 
Melatonin has the potential of readjusting rhythms and breaking the vicious cycles. 
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 Abstract 
 With modern medicine and an awareness of healthy lifestyle practices, people are living longer and 
generally healthier lives than their ancestors. These successes of modern medicine have resulted in 
an increasing proportion of elderly in society. Research groups around the world have investigated 
the contribution of gut microbial communities to human health and well-being. It was established 
that the microbiota composition of the human gut is modulated by lifestyle factors, especially diet. 
The microbiota composition and function, acting in concert with direct and indirect effects of ha-
bitual diet, is of great importance in remaining healthy and active. This is not a new concept, but 
until now the scale of the potential microbiota contribution was not appreciated. There are an esti-
mated ten times more bacteria in an individual than human cells. The bacterial population is rela-
tively stable in adults, but the age-related changes that occur later in life can have a negative impact 
on host health. This loss of the adult-associated microbiota correlates with measures of markers of 
inflammation, frailty, co-morbidity and nutritional status. This effect may be greater than that of diet 
or in some cases genetics alone. Collectively, the recent studies show the importance of the micro-
biota and associated metabolites in healthy aging and the importance of diet in its modulation. 
 © 2015 S. Karger AG, Basel 
 The human gastrointestinal tract has multiple critical roles that are central to health 
and well-being. It serves as a way to process foods and eliminate waste. It helps control 
appetite, it houses the largest mucosal surface in the body housing a large component 
of the immune system, and it even contributes to mood, behaviour and general well-
being. The most numerate cellular part of the gastrointestinal tract is not human but 
microbial. Most of these bacteria are called commensals, meaning they are normally 
resident and metabolizing human dietary components. The microbes in and on the 
human body have a combined number of genes a hundred times that of the human 
gene complement. The gastrointestinal tract is one of the most diverse environments 
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on the planet. The intestinal microbiota is now recognized as a major environmental 
modifier of health risk. Independent of genetic and other lifestyle factors, the gut mi-
crobiota has a coding capacity and potential metabolic activity that has a major impact 
on human physiology. In infancy, the microbiota composition trends towards an 
adult pattern over the first 2–3 years, with low initial diversity increasing over this 
time period. Disruptions of this process may be associated with risk for allergic disease 
in later life. In the adult years, alterations in the microbiota are associated with a di-
verse range of diseases [reviewed in de Vos and de Vos  1 ]. There is a particularly com-
pelling case for studying the microbiota in aging subjects. This phase of life is accom-
panied by a range of physiological and lifestyle changes that can have a big effect on 
the physical environment of the intestine. It has been known for several decades that 
the gut microbiota of older persons, similar to the very young, is in a state of flux  [2] . 
Coupled with a wide range of reported alterations in the composition of the intestinal 
microbiota in seniors, and different rates of age-related health loss in different indi-
viduals, countries and populations, detailed analysis of gut microbiota-health interac-
tions in older people is particularly appropriate. This review summarizes the differ-
ences between the physiology of older subjects and young adults that are relevant for 
microbiota changes and details the major findings of culture-based studies, and then 
examines the health implications of recent culture-independent studies, including 
those from the largest study to date, the ELDERMET consortium. 
 Physiological and Clinical Issues That Can Impact on the Gut Microbiota in Elderly 
 The global proportion of older people is rapidly and continually increasing. This has 
resulted in an increased need for healthcare and societal supports for this cohort of 
our society, and has highlighted the importance of not just longevity but healthy ag-
ing that maximizes functional capacity and quality of life in older age. The diversity 
of the microbiota of an individual is shaped by a number of factors, both internal to 
the host, and external. Common, age-related, physiological changes can modify phys-
iological function, which can in turn alter the composition of the microbiota. 
 Physiological, motor and sensory functions change with age. For instance, a natu-
ral reduction in dentition and deteriorating muscle mass in later life can impact on 
mastication ability. This can limit dietary choices, and changes in the diet can greatly 
impact the microbiota. Aging may be accompanied by impairment of intestinal sen-
sation and consequently increased susceptibility to gastrointestinal complications. 
Other age-related, digestive system complications include dysphagia (difficulty swal-
lowing), functional dyspepsia (painful, difficult or disturbed digestion), gastroesoph-
ageal reflux, delayed intestinal transit time, diverticulosis, and increased rates of con-
stipation, faecal and gaseous incontinence, all of which can significantly impact on 
microbiota composition and host health. Importantly, the impairment of taste and 
thirst sensation, olfaction and digestion, coupled with malabsorption and an increase 
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in the levels of satiation in older people, can lead to imbalances in nutrient intake, 
malnutrition and significant perturbation of the microbiota  [3] .
 Bilateral interaction with the host facilitates functional conditioning of the im-
mune system by the microbiota, which influences the composition of the microbiota 
itself. Microbiota disturbance has been linked with an increased susceptibility to dis-
orders including allergies, cancer, digestive/intestinal disorders, frailty, obesity/meta-
bolic disorder and its related conditions. It can also affect regulatory systems such as 
hormone signalling, leading to changes in mood and behaviour. Host metabolic path-
ways that facilitate connection between the intestine and the brain, can be affected  [3] . 
Disruption to this bidirectional homeostatic pathway has been associated with in-
flammation and alterations in the stress response, among other stress-related symp-
toms such as anxiety, commonly experienced in older age. A healthy, more diverse 
microbiota composition encourages resistance to pathogens and increased interac-
tion with the host immune system. Loss of diversity in old age is associated with less 
resistance to pathogens and a natural decline of immune function (immunosenes-
cence) with the development of chronic, low-grade inflammation typical of older age 
(inflammaging). Both low-diversity microbiota and immunosenescence can lead to 
increased rates of gastrointestinal infection.
 In older age, complex and dynamic exogenous factors, including diet and lifestyle 
modifications, medication use (particularly antibiotics), disease, injury and stress fur-
ther influence the composition of the microbiota. Health throughout life, and par-
ticularly in later years, is dependent on the maintenance of homeostasis, the presence 
of a stable physiological environment. The relative stability of the adult intestinal mi-
crobiota at a species level is a key contributory factor to the promotion and mainte-
nance of health. However, at abundance level the composition of the microbiota can 
fluctuate substantially over a short period of time  [4] . This suggests that the micro-
biota is able to respond to exogenous influences throughout life.
 Culture-Based Analyses of Intestinal Microbiota of Elderly 
 Culture-based methods were traditionally used to analyze the intestinal microbiota. 
An example of some of the methods utilized can be seen from experiments conduct-
ed in 1989 in Japan  [5] . Culture-based methods were used to compare the microbi-
ota of elderly people in Tokyo, Japan, with elderly in Yuzurihara, an area of Japan 
where the elderly tend to live longer. The faecal microbiota of 15 healthy elderly sub-
jects from each of the two areas was collected. A number of experiments were per-
formed to determine the genus, and where possible, species, of isolates found in these 
samples. Serial dilutions in an anaerobic diluent were made, and the samples were 
subsequently spread onto 4 non-selective and 11 selective agar plates. Subculturing 
from anaerobic plates to other plates helped determine which microorganisms were 
strict anaerobes. 
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 In order to identify the isolates, many biochemical tests were performed on broth 
cultures. These tests include detection of bacteria-derived metabolites and the deter-
mination of the effect of bile on bacterial growth. Benno et al.  [5] reported that while 
most of the same genera were observed between the two groups, the Yuzurihara sub-
jects had a larger bifidobacteria contingent than was observed from the Tokyo sub-
jects. However the Yuzurihara subjects had fewer total bacteria, anaerobes, bacilli, 
clostridia,  Bacteroides species, and  Eubacterium aerofaciens . Four genera,  Megamo-
nas ,  Mitsuokella ,  Selenomonas , and  Acidaminococcus , were isolated from the Yuzuri-
hara subjects but not the Tokyo subjects. Intestinal bifidobacteria counts are known 
to decrease with age, and some Enterobacteriaceae increase. That the Yuzurihara el-
derly had more bifidobacteria than the Tokyo elderly, despite being older, suggests 
that the Yuzurihara subjects were not displaying the same age-related microbiota 
changes that we see in other parts of the world. Benno et al.  [5] suggest that this is due 
to the high-fibre diet of the Yuzurihara subjects, and that this is why the Yuzurihara 
people tend to live longer.
 In 2002, another culture-based study focused on elderly suffering from  Clostridium 
difficile -associated diarrhoea (CDAD)  [6] who had a history of antibiotic treatments 
resulting in disturbed microbiota. This altered microbiota provided a reduced resis-
tance to  C. difficile infection. With the widespread use of antibiotics and increasing 
number of elderly, CDAD has become a challenging problem. Hopkins and Macfar-
lane  [6] aimed to characterize the microbiota of elderly subjects with CDAD. They 
classified isolates according to their cellular fatty acid profiles. Their results showed 
that CDAD patients had the lowest species diversity when compared with healthy el-
derly and young subjects, particularly of bifidobacteria,  Bacteroides and  Prevotella . 
Facultative species were higher in CDAD patients than in healthy subjects. Together, 
this shows that  C. difficile is associated with a greatly altered microbiota. The same 
group completed further studies in 2004  [7] , this time comparing healthy young and 
elderly, and hospitalized elderly. Again, they used fatty acids to identify bacteria. They 
reported reduced numbers and species diversity in both bifidobacteria and  Bacteroi-
des in elderly compared with the young subjects.
 The benefits of using such culture-based methods for analyzing intestinal micro-
biota include the low cost, and ability to retain isolates for further analyses. However, 
there are many disadvantages to culture-based methods. It is labour intensive, and 
with current approaches it is still not possible to culture the majority of the estimated 
gut bacteria (estimated 50–90%). Of those species that do grow on current artificial 
media, certain species will outgrow others, leading to further biases. Another disad-
vantage of culture-based approaches is difficulties in phylogenetic classifications. For 
some microbial families, multiple methods must be used to classify genera and species 
of different families, such as those discussed above. Benno et al.  [5] required a large 
number of methods for classification of isolates. This indicates how complex it can be 
to identify isolates using culture-based methods. It also shows how much culture of a 
given isolate is required to identify it. Some of these methods could often not distin-
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guish between two species of a given genus, so biologically-relevant species-specific 
genes or functions could not be accounted for. Speedy, high-throughput, specific and 
reliable alternatives were required.
 The Technological Revolution 
 The last decade has seen the introduction of increasingly intense research techniques. 
Rather than attempting to culture all isolates from a given environment, the DNA can 
be directly extracted from samples. In theory, this approach provides an unbiased 
view of the isolates within a sample. The preferred locus used for identification is the 
16S ribosomal DNA. As a housekeeping gene found in almost all bacteria, often in 
high-copy numbers, it is easily amplified. It contains a number of variable regions that 
differ between species and/or genera and so allows efficient identification. 
 Real-time quantitative PCR is often used to determine the proportion of certain 
bacteria in a sample. This approach is fast, cheap and useful for determining the lev-
el of a specific group of bacteria. However, when trying to assess and compare a num-
ber of different groups, qPCR becomes laborious. This directed approach, while very 
useful in many cases, does not provide an exhaustive view of the gut population, 
which is proving to be increasingly important. In 2009, a phylogenetic microarray 
was developed specifically for the human intestinal tract, known as the HITChip  [8] . 
This chip consists of 4,809 probes, and further probes can be added when required. 
However, microarrays are a high-throughput targeted approach. While they cover 
more targets at once, they are still limited by the probes. Different probes have dif-
ferent hybridization abilities, so biases can be introduced based on the choice of 
probes.
 The current, more commonly used technology is high-throughput sequencing. 
There are a number of different sequencing technologies available; however, micro-
bial community analyses based on 16S ribosomal DNA studies tend to use 454 FLX 
Titanium pyrosequencing due to the longer reads that can be obtained  [9] . Up to 1.6 
million reads can be sequenced in one run. Many different samples can be loaded on 
one slide using barcoded adaptors.
 With any new technology such as pyrosequencing, programs for analysis must be 
developed. The aims are to maximize the data obtained while minimizing the poten-
tial for error. Speed and accuracy are paramount, and as increasing amounts of data 
are obtained, programs that can handle ample quantities of reads are essential. When 
handling pyrosequencing data, many steps can be executed. Multiplexed libraries 
must be separated. Adaptor sequences must be removed. Error correction, or denois-
ing, can be performed. Chimeric sequences are sometimes formed during PCR am-
plification steps. Programs are available to remove these. Clustering is performed to 
reduce the time and volume for further steps. Finally, sequences must be classified at 
different phylogenetic levels.
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 Interest in these techniques has been huge with the formation of large multina-
tional scientific consortiums such as the The Human Microbiome Project  [10] , Me-
taHIT (Metagenome of Human Intestinal Tract)  [11] and the smaller ELDERMET 
project  [12] , as well as numerous labs around the world. These consortia have taken 
advantage of the new high-throughput technologies and have for the first time fully 
characterized the human microbiome in the gut and from other body sites.
 The use of these techniques has illustrated the heterogeneity of the microbial pop-
ulations in our gastrointestinal tracts with large inter-individual differences in the 
presence and absence of the bacterial species. Although some species are present in 
the majority of the population, these are in the minority in terms of the number of 
species that can be found in our gut. These rarer species are no less important for the 
well-being of the host. Species tend to co-occur and may be clustered into co-abun-
dance groups (CAGs)  [12] due to habit preference as defined by diet and cross-feeding 
events and the presence of bacteriocins, a type of bacterially produced antibacterial 
agent that is specific for a limited number or range of species. An alternative to the 
idea of CAGs are enterotypes. The idea of enterotypes predates that of CAGs and is 
different in a number of characteristics ( table 1 )  [13] . Enterotype groups are distinct 
from one another and are often described as being similar to blood groups. Despite 
being controversial, the idea has become popular and has allowed researchers to cat-
egorize samples based on the dominant genera that represent microbial populations 
that have a substantial scope to modify the phenotype of the individual through pro-
duction of metabolites and immunomodulatory effects.
 Culture-Independent Microbiota of Older Persons 
 Microbial-Based Changes in the Elderly 
 Numerous studies from different geographical locations have attempted to character-
ize the microbiota of general healthy populations, and many have compared these 
Table 1.  Comparing enterotypes with CAGs (co-abundance groups)
Enterotypes CAGs
Each individual is associated with one enterotype 
group
Each individual is associated with multiple 
co-abundance groups
Enterotypes are mostly defined by the most 
abundant genera. Normally Bacteroides, Prevotella 
and Ruminococcus (or another genera)
The definition of co-abundance groups is based on 
gradients of taxa and associations between taxa
The Enterotypes definition is rigorous Stable associations defining co-abundance groups are 
yet to be finalized
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with individuals carrying diseases, elderly, and even extreme elderly – individuals 
over 100 years of age. In 2001, Hopkins et al.  [14] analyzed bacterial 16S rDNA se-
quences from children, adults, elderly, and  C. difficile -infected geriatric patients from 
the UK. They revealed an overall decrease in bifidobacteria in elderly compared with 
adults, and a slight decrease in lactobacilli. There was no change in the  Bacteroides -
 Porphyromonas - Prevotella group, contrary to their culture-based study 3 years later 
 [7] , discussed above. This group published again in 2004  [15] , using real-time PCR on 
rDNA to compare bacteria from healthy elderly, hospitalized elderly, and elderly 
treated with antibiotics. The  Bacteroides-Prevotella species were significantly less 
abundant in the hospitalized patients than in healthy elderly, whereas  Enterobacteria-
ceae ,  Clostridium butyricum and  Enterococcus faecalis were increased. Antibiotic-
treated patients showed an increased abundance of  E. faecalis compared with healthy 
elderly, but decreased abundances of  Bacteroides-Prevotella group,  Desulfovibrio ,  En-
terobacteriaceae ,  Faecalibacterium prausnitzii ,  C. butyricum and  Ruminococcus albus . 
 F. prausnitzii has an anti-inflammatory affect, so reduced levels in antibiotic-treated 
patients may be associated with inflammaging. 
 Other studies have focused on other aspects of aging, such as frailty. A study on 
long-term care subjects in one elderly centre in The Netherlands  [16] showed that an 
increase in frailty correlated with an increase in  Ruminococcus and  Atopobium , and a 
decrease in the  Bacteroides-Prevotella group, the  Eubacterium rectale - Clostridium 
coccoides  cluster,  Lactobacillus and  F. prausnitzii . This frail microbial signature was 
similar to that found in the hospitalized subjects discussed by Bartosch et al.  [15] and 
Claesson et al.  [12] . 
 Cultural Microbial Differences Observed in Different Age Groups 
 A European study of subjects from four different countries, France, Italy, Germany 
and Sweden, provides evidence of location-based differences  [17] . No differences 
were observed between age groups from the French or Swedish cohorts. The  E. rec-
tale-C. coccoides group increased with age in the German population, but decreased 
with age in the Italian subjects, a decrease similar to the Dutch study by Bartosch et 
al.  [15] . German adults had lower  Bacteroides-Prevotella than adults from other coun-
tries, while Italian elderly had lower proportions than elderly from other countries. 
 F.  prausnitzii decreased with age in the Swedish and Italian subjects, but not the 
French or German subjects. The  Atopobium cluster increased with age in German and 
 Swedish populations, but not French and Italian.  Bifidobacterium was lower in all el-
derly subjects than their corresponding adult cohorts; however, this was not signifi-
cant. Italian subjects had significantly more bifidobacteria than other populations. 
 Claesson et al.  [12] assessed the microbiota of a large cohort of Irish elderly, from 
four different residence locations – community, long-term care, rehabilitation and 
day-hospital. They reported an overall trend of increasing  Bacteroidetes and decreas-
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ing  Firmicutes from community to long-stay. Reduced abundances of  Coprococcus 
and  Roseburia were observed in long-stay subjects, while they had increases in  Para-
bacteroides ,  Eubacterium ,  Anaerotruncus ,  Lactonifactor and  Coprobacillus . This rela-
tively large study was able to identify a number of microbial relationships between 
microbiota and frailty and other clinical factors while controlling for confounding 
factors such as diet, medication and even age.
 There are few differences between young and healthy elderly subjects with the re-
curring associations with increased Proteobacteria and Bifidobactia. Biagi et al.  [18] 
attempted to address this with centenarians. The centenarians tended to cluster sepa-
rately from elderly and young, which did not differ. The mainly centenarian cluster 
had higher Proteobacteria and Bacilli, and lower  Clostridium cluster XIVa, but no 
reduction in Bacteroidetes was observed.
 These studies convey the large inter-individual differences in microbiota in a given 
population. They also provide us a view of some of the differences that can be seen 
between populations. These illuminate the issues with generalized views of microbi-
ota, and remind us of some of the difficulties we will face when trying to increase lon-
gevity and quality of life. Somewhat personalized or community-based approaches 
may need to be considered in the future.
 Diet as a Driver of Microbiota Variation in Older People 
 Factors Influencing the Gut Microbiota in Older Persons 
 There are a number of challenges facing the study of the role of diet as a modulator of 
gut microbiota variation in older persons including: (1) compositional inter-individ-
ual variability of the gut microbiota; (2) inter-individual variance in dietary intakes 
even among seemingly homogenous population groups, e.g. the elderly  [12] ; (3) vari-
able effects of dietary intervention, dependent on the baseline microbiota; (4) the use 
of medical therapeutics, especially antibiotics  [19] ; (5) classification of an appropriate 
timeframe for dietary intervention and how to quantify its total microbiome effects. 
 The bacterial residents of the human gastrointestinal tract are capable of synthesiz-
ing a number of micronutrients including a number of B-group vitamins, vitamin K 2 
isomers collectively known as menaquinones, and can aid calcium absorption, and 
regulate appetite and insulin release ( fig. 1 ). In fact, long-term dietary choices can 
greatly influence the gut microbiota population, while nutritional status has also been 
shown to impact the composition of the gut microbiota and its functionality  [20] . Di-
etary choice and variety are also influenced by disease which can affect the composi-
tion, diversity and metabolic capacity of the gut microbiota and have important im-
plications for therapies aimed at modulating the large intestinal microbiota. The 
 ELDERMET study illustrated the negative clinical implications of reduced dietary and 
microbiota diversity  [12] . Targeted dietary interventions using prebiotics, probiotics 
Yashin AI, Jazwinski SM (eds): Aging and Health – A Systems Biology Perspective.
Interdiscipl Top Gerontol. Basel, Karger, 2015, vol 40, pp 141–154 ( DOI: 10.1159/000364976 )
 Diet-Microbiota-Health Interactions in Older Subjects 149
or combinations (i.e. synbiotics) may counteract negative age-related changes, and 
address the detrimental effects of long-term broad-spectrum antibiotic therapy on the 
gut. Limited feeding trials show promising results with these supplements.
 The Impact of Diet on Microbiota Variation 
 Diet can have a marked impact on the gut environment, including transit time and 
pH. Changing the intakes of the three main macronutrients (carbohydrates, protein 
and fats) can significantly affect the composition of the microbiota. In a study of the 
effects of long-term diet on the microbiota composition, Wu et al.  [21] found that 
high dietary intakes of animal products were associated with  Bacteroides , while a 
greater intake of plant material promoted the  Prevotella genus. Similarly, the 
 ELDERMET study found an abundance of bacterial species from the  Prevotella ge-
nus among healthy elderly individuals  [12] . A dietary intervention trial investigating 
the effect of different non-digestible carbohydrate (resistant starch and non-starch 
polysaccharide) on overweight individuals, revealed the adaptive nature of the mi-
crobiota  [22] . Plant polysaccharides, excluding starches, are key structural and bio-
Gut microbiota
Dietary components;
carbohydrate (glucose,
lactose, starch, cellulose),
proteins, triglycerides
Glucose and
energy homeostasis
Micronutrient production incl. B vitamins – folates,
biotin, cobalamin, riboflavin, nicotinic acid, thiamine,
panthotenic acid, pyridoxine and vitamin K2  
Calcium absorption
Insulin release and
appetite regulation
Solubilization of complex
polysaccharides (incl.
cellulose, xylan and pectin)
to produce short-chain
fatty acids (incl. acetate,
propionate, butyrate)  
Dietary fat-induced
lipopolysaccharide
productionG inflammation
 Fig. 1. Interaction between diet, gut microbiota and nutritional status  [37] . 
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logical components of the cell membrane and are collectively known as non-starch 
polysaccharides. These structural components cannot be hydrolyzed by the endog-
enous enzymes of humans. Instead, a complex mutual dependence has developed 
between the mammalian host and symbiotic gut microorganisms that possess the 
ability to access this additional energy source which can contribute up to 10% of the 
body’s daily energy requirements. In addition, extensive cross-feeding occurs in the 
colon between the primary degraders of complex substrates and other bacterial spe-
cies that depend on their fermentation and partial degradation products from dietary 
substrates. 
 The importance of diet in modifying the gut microbiota in elderly populations is 
becoming increasingly apparent. A review by Woodmansey et al.  [23] suggests a re-
duced and enhanced complement of carbohydrate and protein metabolizing bacteria 
in old age, respectively. Interestingly, it is thought increased proteolytic activity in the 
gut, caused by increased  Bacteroides and  Clostridium species is responsible for putre-
faction and production of harmful ammonia, amines, phenols and indoles, while high 
fat feeding has been associated with increased systemic endotoxin production and 
low-grade inflammation in animal models  [24] . High-fat, high-protein, low-complex 
carbohydrate diets promote the production of colonic residues that promote micro-
bial production of potentially carcinogenic byproducts  [25] . It is thought that the mi-
crobiota mediates the effect of diet on colon cancer risk by regulating the generation 
of butyrate, folate, and biotin, molecules known to play a key role in the regulation of 
epithelial proliferation. However, unlike high protein and fat intakes, carbohydrate 
increases gut microbial diversity  [21] , which has been associated with several health 
benefits in a number of population groups, including older populations  [12] . Long-
term high dietary fibre consumption has been associated with increased bacterial 
genes for cellulose and xylan hydrolysis and increased production of short-chain fat-
ty acids  [26] , an energy source for epithelial cells which have been shown to have 
anti-inflammatory properties and may be particularly beneficial to aging population 
groups.
 Dietary Interventions 
 The majority of dietary intervention data has focused on the bifidogenic role of pre-
biotics in human subjects, which are defined as non-digestible carbohydrates, as-
sumed to infer benefits for the host health by stimulation of a protective intestinal 
microbiota. The majority of research in this area has focused on the modulatory ef-
fects of single carbohydrate fractions, predominantly long- and short-chain carbohy-
drates which escape digestion in the upper gastrointestinal tract. These include fruc-
to-oligosaccharides (FOS), galacto-oligosaccharides (GOS), resistant starches and 
prebiotics such as inulin and oligofructose. They are then fermented in the colon and 
selectively stimulate the growth of bifidobacteria, which are known to exist at mark-
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edly reduced levels in old age ( table 2 ). Studies have shown that prebiotics affect the 
immune system as a direct or indirect result of changes in the gut microbiota profile 
or in the fermentation potential. In addition, GOS and FOS have been attributed to 
functional claims related to the bioavailability of minerals, lipid metabolism and reg-
ulation of bowel habits. 
 Prebiotic Intervention Studies in Elderly Populations 
 A limited number of intervention trials have been conducted to determine the micro-
biota-modulatory effects of certain prebiotic ingredients. Walton et al.  [27] conduct-
ed a study with thirty-nine, 50- to 81-year-olds supplemented with 8 g GOS or pla-
cebo for 6 weeks and found significant increases in bifidobacteria and butyrate. GOS-
induced bifidogenesis was also reported by Vulevic et al.  [28] , who focused on the 
immunomodulatory effects of a mixed GOS preparation over a 10-week period, re-
sulting in increased phagocytosis and an anti-inflammatory cytokine profile. How-
ever, the inter-individual variation in gut microbiota suggests the response of micro-
bial communities to prebiotic supplementation/dietary modulation may also vary. In 
fact, certain study volunteers have been reported as ‘non-responders’, indicating the 
influence of the initial composition of the gut microbiota. 
 Human studies have also investigated the effects of arabinoxylan-oligosaccharide 
supplementation, which have been reported to impact the protein/carbohydrate fer-
Table 2. Prebiotic intervention studies in elderly populations
Study design Subjects Age,
years
Intervention Intervention
period
Dose, g/day Result Ref.
Randomized, double-blind, 
parallel study
10 (inulin)
15 (lactose)
68–89 inulin or
lactose
19 days 20 (day 1–8)
40 (day 12–19)
↑ Bifidobacteria
↓ Enterobacteria
↓ Enterococci
[34]
Single-treatment study 37 77–91 FOS 3 weeks 8 ↑ Bifidobacteria [35]
Single-treatment study 12 67–71 scFOS 4 weeks 8 ↑ Bifidobacteria [36]
Randomized, double-blind, 
placebo-controlled, 
 crossover study
44 64–79 B-GOS,
placebo
10 weeks 5.5 ↑ Bifidobacteria 
↑ Lactobacillus-Enterococcus spp.
↑ C. coccoides-E. rectale group 
↓ C. histolyticum group
↓ E. coli
↓ Desulfovibrio spp.
[28]
Randomized, double-blind, 
placebo-controlled, 
 crossover study
37 50–81 GOS,
placebo
3 weeks 4 ↑ Bifidobacteria 
↑ butyrate
[27]
scFOS = Short-chain fructo-oligosaccharides; B-GOS = prebiotic GOS mixture.
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mentation balance in the large intestine and thus affect the generation of potentially 
toxic metabolites in the colon. Supplementation trials have been reported to increase 
total bacterial populations including  Bifidobacterium , faecal butyrate concentrations 
 [27] and fermentation activity. Further investigation into the positive modulatory ef-
fects of other promising functional ingredients on microbiota composition in elderly 
cohorts is warranted.
 Prospectus, Knowledge Gaps and Required Studies 
 Diet-Microbiota Interactions 
 It is clear from the preceding text that diet is a major driver of microbiota varia-
tion in the elderly (and other age groups). The large differences in the trending 
microbiota composition changes in European subjects in different countries mea-
sured by the CROWNALIFE study  [17] are almost certainly due to factors includ-
ing diet. As well as differences in the methods employed in culture-dependent 
studies, the difficulty in identifying unifying trends in microbiota composition 
change upon aging, as reviewed by Woodmansey  [23] , is also probably due in 
large part to diet influences. It is therefore necessary to conduct large longitudinal 
microbiota measurements in well-phenotyped individuals who consume a care-
fully measured diet, as well as to preform controlled dietary interventions in sub-
jects whose microbiome has been analyzed at baseline. The NuAge project, fund-
ed by the European Commission (www.nu-age.eu), will go some way to tackling 
the latter aspiration because one of the objectives is to conduct a dietary interven-
tion in 1,250 subjects across 5 geographically spread-out European cities, whereby 
the participants will be switched to a Mediterranean diet. Extensive physical and 
clinical measurements will then seek to correlate any changes recorded with al-
terations in the microbiome, inflammasome and peripheral blood lymphocyte 
epigenome in the subjects. 
 Diet-Microbiota-Medication Interactions 
 Even in healthier subjects, consumption of medication, often multiple types, is com-
mon in the elderly. However, there have been no dedicated studies of how the gut 
microbiota affects or is affected by multiple medications. At least 30 drugs are already 
known to be modified by the microbiota  [29] , and there is good evidence that the ac-
tivity of the microbiota can affect the activity or bioavailability of drugs  [30] . Coupled 
with dietary effects, this could present a complicated environmental modifier with 
particular relevance in the elderly. To unravel the interactions, strongly powered stud-
ies will be required. 
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 Ecosystem Management, Microbiota Restoration and Replacement 
 The term ‘dysbiosis’ is commonly used to convey an altered microbiota, but the dif-
ficulty of defining a core microbiota makes it very challenging to describe when dys-
biosis has occurred. Despite this, what has certainly become clear from recent studies 
is that a low-diversity microbiota is a common feature of subjects undergoing obesity, 
inflammatory bowel disease  [31] and accelerated aging-related health loss  [12] . As 
noted above, our studies of increased frailty and health loss in long-term residential 
care subjects were characterized by a lower diversity microbiota and lower gene counts 
in shot-gun metagenome data  [12] . While dietary adjustment would be the simplest 
way to restore microbiota diversity, it may prove practically difficult to implement 
because of physiological or financial barriers. Furthermore, in older subjects, there is 
a risk that the missing elements of the microbiota cannot be restored by diet alone. 
Faecal microbiota transplants have proved effective for treating  C. difficile in humans 
 [32] and for restoring glucose sensitivity in patients with metabolic syndrome  [33] . 
Transplantation of the entire microbiota between humans poses residual safety con-
cerns, but development of artificial consortia based on defined cultured microbes of-
fers the prospect of a clean reproducible alternative. In the case of older subjects, one 
can imagine there being individuals who have lost the entire community of microor-
ganisms capable of hydrolyzing or metabolizing certain dietary ingredients, such as 
resistant starch or other complex polysaccharide. So-called ‘bacteriotherapy’ may also 
be the only way of restoring desired microbiota elements to these individuals. 
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 Abstract 
Aging is a systemic process which progressively manifests itself at multiple levels of structural and func-
tional organization from molecular reactions and cell-cell interactions in tissues to the physiology of an 
entire organ. There is ever increasing data on biomedical relevant network interactions for the aging 
process at different scales of time and space. To connect the aging process at different structural, tem-
poral and spatial scales, extensive systems biological approaches need to be deployed. Systems biolog-
ical approaches can not only systematically handle the large-scale datasets (like high-throughput data) 
and the complexity of interactions (feedback loops, cross talk), but also can delve into nonlinear behaviors 
exhibited by several biological processes which are beyond intuitive reasoning. Several public-funded 
agencies have identified the synergistic role of systems biology in aging research. Using one of the no-
table public-funded programs (GERONTOSYS), we discuss how systems biological approaches are help-
ing the scientists to find new frontiers in aging research. We elaborate on some systems biological ap-
proaches deployed in one of the projects of the consortium (ROSage). The systems biology field in aging 
research is at its infancy. It is open to adapt existing systems biological methodologies from other research 
fields and devise new aging-specific systems biological methodologies.  © 2015 S. Karger AG, Basel 
 The Emergence of Systems Biology ‘Flavors’ 
 The Conceptual Workflows of Systems Biology 
 Systems biology is a multidisciplinary approach that has been developed over the last 
15 years, and which attempts to elucidate the structural and functional organization of 
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biological systems at the intracellular level as well as the interaction between cells and 
their microenvironment  [1] . What makes the methodology special is that questions 
concerning the structure and function of the biological systems are investigated using 
quantitative experimental data, which are analyzed through the use of sophisticated 
mathematical and computational tools, such as advanced statistics, data mining and 
mathematical modelling. The rationale for the methodology is to apprehend the com-
plexity of biological systems, to derive nonintuitive hypotheses about their functioning, 
to help designing and formulating new experiments able to prove these hypotheses, and, 
ultimately, to develop computational tools with predictive ability in a biomedical focus. 
 In its original conception, the method implied iterative cycles of hypothesis formu-
lation, design of experiments, and integration of the obtained data using advanced 
mathematical tools like modelling and simulation  [1, 2] . The method included the 
following steps ( fig. 1 ):
 (a) Relevant biomedical knowledge is retrieved from publications, databases and 
public repositories of biological data using computational tools, text mining and man-
ual curation. The information is used to construct a graphical depiction of the bio-
chemical system (i.e. the network), its compounds (mRNAs, microRNAs, proteins, 
small molecules, protein complexes…), as well as relevant interactions. This graphical 
depiction is often called ‘regulatory map’ of the system and contains the up-to-date 
biological, biomedical, and sometimes clinical, knowledge on the investigated system.
Biological
hypothesis
Biomedical
knowledge
Mathematical
modelling
Design of
experiments
Model
refinement
Model
validation
New biological knowledge
Predictive simulations
and model analysis
 Fig. 1. General structure of the canonical systems biology method. The procedure includes: con-
struction of the regulatory map for the system under investigation using existing biomedical infor-
mation; set up of mathematical model representing interesting part of the map; characterization of 
the model equations calibration using quantitative experimental data; model assessment and re-
finement; model validation through additional experiments, and use of the model to make predic-
tions on the basic features of the system, which are tested with additional experiments. 
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 (b) The regulatory map itself is a resource that can be analyzed and mined using 
computational tools from network biology. This helps organizing the network in 
modules relevant to the investigated problem, or finding unexpected connections be-
tween pathways thought to be independent (i.e. cross talk).
 (c) Critical parts of the regulatory network are translated into a mathematical mod-
el, consisting of nothing but a set of mathematical equations that encode the knowl-
edge and hypothesis about the systems investigated. Under some circumstances, the 
analysis of this preliminary model can yield already useful information. But in most 
of the cases, the model has to be better characterized using quantitative data gener-
ated in customized experiments. Usually, one proceeds in iterative cycles of mathe-
matical model derivation, integration of the experimental data in the model and re-
formulation of model equations in case the agreement between the experimental data 
and the model simulations is not satisfactory.
 (d) The output of this process is a computational tool, the  calibrated mathematical 
model, which has predictive abilities. This means that model simulations can be used 
to predict the behavior of the network under experimental scenarios not yet tested. In 
fact, many examples of validated mathematical model are available in the literature, 
for example to predict drug targets  [3] or chemoresistance  [4] , and to identify diag-
nosis biomarkers  [5] for cancer and other human diseases.
 Systems Biology Comes in Several ‘Flavors’ 
 While in the last years several new communities of researchers (with very different 
scientific background) have joined the biomedical sciences in an attempt to break 
down prevalent diseases like cancer and diabetes, the philosophy behind the systems 
biology approach has been expanded, and other workflows can be found in the recent 
literature under this epigraph. The common point among all of them is the intensive 
use of advanced mathematical and computational tools to analyze, dissect, mine and 
make sense out of large sets of quantitative experimental data. We can distinguish be-
tween the omics approach, reconstruction and simulation of large biological net-
works, elucidation of the complexity emerging from nonlinear network motifs, and 
multi-scale data integration and modelling. 
 The Omics Approach 
 In an increasing amount of subfields, researchers face the problem of analyzing and 
integrating massive amounts of high-throughput biological or biomedical data. In 
this case, it has become very popular to make use of advanced statistical techniques in 
an attempt to identify global expression patterns. In cancer and other multifactorial 
diseases, large amounts of high-throughput and clinical data obtained from large co-
horts of patients are analyzed using this strategy, aiming at ‘fishing’ unknown and 
unexpected molecular mechanisms triggering the disease. Or even more important, 
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obtaining reliable sets of biomarkers (the so-called gene signatures), able to accurate-
ly stratify populations of patients in a predictive fashion, making possible to make 
more precise the diagnosis and foresee the patient response to therapies  [6] . 
 Reconstruction and Simulation of Large Biological Networks  
 In the last years, the certainty emerged that intracellular biochemical processes 
can rarely be compartmentalized into small pathways, especially when consider-
ing biomedical questions. The new pictures of many diseases show massive and 
complex biochemical networks, composed of coding genes, small and long non-
coding RNAs, metabolites, small molecules and interacting proteins, all of them 
interconnected by a myriad of different kinds of interactions and molecular mod-
ifications  [7] . The natural way to characterize these systems is the use of multi-
level sets of  in vitro or in vivo high-throughput data. Under these conditions, hu-
man intuition or basic data analysis techniques are clearly inadequate and limited 
tools, and hence advanced methods for data analysis, network reconstruction and 
simulation are required, which have been used with remarkable success in the last 
years  [4, 8] . 
 Elucidation of the Complexity Emerging from Nonlinear Network Motifs  
 If the size of biomedical relevant networks and the multiplicity of high-throughput 
data sources necessary to characterize them was already a challenge big enough, 
we have found that these networks are extensively enriched in nonlinear network 
motifs. We mean systems of interactions between network compounds displaying 
the structure, and therefore the behavior, of structures like positive and negative 
feedback loops, but also coherent and incoherent feed-forward loops, or network 
hubs (see  fig. 2 )  [7, 9, 10] . Even more challenging, rather than isolated, these mo-
tifs very often overlap and cross talk, resulting in a structural and functional com-
plexity that is far beyond the understanding of our mind  [11] . However, feedback 
loops have been extensively investigated for decades by engineers and physicists, 
who have developed a vast framework of analysis based on the use of mathemati-
cal modelling. This framework has been largely exploited in systems biology  [12, 
13] . 
 Multi-Scale Data Integration and Modelling 
 We know now that in order to apprehend the complexity of many biological phenom-
ena, we have to go beyond the scale of the intracellular biochemical processes, and 
consider the communication between cells and their microenvironment, the dynam-
ics of tissue organization and replenishment, and even the influence of the whole-
body processes. When integrating quantitative biological data with different struc-
tural, spatial and temporal scales of these biological phenomena (e.g. intracellular-
omics data, live microscopy and systemic blood markers), the so-called multi-scale 
mathematical modelling has emerged as a tool to make sense out of this complexity. 
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This approach has been especially successful at investigating complex spatial-tempo-
ral phenomena occurring in solid tumors and leukemia, including angiogenesis, or 
systemic response after chemotherapy  [14, 15] . 
 Why Systems Biology in Aging? 
 If we integrate the definition of systems biology and the different subfields discussed 
in previous sections with aging research, then we can conclude that aging research 
appears to be an ideal research field to deploy extensive systems biology efforts. 
 Aging Phenotypes Are Associated with Large and Complex Networks 
 Contrary to most of the other fields in biomedicine, the notion of biochemical net-
works and their dysfunction as drivers for the emergence of aging has been firmly 
established for decades. Back in 1994, Kowald and Kirkwood hypothesized that mul-
tiple biological processes, some of them involving the progressive dysfunction of crit-
ical metabolic and repair pathways, work in parallel and probably cross talk during 
the emergence of aging  [16, 17] . To test the consequences of their hypothesis, they 
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enzymes
 Fig. 2. Biochemical networks are enriched in nonlinear motifs, like positive feedback loops (left), a 
regulatory structure in which the activation of a signaling event positively regulates a signaling pro-
cess upstream of the pathway. Positive feedback loops can induce signal amplification, ultrasensitiv-
ity to input signal, but also in some special cases bistability (right).  a Ultrasensitivity enables a cel-
lular system to transform graded input signals at a certain threshold into discrete all-or-none output. 
 b In systems showing bistability, for some given experimental regime, small perturbations in the 
setup may induce totally different fates for the system, inducing for example quick and irreversible 
signal termination or persistent activation. 
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derived, simulated and analyzed a mathematical model, which integrates several exist-
ing theories about the triggers of aging at the cellular level, including the so-called free 
radical theory and the protein error theory. The model results were in agreement with 
the caloric restriction hypothesis and its role in reducing free radical production, pro-
tein damage and hence extending life span. 
 Franceschi and coworkers further extended the network theory of aging by includ-
ing the role of the immune system and the inflammatory signals in it  [18] . In their 
opinion, an age-related decline in the ability of the tissues to mitigate the effects of 
environmental and internal stress, probably connected to the progressive dysfunction 
of the damage repair systems hypothesized by Kirkwood and Kowald, triggers a pro-
gressive systemic proinflammatory phenotype. This proinflammatory phenotype 
negatively influences body performance and contributes to the emergence of many 
aging-associated diseases like Alzheimer’s disease, osteoporosis and diabetes.
 To a certain extent, Franceschi’s hypothesis of the so-called ‘inflamm-aging’ sup-
ports the notion that aging is the consequence of the progressive deregulation of a ‘net-
work of networks’. In line with this, De Magalhaes and Toussaint developed the first 
curated database of genes related to human aging  [19] . The information contained in 
the database was further used to construct the first large proteomic network map of 
human aging. Interestingly, when they analyzed the obtained network, they found that 
many of the genes in their aging network are commonly associated with the genetics 
of development. This work has been continued by other groups who have worked in 
establishing the topology of this aging ‘network of networks’. To mention an addition-
al example, Xue and collaborators combined information on protein-protein interac-
tions and gene expression data during fruit fly life span to construct and modularize a 
network of interacting proteins playing a role in aging  [20] . Interestingly, their results 
pinpoint to a reduced number of network modules as critical mediators of aging. But 
they also suggest that the structure of the obtained network was such that dysfunction 
in few critical regulatory nodes, which connect some of these aging modules, may be 
behind what they call ‘the molecular basis for the stochastic nature of aging’.
 Motifs of Nonlinear Dynamics in Aging Networks 
 The aging network is enriched in motifs that govern the emergence of aging in a time-
ly and spatially nonlinear fashion. Further investigation into the network and the 
pathways guilty of mediating aging emergence found that, to the surprise of many 
researchers, they are enriched in motifs like feedback and -forward loops  [21, 22] . 
Thus, their likely nonlinear dynamics are in clear contradiction to the vision of aging 
as a progressive process. Furthermore, some results support the idea that at least some 
of the critical events triggering aging emergence may not behave linearly  [18] . As Ki-
tano, Kirkwood and others mention, the motivation behind the existence of large bio-
chemical networks enriched in nonlinear motifs may be to provide robustness against 
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perturbation, and the loss of this robust performance due to pathway dysfunction may 
be the basis of several mechanisms involved in aging  [23–25] . 
 Further examples illustrate the effect of nonlinear regulatory circuits involved in 
aging-related phenotypes. Passos and collaborators found a delayed feedback loop sys-
tem involving a long signaling circuit, by which long-term activation of p21 and reactive 
oxygen species (ROS) production and subsequent cell senescence can be activated upon 
a sufficiently long-lasting DNA damage response  [26] . In line with this, Lai and col-
laborators show that p21 can be regulated in a cooperative manner by multiple  miRNAs, 
which allows for a context-dependent regulation of p21 signaling in several aging-asso-
ciated contexts. Kriete and collaborators constructed a regulatory network, which in-
cluded most of the central cellular mechanisms involved in aging, and showed that most 
of them were connected and cross-talked via a number of overlapping positive and 
negative feedback loops  [22] . When translated into a mathematical model, their model 
simulations showed that dysfunction of key, positive-feedback loop-regulated process-
es in the cellular energy metabolism may lead to enhanced and accelerated cellular dam-
age. Furthermore, they showed that a number of negative-feedback loop systems in-
volved in the NFκB and mTOR signaling have the ability to alleviate cellular damage by 
regulating processes that are essential for cell survival, such as mitochondrial respira-
tion or biosynthesis, and their deregulation may enhance aging phenotypes.
 Aging as a Systemic Phenomenon 
 Aging is not a cellular phenotype, but it manifests at multiple levels of organization in the 
human body. It is even intuitive to say that aging as a phenomenon evades the frontiers 
of the intracellular machinery, and involves complex interactions between the cell and 
its microenvironment, the role of cell dynamics in tissue organization and replenish-
ment, but also higher-scale processes connecting the functioning of organs with system-
ic, whole-body like processes. The emerging multi-scale system (cell damage  → tissue/
organ dysfunction  → whole body deregulation) is enriched in equally multi-scale feed-
back loops, which connect the progressive cellular dysfunction with systemic stress sig-
nals, and the way back (systemic stress signals  → tissue/organ dysfunction  → cell damage 
 [18, 24] . In line with this perception, the ultimate aim of aging research is to create a 
framework to connect experimental evidence of aging progression emerging at different 
structural, spatial and temporal scales, similar to what has been done in cancer  [14] . 
 The use of this approach in aging is still in its infancy, but we still can find some 
notable examples. Hoehme and collaborators derived and characterized using mul-
tiple sources of data a multi-scale mathematical model accounting for the liver regen-
eration after damage in mice  [27] . Remarkably, the model was able to predict novel 
essential mechanisms for liver regeneration, a process that must be critical to impede 
aging-associated deterioration of the liver. Van Leeuwen and coworkers made use of 
mathematical modelling to interconnect biological processes happening at different 
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organizational scales within the body, which connect caloric restriction and the dy-
namics of oxidative cellular damage, metabolism, body weight change and ultimately 
life span extension  [28, 29] . The obtained mathematical model was able to reproduce 
growth and survival data on mice exposed to different food levels and supported the 
caloric restriction hypothesis. McAuley and collaborators developed a whole-body 
mathematical model of age-related deregulation of the cholesterol metabolism  [30] ; 
for its characterization, they used multifactorial data, accounting for the dynamics of 
the system from both the molecular and the physiological perspectives. Model simu-
lations and analysis were used to investigate the actual relevance of known molecular 
mechanisms in the age-associated deregulation of cholesterol.
 From Understanding to Manipulation 
 When thinking about fighting aging, an engineering approach can be used. This idea 
is behind one of the most controversial theories in aging research, the so-called SENS 
hypothesis postulated by Aubrey de Grey  [31, 32] . This hypothesis assumes that aging 
emerges due to the progressive accumulation of different kinds of damage during life 
span, which act in a potentially synergistic manner. These sources of systemic damage 
include mutations and epigenetic modifications in critical genes, stress-induced mu-
tations in the mitochondrial genome, as well as intracellular and extracellular accu-
mulation of different sorts of cellular debris, which are the basis of many aging-linked 
diseases. The concept is quite in agreement with Kowald and Kirkwood’s Network 
Theory of Aging. However, the disputed point of de Grey’s theory is that it proposes 
an engineering-like approach to fight the emergence of aging, which neglects the deep 
understanding of aging’s origin and focuses on the design of biomedical therapies 
aimed at mitigating, preventing or repairing the sources of these cumulative organic 
damage that defines aging. 
 If at some point in the near future, the idea behind the SENS hypothesis becomes 
prevalent, then systems biology-like approaches would become an even more integrative 
part of aging research: system biology is in fact inspired by the methodology used by 
physicists and engineers to design and optimize complex technological devices, whose 
behavior is governed by nested regulatory circuits, especially feedback loops, as it is in 
the case of the network of networks whose dysfunction causes the emergence of aging.
 Aging Research Projects Using the Systems Biology Approach: The GerontoSys 
Initiative 
 Having in mind the motivations discussed in the previous section, it is not a surprise 
that worldwide several public funding agencies have identified the synergistic role of 
systems biology in aging research and promoted in the very last years a number of 
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projects making use of systems biology in aging research. A remarkable one is the 
Gerontosys initiative funded by the German Federal Ministry of Education and Re-
search, which is being funded for the period 2009–2016, with a global budget of about 
EUR 32 million.  Figure 3 summarizes the majority of projects funded in the second 
call. In the following, we examine some of these projects to illustrate the overall struc-
ture of an aging systems biology project and how most of them were conceived as 
rather large interdisciplinary research networks. Finally, we will focus on our own 
project, the ROSAge project, to provide an example for the initial conception, the 
work plan for the integration of different disciplines, and its development, but also 
the particular difficulties that one faces when approaching aging from a systemic 
view. 
 The Hematopoietic System Is an Aging Research Hub 
 Several projects in the Gerontosys initiative focus on aging in the hematopoietic sys-
tem. Some of them examine the aging effects in hematopoietic stem cells (HSC), 
whereas others focus on aging-associated defects of the immune system. SyStaR (Mo-
lecular Systems Biology of Impaired Stem Cell Function in Regeneration during Ag-
ing; A in  fig. 3 ) and MAGE (Model of the Aging Epigenome; B in  fig. 3 ) are the proj-
ects with stem cell focus. Aging of the immune system is covered by Primage (Protec-
tive Immunity in Aging) and GerontoShield (C in fig. 3 ). 
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 Fig. 3. Intracellular biochemical systems, tissues and phenotypes related to aging emergence and 
some systems biology projects addressing them. Legend of projects: A = SyStaR, B = MAGE, C = 
Gerontoshield and Primage, D = SyBACol, E = NephAge, F = GerontoMitosys, G = JenAge, H =  ROSage. 
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 To mention some of the insights emerging from the systems biology approach used 
in these projects, the researchers involved in the SyStaR project could prove that HSC 
differentiation in response to DNA damage is a protection strategy which operated 
through the BATF (basic leucine zipper transcription factor-ATF like) pathway, and 
can reduce the burden of mutations in the stem cell niche (A1 in  fig. 3 ). Interestingly, 
Wang et al. (2012)  [33] corroborated the experimental findings theoretically by encod-
ing the cellular processes of proliferation, differentiation and apoptosis into a mathe-
matical model. The model simulations ruled out the role of apoptosis and strengthened 
the conclusion that differentiation is the driving force behind the reduction of the HSC 
pool in their niche, and not apoptosis. Moreover, the modelling and experimental re-
sults can explain the uneven differentiation levels between lymphoid and myeloid 
competent HSCs. The mechanistic interpretation emerging out of the systems biology 
analysis performed is that the increase in the BATF level stimulates predominantly the 
differentiation of lymphoid-competent HSCs, thereby draining their stem cell pool 
 [33] .
 Histone Modifications and Stem Cell Fate 
 It is known that epigenetic histone modifications have a big impact on stem-cell-
based organ regeneration and hence on the emergence of aging-associated organ de-
terioration. The team of the SyStar project could experimentally show epigenetic his-
tone deacetylation via activation of Wnt5a and CDC42 signaling, which ultimately 
contributed to the cellular stem cell aging (A2 in  fig. 3 ). In line with this, the effects of 
similar epigenetic changes on aging were investigated via mathematical modelling 
and simulation in the MAGE project  [34, 35] (B in fig. 3 ). Interestingly, epigenetic 
modifications are processes inviting systems biological interpretations as they com-
prise several nonlinear network motifs like feedback loops  [36] , which are an integral 
part of engineering approaches, as discussed in the section Systems Biology Comes in 
Several ‘Flavors’. Precisely, a positive feedback loop is generated when modified his-
tones stimulate recruitment of modification enzymes and can lead either to a rapid 
increase of histone modifications (H + ), or to a second steady state with low modifica-
tions (H 0 ; see  fig. 2 )  [36] . Modelling results indicate that this switch from high to low 
modifications can be triggered by the dilution of histone modifications during DNA 
replication  [34] . Ultimately, this process leads to impaired stem-cell function, loss of 
stem cell pools and hence the emergence of aging-associated phenotypes. 
 Given the general importance of histone modifications in the aging process of 
HSCs, Przybilla and collaborators further performed an in silico simulation of the ef-
fect of histone and DNA modification rates on transcriptional activities of quiescent 
cells in the stem cell niches. They found that fluctuations in this DNA modification 
process could rejuvenate aged HSC and further activate their proliferation and dif-
ferentiation capacity  [35] . Genes of HSC become silenced during proliferation be-
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cause of the dilution of histone methylation, and this silencing induces age-related 
phenotypes and reduces the overall the capacity of proliferation and differentiation. 
Because of the reduced proliferation, histone modification can reactivate silenced 
genes leading to stem cell rejuvenation. In line with this, Przybilla and coworkers’ 
simulations indicate that an efficient DNA demethylation activity is necessary to en-
able sufficient plasticity of histone modifications  [35] . Overall, the results emerging 
from the use of a systems biology workflow in the MAGE project suggest that aged 
cells with low proliferation rate accumulate in the HSC niche, and young active cells 
are pushed to differentiate, thus keeping the age of differentiated cells young.
 Understanding mTOR Activation through Computational Modelling 
 mTOR is a central signal transducer of the nutritional cell status and growth signals 
 [37] . In particular, organs with high metabolic activity, like liver, muscles and adipose 
tissue, and kidney are sensitive to mTOR signaling  [37, 38] . Kidney diseases are among 
the leading ailments in the elderly, and the NephAge project was conceived to inves-
tigate the involvement of aging in them via a systemic approach (E  in  fig. 3 ). One of 
the starting points is that dynamics of the activation of the protein complex mTORC2 
is insufficiently understood. Thus, the NephAge consortium ran an iterative cycle of 
hypothesis formulation, mathematical modelling analysis and experimental valida-
tion in order to understand the mTORC2 activation. Modeling enabled hypothesizing 
a new mechanism, which could reproduce all the findings. The new mechanism was 
then validated in subsequent experiments  [39] . 
 The GerontoMitoSys project tracks the eluding principles of aging by examining 
the consequences of protein quality and ROS in fungus, mouse, and man (F in fig. 3 ). 
Advanced statistical techniques were employed on transcriptome data of the fungus 
 Podospora anserina in an attempt to identify global expression patterns. The data 
analysis indicated that the mTOR signaling pathway turned out to be important dur-
ing aging, which provided protein quality control through autophagy  [40] .
 ROS – The Dose Makes the Poison 
 The GerontoMitoSys project finds that in addition to autophagy, protein quality con-
trol is also important to delay detrimental effects of aging  [40] . Among the principal 
agents of protein damage are ROS. In order to further elucidate the role of ROS in the 
emergence of aging-associated phenotypes, a mathematical model was generated us-
ing a set of differential equations describing the time course of ROS, its scavengers like 
cellular antioxidants (SOD) and a protease involved in protein quality control (F2 in 
fig. 3 ). Model simulations indicated that the mechanism by which ROS mediates cel-
lular damage is far more complicated than originally stated by the free radical theory 
Yashin AI, Jazwinski SM (eds): Aging and Health – A Systems Biology Perspective.
Interdiscipl Top Gerontol. Basel, Karger, 2015, vol 40, pp 155–176 ( DOI: 10.1159/000364981 )
166  Chauhan · Liebal · Vera · Baltrusch · Junghanß · Tiedge · Fuellen · Wolkenhauer · Köhling 
of aging. In the paper, the authors suggest that a systems biology approach, similar to 
the one deployed in the paper, is the one required for an effective integration of the 
various pathways known to be involved in the control of biological aging. 
 Although higher ROS levels contribute to accumulation of damage with age, ROS 
at lower levels trigger defense mechanisms and even provide life extension  [41] . These 
dose-dependent antagonistic actions of ROS are particularly interesting from a sys-
tems biology perspective, though explicit systemic studies have yet to be published. In 
line with this, two separate endogenous mechanisms of ROS production in  Cae-
norhabditis elegans were recently described by the JenAge initiative (G). One mecha-
nism commences with impaired insulin and IGF-1 signaling  [42] , the other is rooted 
in the deacetylation reaction catalyzed by the sirtuin Sir-2.1  [43] .
 Taken together, we have shown that several projects within the Gerontosys initia-
tive have proved to make significant contributions in aging research applying systems 
biology approaches that rely on either advanced analysis of high-throughput data or 
mathematical modelling of aging-relevant signaling pathways. We think that systems 
biology in aging is particularly challenging because of the multiple aging phenotypes 
that exist, the large and often poorly characterized regulatory networks involved and 
the multiple levels of organization cross talking in the emergence of aging. To make 
the situation more cumbersome, even for aging processes where the involved path-
ways are fairly well characterized, experimentally measured output may lead to am-
biguous results, because of unexpected interferences by other pathways. It is therefore 
challenging to devise and plan interdisciplinary research projects in the field of aging. 
To substantiate this claim, in the next section we discuss the concept, development, 
and challenges of implementing systems biological approaches in a real case study, a 
project dealing with the interplay between oxidative phosphorylation, ROS produc-
tion and aging effects in mice that we have developed over the last 4 years.
 Design Concept, Development and Challenges of a Systems Biology Aging Project: 
The Case Study of the ROSage Project 
 Hypothesis, Goals and Strategy 
 The ROSage project has been also part of the Gerontosys Initiative. The acronym of 
the project stands for ‘Reactive Oxygen Species and the Dynamics of Ageing’. The 
underlying hypothesis of the project, similar to others already mentioned, was that 
mitochondrial dysfunction and subsequent ROS production are crucial players in the 
emergence of aging phenotypes via the induction of DNA damage, inflammation and, 
ultimately, cell senescence and tissue dysfunction, in a probably tissue-dependent 
manner. The project put emphasis on the role of mutations of the proteins integrated 
in the mitochondrial respiratory chain complexes as drivers of age-associated dys-
function. Published results indicate that each complex causes diverse but still unique 
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phenotypes in an organ-specific manner, but also different organs seem to have dif-
ferent energy requirements and ROS sensitivities (see  table 1 ). 
 To further substantiate our hypothesis, we conceived a complex systems biology 
workflow, which combines systematic measurements of intracellular signals and tis-
sue markers of organ function during the life span of mice, advanced data analysis and 
mathematical modelling of selected signaling pathways.
 As experimental system, we used several conplastic mouse strains, which hold de-
fined stable mtDNA mutations in several critical proteins involved in the respiratory 
chain complexes  [44] . Since the mitochondrial respiratory chain complexes carry out 
oxidative phosphorylation, and its malfunctioning can generate excessive ROS, we ex-
pected to generate valuable data on the relation between the overproduction of ROS, 
the activation of cell damage signaling pathways and the triggering of cell senescence 
and certain tissue-specific aging phenotypes. To this end and for different organs whose 
dysfunction is associated with aging, we have measured over the life span of the mice: 
(a) molecular and functional markers of the mitochondrial function, including ROS 
production, oxygen consumption, quantification of OXPHOS components, intracellu-
lar calcium dynamics, mitochondrial dynamics; (b) ROS-mediated activation of signal-
ing pathways involved in damage response like p53, NFκB and JNK; (c) markers for the 
triggering of phenotypes of cell cycle arrest, senescence and apoptosis, and (d) tissue-
specific markers of tissue function, for example neuronal plasticity and learning behav-
ior to account for the phenotypic effects of mitochondria dysfunction in the brain 
( fig. 4 ). Five model systems of organ aging were considered: brain function (neurode-
Table 1. Proteins and protein complexes in the focus of the ROSage research initiative. ROSage used 
defined mutations of components of the oxidative phosphorylation with phenotypes of clinical sig-
nificance 
Complex Mutations and clinical implications
Complex I
(NADH:ubiquinone
oxidoreductase)
complex I mutations are responsible for about 40% of mitochondrion- associated 
clinical pathologies; however, effects of complex I mutations are diffuse; whereas 
Koopman’s group observe a fragmentation of mitochondria and ROS increase in 
fibroblast cells, others fail to observe these effects, and only find reduced oxygen 
consumption and delayed recovery following  membrane uncoupling stress
Complex III
(coenzyme Q:cytochrome c
oxidoreductase)
this complex is required as an oxygen sensor that produces ROS upon hypoxia, 
and its dysfunction can cause exercise intolerance in humans
Complex IV
(cytochrome C oxidase)
a polymorphism with a substitution of nt9348A (V>I) increases the ATP level in 
the cells which is associated with protection against colitis and A-β  accumulation 
during Alzheimer disease progression
Complex V
(ATP synthase)
the substitution of nt778T (D>Y) of mice is associated with multiple aging- 
associated autoimmune diseases like diabetes, nephritis, pancreatitis, arthritis
Uncoupling protein (UCP2) strains with dysfunctional UCP2 easily develop autoimmune and chronic 
 inflammatory diseases, while its upregulation confers long life
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 Fig. 4. Regulatory map of the modelling strategy proposed for the ROSage project. The model in-
vestigates how enhanced ROS production due to impairment of respiratory chain complexes (I, II, III, 
IV, V) affects energy homeostasis ( a ), activates inflammatory responses leading to cellular dysfunc-
tion and senescence ( b ), and induces further impairment of mitochondrial function ( c ). The interplay 
between these molecular mechanisms inducing metabolism and inflammation is being further char-
acterized and refined in modules  a–c . 
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generation), liver- and pancreatic function (metabolic syndrome), pancreatic function 
(inflammation), hematopoietic system (autoimmune processes) and skin.
 To analyze these data, we designed a systems biology workflow that combined ad-
vanced data analysis techniques and mathematical modelling. Concerning data anal-
ysis, we have been using unsupervised clustering and machine learning techniques to 
dissect the three-dimensional data grid, which emerges when measuring the indicated 
markers over the life span for the different organs and developmental stages in the 
mice strains with different mtDNA mutations ( fig. 5 ). The aim is to find systemic pat-
terns relating ROS generation across time, organ and mitochondrial gene mutations, 
as well as their relation to organ function/viability. This analysis was complemented 
with the derivation and characterization of mathematical models accounting for crit-
ical parts of the ROS-related network proposed.
 Precisely, the network was organized into interconnected modules, accounting for 
mitochondrial performance, metabolism and inflammation ( fig. 4 a–c, respectively).
 An Overall Perspective on the Current Biological Insights Generated in the Project 
 The project is still in progress, and most of the data related to life span-related chang-
es in the mice strains are still to be processed. Nevertheless, preliminary results confer 
to mutations in complexes I, IV, and V, known to be important contributors to a 
1 2 3 4
Developmental stage
Short life span
mut 6
mut 4
mut 3
mut 2
mut 5
mut 1
Long life span
mtDNA
mutation
Control
5
CNS
Endo-/exocrine
Metabolism
Immune system
Organ system
Organ
Viability
 Fig. 5. Systematic measurement of experimental parameters across the dimensions of mitochon-
drial mutations, organ and developmental stage (age) proposed for the Gerontosys project ROSage. 
Each dot in the grid represents a set of biomedical insights; the size of the dot corresponds to organ 
function/viability measured independently for the same mutation, organ and age. Given a similarity 
measure, a clustering based on modeling insights yields further understanding. 
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healthy physiology, clear tissue-dependent effects; for example, only the central neu-
ral system (CNS) differences between control mouse strains and those mice carrying 
a mutation in complex I (NADH:ubiquinone oxidoreductase). The differences are a 
higher ROS level in early life, which reduced to normal level from middle age on-
wards. Also during middle age, mutant mouse strains displayed reduced plasticity and 
learning performance. 
 Mutations in complex IV (cytochrome C oxidase) reduced learning performance 
in the CNS as well, but the effects were only apparent late in life (24 months). How-
ever, no differences in ROS levels were detectable. In addition to the central nervous 
system, complex IV profoundly affected the liver. By the age of 6 months, mitochon-
dria start to aggregate and ROS as well as antioxidants increase.
 Mutations in complex V (ATP synthase) affected the hematopoietic system and 
the endocrine pancreas. The ROS level was increased in the β-cells of the endocrine 
pancreas, whereas the ATP level was decreased, although the ATP/ADP ratio was 
comparable to the wild type  [45] . In a high-fat diet condition, the mitochondria 
grow in size in β-cells of the wild type, but not in complex V mutants. The mutants 
were also subjected to reductions in insulin secretion and insulin sensitivity along 
with higher serum insulin concentrations. To counterbalance the loss in insulin se-
cretion due to the lower absolute ATP level, complex V mutants experienced an 
increase in the total β-cell mass  [45] . In the hematopoietic systems of aged mice, the 
effect of mutations in complex V was surprisingly different – ROS was reduced and 
ATP increased. ROS reduction and ATP increase could be the result of a metabolic 
switch to energy conservation in a background with ATP synthase mutations.
 Taken together, our preliminary results indicate that (a) overall, organs and tissues 
are surprisingly robust regarding the mtDNA mutations investigated, and (b) the ef-
fect of mutations is tissue-dependent. The phenotypes of mutants are often compa-
rable to the wild type in conventional rearing conditions over most of the mouse life 
span. This resilience to genetic perturbation highlights the extraordinary capacity of 
the OXPHOS system and the metabolism in general to balance energy demands. In 
particular, the mutations of complex III and UCP2 are buffered well because for con-
ventional treatment, physiological conditions and ROS level were comparable in the 
four examined organs for mutant and wild-type strains.
 Results Derived from the Modeling Approach Used 
 As mentioned before, in the project, the network was organized into interconnected 
modules, accounting for mitochondrial performance, metabolism and inflammation 
( fig. 4 ). We have derived mathematical models for these modules and used them to 
investigate critical features of the modules associated with aging. For example, com-
bining modeling and experiments, we demonstrated that miRNAs, whose deregula-
tion has been related to aging  [46] , can modulate, alone or synergistically, the activa-
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tion of p21 by signals activating the DNA damage response like ROS  [9, 47] . Our 
model simulations indicate that miRNAs can posttranscriptionally regulate p21 basal 
levels in a biological context-dependent manner. Since p21 has been recently involved 
together with ROS in a feedback loop system able to trigger cell senescence upon a 
sufficiently long-lasting DNA damage response  [21] , one can expect miRNA regula-
tion to play a role in this process. 
 Although this is a promising result, most of the modeling effort in the project has 
focused on the relation between ROS and metabolic performance ( fig. 4 b). Despite glu-
cose homeostasis being so crucial for long-term metabolic consequences, there are only 
a few models which deal with the long-term changes during the life span  [48] . The pau-
city of long-term models is due to several challenges. One of the formidable challenges 
is that glucose homeostasis involves multiple levels of structural and functional organi-
zation, from molecular reactions and cell-cell interactions in tissues like pancreas and 
liver to the physiology of the entire organs.  Figure 6 depicts the involvement of several 
tissues and organs in carrying out the glucose insulin metabolism in response to nutri-
ent stress, during the life span of a mouse. Although disperse, unconnected mathemat-
ical models exist in the literature at all levels of organization  [49] ; the real challenge here 
Glucose
Insulin Leptin
Nutrients
Liver
Pancreas Adipose
Brain
 Fig. 6. Multiple levels of structural and functional organization of nutrient-induced glucose metab-
olism during aging. Glucose is produced (mainly by liver), distributed and utilized by pancreas-in-
duced insulin and adipose tissue-induced insulin and leptin. High-fat nutrient results in higher en-
ergy intake, which increases fat accumulation in adipose tissues. Increased fat mass is sensed by the 
brain, which then signals an increase in leptin and insulin levels in blood for a more rigorous utiliza-
tion of glucose by other tissues so as to bring glucose levels to levels prior to perturbation. With our 
aging mice strains, we are deriving and characterizing a mathematical model of this system, which 
describes the role played by systemic signals like leptin and insulin in modulating cross talk between 
the organs involved in glucose metabolism and the overall regulation of the glucose metabolism. 
Interestingly, the system is enriched in insulin- and leptin-mediated feedback loops, which we think 
control the nonlinear behavior in the blood glucose levels of several strains of mice used in our proj-
ect (negative feedback loops: glucose  → insulin  glucose; glucose  → leptin   glucose). 
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is to integrate multiple levels of data, models and knowledge into a comprehensive 
multi-level model able to interpret data on the evolution of glucose homeostasis over 
life span. Multi-levelness and integration of knowledge can be addressed through multi-
scale modeling, a topic strongly developed in the last years in cancer biology, but still in 
its infancy for most of the other biomedical fields, including aging research.
 In line with the idea and in the context of the ROSage project, we have been ana-
lyzing the relation between glucose metabolism and mitochondria performance in 
aging by deploying a cascade of models describing different levels of organization. At 
the physiological level ( fig. 6 ), we have developed a phenomenological mesoscopic 
mathematical model, which accounts for the interplay between different critical or-
gans (liver, pancreas, adipose tissue, brain) via molecules that act in this context as 
systemic signals, secreted by these organs and used to mediate their cross talk and the 
overall regulation of the glucose metabolism (insulin, leptin). The mathematical mod-
elling has been used to establish the role played by several insulin- and leptin-medi-
tated feedback loops in shaping nonlinear behavior in the glucose blood levels of sev-
eral of our aging mouse strains.
 In parallel to this, we built upon one of the assumptions of damage accumulation in 
the mtDNA during the life span and their effect on the mitochondrial performance 
through its effect in the balance between the antagonizing forces of mitochondrial fis-
sion and fusion  [50] Mitochondria organize themselves as dynamic populations with-
in a cell, by undergoing continuous cycles of fission and fusion. In several neurodegen-
erative and metabolic diseases, the dynamic balance of fission and fusion is disturbed. 
A diversified mitochondrial population is generated by the heterogeneous availability 
of nutrients and signals in cellular cross-section  [51] . Segregation through fission in-
creases local sensitivity of mitochondria towards signals, whereas fusion interconnects 
mitochondrial networks from one location to another, hence increasing their global 
sensitivity. One can say that global coupling of excitatory and restoring mitochondrial 
subpopulations in a heterogeneous environment enables the system to selectively adapt 
the response at one location, while amplifying the response at another location.
 We were interested in establishing how the equilibrium between fission and fusion 
is altered over the life span of the investigated mouse strains. To this end, we estab-
lished a mathematical model of antagonistic fission and fusion subpopulations of mi-
tochondria by adapting the model proposed by Wallach and coworkers to investigate 
spatially heterogeneous neuronal systems  [52] .
 Fission and fusion subpopulations encounter heterogeneous signals in the periph-
eral (high frequency signal) and perinuclear (low frequency signal) cellular locations 
 [51] . In our mathematical model, we divide the mitochondrial subpopulations into 
three: peripheral fission, perinuclear fission and global fusion subpopulations (see 
 fig. 7 a for graphical depiction of the model and explanation of the mathematical equa-
tions). Two fission subpopulations interact antagonistically with the global fusion sub-
population ( fig. 7 a). Model simulations and analysis indicate that global coupling of 
mitochondrial subpopulations in a heterogeneous environment enables the system to 
Yashin AI, Jazwinski SM (eds): Aging and Health – A Systems Biology Perspective.
Interdiscipl Top Gerontol. Basel, Karger, 2015, vol 40, pp 155–176 ( DOI: 10.1159/000364981 )
 Systems Biology Approaches in Aging Research 173
Fusion
Fission
Perinuclear Peripheral
a
b
Frequency of global stimulus (fglobal)
0 3
0
1.5
0.2
0.4
0.6
0.8
1.0
 = 10
 = 5
 = 3
 = 2
 = 1
c
Re
sp
on
se
 a
t p
er
in
uc
le
ar
 si
te
fhighflow
Time
amplified
response
Time
adapted
response
Response
Stimulus
 Fig. 7.  a Our model of mitochondria performance includes two antagonistic subpopulations of di-
viding (fission) and fusing mitochondria, which are globally coupled through fusion in the hetero-
geneous cellular environment. At the peripheral locations, high-frequency stimuli are prevalent, 
while at the perinuclear location low-frequency stimuli are prevalent. In our mathematical model, 
we divide the mitochondrial subpopulations into three: peripheral fission, perinuclear fission and 
global fusion subpopulations. Two fission subpopulations interact antagonistically with global fu-
sion subpopulation. The three subpopulations are represented by three equations of following type: 
(1)
 
 P denotes the availability of respective subpopulation: peripheral fission, perinuclear fission or glob-
al fusion. The availability of a subpopulation depends on the time an average mitochondrial sub-
population takes to recover, and on the depletion of resources in maintaining the activity  (Ψ) of re-
spective average subpopulation. Activity is a function of availability of subpopulations  (P) and exter-
nal stimulation  (f) , such that fission subpopulations are antagonistic to the global fusion 
subpopulation. τ represents the recovery time constant. Next, mitochondrial response is defined as 
the ratio of activity upon stimulation with a certain frequency  (f) and activity without stimulation (0). 
(2)
  
In the model, we introduce a parameter  δ to describe the degree of variability between the periph-
eral ( f high ) and perinuclear ( f low ).  δ is defined by a ratio of global frequency  f global ( f high +  f low ) and  f low . 
 f global is the frequency with which fusion population is stimulated as a result of global coupling of 
stimuli: 
(3) 
 
b Schematic representation of two types of stimuli ( f low ,  f high ) and their responses.  c Model simula-
tions. Mitochondrial Ca 2+ levels adapt ( b and  δ  = 1–3 in  c ) to high-frequency stimuli, whereas in re-
sponse to low-frequency stimulation mitochondrial Ca 2+ levels amplify ( b and  δ  = 5–10 in  c ). 
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selectively adapt the response at one location while amplifying the response at another 
location ( fig. 7 b). In  figure 7 c, a model simulation is shown. Here, we can see that ad-
aptation emerges in the response of the system to low scenarios of variability between 
the frequency of peripheral and perinuclear stimuli driving fission-fusion cycles ( δ  = 
1–3). In contrast, amplification appears for scenarios of high variability ( δ  = 5–10).
 At the moment, we are elaborating a strategy to design experiments able to test our 
model predictions. Furthermore, we are expanding our model to account for the con-
nection between the dynamics of mitochondrial subpopulations and the response of 
critical cell/tissues to environmental perturbations on the longer timescales that cor-
respond to the emergence of aging phenotypes.
 Conclusions 
 In this chapter, we support the idea that boosting aging research will require the use of 
systems biology-inspired approaches because (a) the dysfunction of large, interconnect-
ed biochemical networks is in the origin of aging-associated phenotypes; (b) these net-
works are enriched in nonlinear regulatory motifs like positive and negative feedback 
loops; (c) aging manifests at multiple, interconnected and interdependent levels of or-
ganization in the body, from the intracellular machinery to the dynamics of tissue orga-
nization and beyond, and (d) the optimal design of biomedical strategies to counteract 
aging-associated pathologies will require the use of tools and strategies adapted from 
engineering. 
 The specific problems that one will face when designing a systems biology project 
in aging are not minor. The difficulty to generate reliable experimental data for the 
investigation of aging phenotypes increases when thinking from a systemic view be-
cause one will require more systematic and frequent and better quantifiable experi-
mental measurements, but also an increase in the number of experimental replicates. 
The strategy to overcome the difficulties of integrating in a coherent manner quanti-
tative data produced at multiple levels of organization to measure the emergence of 
aging phenotypes is still an open question. In line with this, the strategy to adapt the 
multi-scale methodologies used in other biomedical fields like cancer is still to be es-
tablished. The question of establishing reliable methodologies for actual quantifica-
tion of aging phenotypes at the intracellular, tissue and organ levels is open to debate. 
Finally, large and long-lasting collaborative systems biology projects like those ad-
dressing the molecular basis of aging can only prosper when a good data management 
strategy is designed prior to project initiation.
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 Abstract 
 Inactivation of the GH/insulin/IGF-1 signaling molecules corresponding genes as well as the inacti-
vation of serine/threonine protein kinase mTOR increases life span in nematodes, fruit flies and mice. 
Evidence has emerged that antidiabetic biguanides and rapamycin are promising candidates for 
pharmacological interventions leading to both life span extension and prevention of cancer. The 
available data on the relationship of two fundamental processes – aging and carcinogenesis – have 
been suggested to be a basis for understanding these two-side effects of biguanides and rapamycin. 
 © 2015 S. Karger AG, Basel 
 There are nine tentative hallmarks of aging in mammals, which may represent com-
mon denominators of aging in different organisms: genomic instability, telomere at-
trition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mito-
chondrial dysfunction, cellular senescence, stem cell exhaustion, and altered cell-to-
cell communication  [1] . At the same time, there is also sufficient similarity in the 
patterns of changes observed during normal aging and the process of carcinogenesis 
( table 1 )  [2] . As can be seen in  figure 1 , DNA damage induced by environmental and 
endogenous carcinogenic factors [reactive oxygen species, ionizing radiation, ultra-
violet, constant illumination (light at night), some diets, oncogenes, etc.] may lead to 
cellular senescence or cellular lesions which could be deleted by apoptosis. The same 
agents can induce damage which is followed by neoplastic transformation, thus lead-
ing to cancer  [2, 3] . During the last decade, the intensive search for antiaging remedies 
has led to the conclusion that both insulin/IGF-1 signaling (IIS) and nutrient response 
pathways defined by the mTOR protein kinase pathways control aging and age-asso-
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Table 1.  Changes developing in organism during natural aging and carcinogenesis: effects of gero-
protectors
Parameters Aging Carcinogenesis Biguanides Rapamycin
Molecular level
Free radical generation ↑ ↑ ↓ ↓
AGE formation ↑ ↑ ↓ ↓
DNA adduct formation ↑ ↑ ↓ ↓
DNA repair efficacy ↓ ↓ ↓ ↓
Genomic instability ↑ ↑ ↓ ↓
Telomerase activity ↓ ↑ ↓ ↓
Telomere length ↑ ↓ ↑ ↑
mTOR activity ↑ ↑ ↓ ↓
IKK-β/NF-κB activity ↑ ↑ ↓ ↓
Clock gene expression (Per1, Per2) ↓ ↓ ↓ ↑
Mutation rate ↑ ↑ ↓ ?
Oncogene expression ↑ ↑ ↓ ↓
p53 mutations ↓ ↑ ? ?
Cellular/tissue level
Oxidative stress ↑ ↑ ↓ ↓
Chromosome aberrations ↑ ↑ ↓ ↑
Induced pluripotent stem cells ↓ ↓ ↑ ↑
Proliferative activity ↓ ↑ ↓ ↓
Focal hyperplasia ↑ ↑ ↓ ↓
Apoptosis ↓ ↓ ↑ ↑
Autophagy ↓ ↓ ↑ ↑
Angiogenesis ↓ ↓ ↓ ↓
Cell-to-cell communication ↓ ↓ ↑ ↑
Senescent cells number ↑ ↑ ↓ ↓
Latent (dormant) tumor cell number ↑ ↑ ↓ ↓
Systemic/organism level
Melatonin circadian rhythm ↓ ↓ ↓ ?
Serum melatonin level ↓ ↓ ↓ ?
Hypothalamic threshold of
sensitivity to homeostatic 
inhibition by steroids ↑ ↑ ↓ ?
Tolerance to glucose ↓ ↓ ↑ ↓
Serum insulin level ↑ ↑ ↓ ↓
Susceptibility to insulin ↓ ↓ ↑ ↑
LDL and cholesterol level ↑ ↑ ↓ ↓
Ovulatory function ↓ ↓ ↑ ↑
Fertility ↓ ↓ ↑ ?
T cell immunity ↓ ↓ ↑ ↓
Inflammation ↑ ↑ ↓ ↓
Cancer risk ↑ ↑ ↓ ↓
Life span ↓ ↓ ↑ ↑
 ↑ = Increases; ↓ = decreases; ? = no data.
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ciated pathology in worms, insects and mammals  [4] . In each of these organisms, ge-
netic downregulation or interruption of this signaling pathway can lead to major ex-
tension of longevity. There are two functionally distinct mTOR complexes called 
mTORC1 and mTORC2. mTORC1 is activated by insulin and related growth factors 
through phosphatidylinositol-3-OH kinase and AKT kinase signaling and repressed 
by AMP-activated protein kinase, a key sensor of cellular energy status  [4] . The 
mTORC1 is involved in promoting messenger RNA translation and protein synthesis 
through ribosomal protein S6 kinases (S6Ks) and 4E-BP protein, which in the hypo-
phosphorylated form acts as a negative regulator of the cap-binding protein eIF4E. 
mTORC1 also stimulates lipid biosynthesis, inhibits autophagy, and through hypoxic 
response transcription factor HIF-1α regulates mitochondrial function and glucose 
metabolism. Rapamycin suppresses mTORC1 and indirectly mTORC2, which leads 
to metabolic lesions like glucose intolerance and abnormal lipid profile  [4] . The phos-
phorylation of S6K1 at T389 by TORC1 is susceptible to rapamycin. The life span of 
S6K1-deficient female mice increased by 19% in comparison to the wild-type controls 
without any effect on the incidence of tumor development  [5] . It is worth noting that 
there was no significant effect of the protein knockout on the life span of male mice. 
Stem
cell
Dormant cell Differentiated cell
Transformed cell
Autophagy
mTORC1
mTORC2
IIS
DDR
Dedifferentiation
Metformin
Rapamycin
Resveratrol
Melatonin
CR
Carcinogenic
agent
Differentiation
Senescent
cell
Cancer
cell
Damaged
cell
Longevity
Cell death
 Fig. 1. Relationship between aging and carcinogenesis: the key role of IIS and mTOR signaling. DNA 
damage induced by environmental and endogenous factors (reactive oxygen species, ionizing ra-
diation, ultraviolet, constant illumination, some diets, oncogenes, etc.) may lead to cellular senes-
cence or cellular lesions which could be deleted by apoptosis. The same agents can induce damage 
followed by neoplastic transformation, thus leading to cancer. Metformin, rapamycin, and some 
other compounds with mTOR and IIS-inhibitory potential (resveratrol, melatonin) are able to modify 
both aging and carcinogenesis. DDR = DNA damage response. 
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These data suggest that S6K1 is involved in mammalian life span regulation down-
stream of TORC1. Taking into consideration the negative effect of rapamycin on glu-
cose tolerance and liver insulin sensitivity  [5] , Lamming et al.  [6] studied the effect of 
mTORC1 and mTORC2 regulator gene modification on the life span of mice. There 
was no increase in life span in either female or male  mtor +/– ,  Raptor +/– ,  mlst8 +/– or 
 mtor +/–  Raptor +/– mice. However, female  mtor +/–  mlst8 +/– mice lived longer by 14.4% 
in comparison to wild-type mice. The longevity of male  mtor +/– mlst8 +/– mice was un-
affected. Female  mtor +/–  mlst8 +/– mice were not calorie restricted through reduced 
food intake or increased energy expenditure, and had normal body weights and levels 
of activity consistent with the phenotypic effects.  mtor +/– mlst8 +/– mice exhibited an 
approximately 30–60% reduction in the abundance of hepatic mTOR, Raptor, mLST8, 
and Rictor, whereas the expression of mTOR complex subunits was less affected in 
 Raptor +/– and  mtor +/– Raptor +/– heterozygotes. The authors believe that suppression 
mTORC1 signaling is sufficient for life span prolongation independent of changes in 
glucose homeostasis. 
 Calorie restriction (CR) is the only known intervention in mammals that has been 
consistently shown to increase life span, reduce incidence and retard the onset of age-
related diseases, including cancer and diabetes. CR has also been shown to increase 
resistance to stress and toxicity, and maintain youthful levels of function and vitality 
in laboratory mammals at advanced chronological age  [7] . CR in rhesus monkeys have 
produced physiological responses strikingly similar to those observed in rodents and 
delayed the onset of age-related diseases, but effects on longevity were not consistent 
 [8] . Data from these studies indicate that long-term CR reduces morbidity and mortal-
ity in primates, and thus may exert beneficial ‘antiaging’ effects in humans. Although 
understanding the role of GH and IIS in the control of human aging is incomplete and 
somewhat controversial, available data indicate that dietary prevention of excessive 
IGF-1 and insulin secretion and using diet and exercise to enhance insulin sensitivity 
may represent the most hopeful approaches to cancer prevention and to extending hu-
man health span and life span  [2–4] . Metformin, rapamycin, and some other com-
pounds with mTOR- and IIS-inhibitory potential (resveratrol, melatonin) are able to 
modify both aging and carcinogenesis. This chapter focuses on the effects of bigua-
nides and rapamycin, whereas data on resveratrol and melatonin will be discussed 
elsewhere.
 Antidiabetic Biguanides as Geroprotectors 
 The concept of CR mimetics is now being intensively explored  [3] . The antidiabetic 
biguanides, phenformin, buformin and metformin were observed to reduce hyper-
glycemia, improve glucose utilization, reduce free fatty acid utilization, gluconeo-
genesis, serum lipids, insulin, and IGF-1, reduce body weight and decrease meta-
bolic immunodepression both in humans and rodents  [3] . The results of studies on 
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the effect of antidiabetic biguanides on the life span in mice and rats are summarized 
in  table 2 . 
 The treatment with phenformin prolonged the mean life span of female C3H/Sn 
mice by 21% (p < 0.05) and the maximum life span by 26% in comparison with the 
controls  [9] . At the time of death of the last mice in the control group, 42% of phen-
formin-treated mice were alive. The treatment with phenformin failed to influence 
the mean life span of female LIO rats; however, it increased the maximum life span by 
3 months (10%) in comparison with the controls  [9] . The treatment with phenformin 
slightly decreased the body weight of rats and delayed age-related switching off of es-
trous function. Similar findings were observed in female rats exposed to another bi-
Table 2.  Summary on effects of biguanides and rapamycin on life span and spontaneous carcino-
genesis in rodents
Strain, species Sex C/T mice Age at start 
of treatment,
months
Drug Dose and route
of treatment
Effect on
mean life
span, %
Effect on
carcinogenesis
Ref.
Biguanides
C3H/Sn mice F 30/24 3.5 PF 2 mg/mouse, p.o. +21 ↓ [9]
HER-2/neu mice F 34/32 2 MF 100 mg/kg, p.o. +8 ↓ [10]
HER-2/neu mice F 31/35 2 MF “ +4 ↓ [11]
SHR mice F 50/50 3 MF “ +38 = [12]
SHR mice F 119/51 3 MF “ +14 = [13]
97/45 9 MF “ +6 =
69/33 15 MF “ 0 =
129/Sv mice M 41/46 3 MF “ –13 = [14]
129/Sv mice F 47/41 3 MF “ +5 ↓
С57BL/6 M 64/83 12 MF 0.1% in diet +5.83 = [17]
M 90/88 12 MF 1% in diet –14.4 ↓
B6C3F1 M 297/36 12 MF 0.1% in diet +5.83 =
LIO rats F 41/44 3.5 PF 5 mg/rat, p.o. 0 ↓ [9]
LIO rats F 74/42 3.5 BF “ +7 ↓
F344 rats M 31/40 6 MF 300 mg/kg, food 0 ND [16]
Rapamycin
UM-HET3 mice M 357/134 20 Rap 14 mg/kg, food +9 = [18]
UM-HET3 mice F 289/144 20 Rap “ +14 =
UM-HET3 mice M 50/50 9 Rap “ +10 = [19]
UM-HET3 mice F 50/50 9 Rap “ +18 =
HER-2/9eu mice F 28/30 2 Rap 1.5 mg/kg, s.c. +4 ↓ [20]
129/Sv mice F 31/35 2 Rap “ +4 ↓ [21]
p53+/– mice M 38/37 >5 Rap 1.5 mg/kg, d.w. +10 ↓ [22]
p53–/– mice M 17/21 2 RapT 0.5 mg/kg, p.o. +30 ↓ [23]
Rb1+/– mice M 97/98 2–3 Rap 14 mg/kg, p.o. +14 ↓ [24]
F 2–3 +9 ↓
 C/T = Control/treatment; BF = buformin; MF = metformin; PH = phenformin; Rap = rapamycin; RapT = Rapa-
tar; d.s. = with drinking water; s.c. = subcutaneously; p.o. = gavage; food = with diet; ↑ = increases; ↓ = decreas-
es; = = no effect; ND = not detected.
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guanide, buformin  [9] . Administration of metformin to female transgenic HER-2/
neu mice did not change the body weight or temperature; it slowed down the age-
related rise in blood glucose and triglyceride levels, decreased the serum level of cho-
lesterol and β-lipoproteins, delayed the age-related irregularity in estrous cycle, ex-
tended the mean life span by 4–8% and the maximum life span by 1 month in com-
parison with the control animals  [10, 11] . It is well known that excess of body weight 
and obesity leads to development of metabolic syndrome, type 2 diabetes, premature 
switching off of reproductive function and risk of cancer  [2, 9] . The mechanism be-
hind the geroprotective effect of metformin could reside in its ability to lower body 
weight.
 Metformin increased the mean life span of the last 10% of survivors by 20.8% and 
the maximum life span by 2.8 months (10.3%) in female SHR mice in comparison 
with control mice  [12] . The decreased body temperature and postponed age-related 
switching off of estrous function were observed in the group of metformin-treated 
mice. In another set of experiments, female SHR mice were given metformin from the 
age of 3, 9 or 15 months  [13] . Metformin started at the age of 3 months increased the 
mean life span by 14% and maximum life span by 1 month, whereas the treatment 
started at the age of 9 months by 6%; metformin started at the age of 15 months did 
not affect life span.
 The treatment with metformin slightly modified the food consumption but failed 
to influence the dynamics of body weight. Metformin decreased by 13.4% the mean 
life span of male 129/Sv mice and slightly increased the mean life span of females (by 
4.4%). Metformin failed to influence spontaneous tumor incidence in male 129/Sv 
mice, decreased 3.5-fold the incidence of malignant neoplasms in female mice, while 
somewhat stimulated formation of benign vascular tumors  [14] .
 Significant prolongation (by 20.1%) of the survival time was observed in male (but 
not female) transgenic mice with Huntington’s disease without affecting fasting blood 
glucose levels. Increasing the dose of the drug did not improve the survival of mice 
 [15] . In the NIA study  [16] , 6-month-old male F344 rats were randomized to one of 
four diets: control, CR, diet supplemented with metformin and standard diet pair fed 
to metformin. There were no significant differences in the mean life span of the last 
surviving 10% of each group in the CR, metformin-treated and pair fed rats as com-
pared with control  [16] . CR significantly increased life span in the 25th quantile but 
not the 50th, 75th, or 90th quantile. The groups of rats exposed to metformin or pair 
feeding were not significantly different from controls at any quantile. The reduced ef-
ficacy of CR in this study might provide a partial explanation for the lack of an in-
crease in life span with metformin.
 Male C57BL/6 mice were given ad libitum diet with supplementation of 0.1 or 1% 
of metformin starting from the age of 12 months until natural death  [17] . The mean 
life span of mice given 0.1% metformin in the diet was increased by 5.83% as com-
pared with the relevant control mice. The 1% dose was toxic and reduced the mean 
life span by 14.4%. Diet supplementation with 0.1% metformin increased life span by 
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4.15% in male B6C3F1 mice. There were no significant differences in pathologies ob-
served in both strains of mice fed diet with 0.1% metformin. However, diet with 1% 
metformin reduced the incidence of liver cancers (3.3% in the metformin group vs. 
26.5% in control group, p < 0.001). Male C57BL/6 mice given metformin had de-
creased rates of cataracts  [17] . The treatment with metformin mimics some of the 
benefits of CR, such as improved physical performance, improved glucose-tolerance 
test, increased insulin sensitivity, and reduced low-density lipoprotein and choles-
terol levels without a decrease in caloric intake. Metformin also increased AMP-acti-
vated protein kinase activity and increased antioxidant protection, resulting in reduc-
tions in both oxidative damage accumulation and chronic inflammation  [17] . The 
administration of metformin to mice induced CR-like genomic and metabolic re-
sponses which were interpreted as induction of pathways associated with longevity.
 Thus, available data showed that antidiabetic drugs can increase survival of rodents 
in some cases ( table 2 ). This effect varied depending on the strain and species of ani-
mals. Female mice were treated in the majority of these studies. Due to gender differ-
ences in the effect of metformin  [3] , the experiments with males of different strains 
need to be performed to draw a conclusion regarding the geroprotective potential of 
antidiabetic biguanides. Only single studies were performed with female rats treated 
with buformin or phenformin and with male rats treated with metformin. Both male 
and female animals of different strains need to be treated in the same study for a more 
exact conclusion on the geroprotective potential of antidiabetic biguanides.
 Routes of administration and doses of metformin were different in the majority of 
experiments discussed here. The NIA (National Institute of Aging, NIH USA) team 
used diet supplementation with 0.1 or 1% metformin in male C57BL/6 mice and a 
diet with 0.1% metformin in male B6C3F1 mice  [17] , whereas the PRIO (Petrov Re-
search Institute of Oncology, St. Petersburg, Russia) team administered metformin 
with drinking water at a dose of 100 mg/kg to female HER-2/neu mice in two inde-
pendent studies, to outbreed female Swiss-derived SHR mice also in two sets of ex-
periments, and in male and female inbred 129/Sv mice in one study  [10–14] ( table 2 ). 
Calculations show that C57BL/6 mice consuming the diet with 0.1% metformin re-
ceived the drug at a dose ranging from 75 to 100 mg/kg body weight, and B6C3F1 
mice at a dose between 67 and 90 mg/kg. They are practically the same doses given 
with drinking water in our studies. The biggest dose of metformin given to C57BL/6 
mice (1% in diet) reduced their mean life span by 14.4%, and at first seems toxic for 
the kidney as it induces its enlargement, lumpiness and decoloration  [17] . The NIA 
team started the treatment with metformin at the age of 12 months, whereas the 
PRIO team started the treatment at the age of 2–3.5 months in the majority of ex-
periments. When metformin was given to female SHR mice staring at the age of 3, 9 
or 15 months, an attenuation of the effect on life span with the increase in the age at 
start was observed  [13] .
 On the whole, the data in the literature and the results of our experiments suggest 
that antidiabetic biguanides are promising interventions for slowing down aging and 
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life span extension. Additional studies are required to provide more information on 
the optimal doses, appropriate age intervals, and other conditions under which expo-
sure to metformin could prevent premature aging in humans.
 Effects of Rapamycin on Aging and Longevity 
 In the National Institute on Aging Intervention Testing Program, male and female 
genetically heterogeneous mice (UM_HET3) aged 600 days were fed with encapsu-
lated rapamycin in diet  [18] . On the basis of age at 90% mortality, rapamycin led to 
an increase in the mean life span by 14% for females and 9% for males. The authors 
claimed that disease patterns of rapamycin-treated mice did not differ from those of 
control mice. It was stressed that rapamycin may extend life span by postponing death 
from cancer, by retarding aging, or both. However, only a small part of mice was re-
ally studied pathomorphologically. In the same paper, similar results of the treatment 
with rapamycin started at the age of 270 days have been reported. In another set of 
experiments, rapamycin was given with food (14 mg/kg food; 2.24 mg/kg mouse 
weight per day) to UM_HET3 mice from the age of 9 months  [19] . The mean life span 
was increased by 10% in males and 18% in females. For male mice, 3% of the control 
and 24% of the rapamycin-treated animals were alive at the age of 90% mortality. 
Practically the same survival rate was in females. The causes of death were similar in 
control and rapamycin-treated mice. 
 In our study  [20] , fifty-eight 2-month-old female FVB/N transgenic HER-2/neu 
mice were randomly divided into two groups. The first group of animals received 1.5 
mg/kg rapamycin subcutaneously (s.c.) 3 times a week for a period of 2 weeks followed 
by 2-week intervals. In the second group, mice received solvent without rapamycin 
and served as controls. Treatment with rapamycin significantly inhibited age-related 
body weight gain. While control mice constantly gained weight during their life span, 
mice that received rapamycin demonstrated a very modest weight increase. Most im-
portantly, in the control group, only 4 mice survived until the age of 11 months 
(14.3%) compared to 13 (43.3%) in the rapamycin-treated group (p < 0.001). Rapamy-
cin treatment slightly increased the mean (+4.1%) and maximal life span (+12.4%). 
The mean life span of long-living animals (last 10% of survivors) was significantly 
greater in the group receiving rapamycin (+11%) compared to control. Parameter α 
of the Gompertz model, which is interpreted as the rate of demographic aging, was 
1.8 times lower in the group subjected to rapamycin treatment than in control. A half 
of control mice develop mammary adenocarcinomas (MAC) by day 206, whereas in 
rapamycin-treated group, this period was extended to 240 days. Remarkably, rapamy-
cin decreased the mean number of tumors per tumor-bearing mouse by 33.7% and 
the mean size of MAC by 23.5%.
 In another our study, 66 female 129/Sv mice at the age of 2 months were randomly 
divided into two groups. The first group of animals received rapamycin as HER-2/neu 
Yashin AI, Jazwinski SM (eds): Aging and Health – A Systems Biology Perspective.
Interdiscipl Top Gerontol. Basel, Karger, 2015, vol 40, pp 177–188 ( DOI: 10.1159/000364982 )
 GH/IGF-1 and mTOR Signaling in Aging Prevention 185
mice, and the second group served as controls. Treatment with rapamycin significant-
ly inhibited age-related weight gain in female mice  [21] . While control mice constant-
ly gained weight during their life span, mice that received rapamycin demonstrated a 
very modest weight increase. As a result, from the 5th to the 23rd month, body weight 
was increased by 21.9% and 12.4% in the control and rapamycin-treated groups, re-
spectively. The body weight in the rapamycin-treated animals was significantly less 
compared with the control between the age of 20 and 27 months. Rapamycin slightly 
affected food consumption in young mice and decreased food consumption by 23% in 
old mice. There was no significant difference in age-related dynamics of the length of 
the estrous cycle and in the ratio between the estrous cycle phases in the control and 
rapamycin-treated groups. However, at the age of 18 months, 46 and 65% of mice had 
a regular estrous cycle in the control and rapamycin-treated groups, respectively. Most 
importantly, 35.5% of control mice survived until the age of 800 days compared to 
54.3% in the rapamycin-treated group, whereas until the age of 900 days – 9.7 and 
31.4%, respectively (p < 0.01). Twenty-tree percent of female mice exposed to rapamy-
cin survived the age at death of the last mouse in the control group. Rapamycin sig-
nificantly decreased the incidence of spontaneous tumors in these mice as well.
 In the study of Komarova et al.  [22] , rapamycin was given in drinking water to 35 
male mice heterozygous for a germline p53 null allele ( p53 +/– ) beginning at various 
ages. Thirty-eight intact mice served as controls. The mean life span of animals in the 
control group was 373 days, whereas in rapamycin-treated mice 410 days. Spontane-
ous carcinogenesis was significantly delayed in rapamycin-treated mice compared to 
control mice. Then, during analysis of the results, all mice were subdivided into two 
groups: ‘young’ (receiving rapamycin from the age of 5 months or earlier) and ‘old’ 
(receiving rapamycin starting at 5 months of age or older). The mean life span in ra-
pamycin-treated ‘young’ mice reached 480 days, a 3.5-month increase over the con-
trol group. Thus, the life-extending effect of rapamycin is more pronounced in the 
group exposed to the treatment earlier in life.
 Nanoformulated micelles of rapamycin, Rapatar, were given as gavage to p53 null 
 (p53 –/– ) male mice  [23] . The treatment with Rapatar extended the mean life span by 
30% and delayed tumor development in highly tumor-prone  p53 –/– mice. Mean tu-
mor latencies for the control  p53 –/– and Rapatar-treated  p53 –/– mice were 161 and 261 
days, respectively.
 Beginning at 9 weeks of age until natural death,  Rb1 +/– (B6.129S2(Cg)-Rb1 tm1Tyj ) 
and  Rb1 +/+ mice were fed a diet without or with enterically released formulation of 
rapamycin  [24] . The mean life span of rapamycin-treated female  Rb1 +/– mice was in-
creased by 8.9% and by 13.8% in males as compared with the sex-matched controls. 
Once all  Rb1 +/–  mice had died, the  Rb1 +/+ littermates were euthanized. Approximate-
ly 85% of rapamycin-treated versus 50% of controls survived this age in females, 
whereas 60 versus 25%, respectively, in males. Thus, the life span was extended more 
in female than in male wild-type littermates. Exposure to rapamycin was followed by 
inhibition of C-cell thyroid carcinomas in Rb1 +/– mice.
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 Conclusion 
 Data on physiological and molecular mechanisms of the beneficial effects of bigu-
anides and rapamycin on life span and inhibitory tumorigenesis have been dis-
cussed in several recent papers  [3, 10, 17, 22] and are summarized in  table 1 . The 
effects of biguanides and rapamycin are presented in accordance with their levels 
of integration: molecular, cellular/tissue and systemic/organismal. There is a sig-
nificant similarity in the majority of effects of these two groups of drugs and in the 
main patterns of their activities as antiaging and anticarcinogenic remedies. It 
means that the key targets as well as signaling pathways and regulatory signals are 
also similar. Moreover, there is also sufficient similarity in patterns of changes ob-
served during normal aging and in the process of carcinogenesis. DNA damage re-
sponse signaling seems to be a key mechanism in the establishment and mainte-
nance of senescence as well as carcinogenesis. Some aspects of the problem have 
been discussed elsewhere  [2] . The available data on cellular senescence in vitro and 
on accumulation of various human pre-malignant lesions in the cells in vivo pro-
vide evidence suggesting that senescence is an effective natural cancer-suppressing 
mechanism  [25] . At the same time, adequate clinical application of therapy-in-
duced ‘accelerated senescence’ for prevention, progression, or recurrence of human 
cancers is still insufficiently understood. The mechanisms underlying the bypass of 
senescence response in the progression of tumors still have to be discovered. Recent 
studies reveal a negative side of cellular senescence, which is associated with the 
secreted inflammatory factors, and may alter the microenvironment in favor of 
cancer progression designated as syndrome of cancerophilia  [26] or senescence-
associated secretory phenotype (SASP)  [4] . Thus, cellular senescence suppresses the 
initiation stage of carcinogenesis, but is the promoter for initiated cells. We believe 
that the similarity between two fundamental processes – aging and carcinogenesis – 
is a basis for understanding the two-side effects of biguanides and rapamycin 
( fig. 1 ). The reasons for the difference in response to metformin and rapamycin in 
different strains of mice are not well understood. Recent findings provide evidence 
for inhibitory effects of metformin and rapamycin on the SASP interfering with 
IKK-β/NF-κB  [4, 26] – an important step in the hypothalamic programming of sys-
temic aging  [27] and in carcinogenesis  [2] . It remains to be shown whether anti-
diabetic biguanides and rapamycin can extend life span in humans. 
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